<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"><channel rdf:about="http://onlinelibrary.wiley.com/rss/journal/10.1111/(ISSN)1600-0412" xmlns="http://purl.org/rss/1.0/"><title>Acta Obstetricia et Gynecologica Scandinavica</title><description> Wiley Online Library : Acta Obstetricia et Gynecologica Scandinavica</description><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2F%28ISSN%291600-0412</link><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc</dc:publisher><dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">en</dc:language><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">© Nordic Federation of Societies of Obstetrics and Gynecology. Published by John Wiley &amp; Sons Ltd</dc:rights><prism:issn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">0001-6349</prism:issn><prism:eIssn xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">1600-0412</prism:eIssn><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-06-01T00:00:00-05:00</dc:date><prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">June 2013</prism:coverDisplayDate><prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">92</prism:volume><prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">6</prism:number><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">611</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">735</prism:endingPage><image rdf:resource="http://onlinelibrary.wiley.com/store/10.1111/aogs.2013.92.issue-6/asset/cover.gif?v=1&amp;s=ed132c2a3c97a85b5d2f4024e095724551d80e60"/><items><rdf:Seq><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12184"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12183"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12182"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12180"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12179"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12178"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12177"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12175"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12174"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12173"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12172"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12171"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12170"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12169"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12168"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12167"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12166"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12165"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12164"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12163"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12162"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12161"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12160"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12159"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12158"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12156"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12154"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12148"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12157"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12152"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12155"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12147"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12150"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12145"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12149"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12144"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12151"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12146"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12098"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12143"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12132"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12141"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12142"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12140"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12136"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12133"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12095"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12129"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12137"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12131"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12114"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12115"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12116"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12104"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12096"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12062"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12153"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12091"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1600-0412.2012.01473.x"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12111"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12097"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12124"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12070"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12090"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12092"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12059"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12128"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12138"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12107"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12134"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12119"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12135"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12127"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12120"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12088"/><rdf:li rdf:resource="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1600-0412.2012.01513.x"/></rdf:Seq></items></channel><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12184" xmlns="http://purl.org/rss/1.0/"><title>Nerve stimulation for chronic pelvic pain and bladder pain syndrome: a systematic review</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12184</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Nerve stimulation for chronic pelvic pain and bladder pain syndrome: a systematic review</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Seema A Tirlapur, Antonis Vlismas, Elizabeth Ball, Khalid S Khan</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-24T07:38:08.502351-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12184</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12184</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12184</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Review Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12184-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Background</h4><div class="para"><p>Chronic pelvic pain (CPP) and bladder pain syndrome (BPS) can have a negative impact on quality of life. Neuromodulation has been suggested as a possible treatment for refractory pain.</p></div></div>
<div class="section" id="aogs12184-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Objectives</h4><div class="para"><p>To assess the effectiveness of tibial and sacral nerve stimulation in the treatment of BPS and CPP.</p></div></div>
<div class="section" id="aogs12184-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Data sources</h4><div class="para"><p>We searched until July 2012: The Cochrane Library, EMBASE (1980-2012), Medline (1950-2012), Web of knowledge (1900-2012), LILACS (1982-2012) and SIGLE (1990-2012) with no language restrictions. We manually searched through bibliographies and conference proceedings of the International Continence Society.</p></div></div>
<div class="section" id="aogs12184-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Study selection</h4><div class="para"><p>Randomized and prospective quasi-randomized controlled studies versus sham nerve stimulation treatment or usual care of patients with CPP and BPS who underwent sacral or tibial nerve stimulation were included. Any studies involving transcutaneous stimulation were excluded. The outcome was a cure or improvement in symptoms.</p></div></div>
<div class="section" id="aogs12184-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Three studies with 169 patients treated with tibial nerve stimulation were included; two for CPP and one for BPS. There were improvements in pain, urinary and quality of life scores. There was no reported data for sacral nerve stimulation.</p></div></div>
<div class="section" id="aogs12184-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>There is scanty literature reporting variable success of posterior tibial nerve stimulation in improving pain, urinary symptoms and quality of life in CPP and BPS. In view of the dearth of quality literature, a large multi-centered clinical trial investigating the effectiveness of electrical nerve stimulation to treat BPS and CPP along with the cost-analysis of this treatment is recommended.</p></div><div class="para"><p>This article is protected by copyright. All rights reserved.</p></div></div>
]]></content:encoded><description>


Background
Chronic pelvic pain (CPP) and bladder pain syndrome (BPS) can have a negative impact on quality of life. Neuromodulation has been suggested as a possible treatment for refractory pain.


Objectives
To assess the effectiveness of tibial and sacral nerve stimulation in the treatment of BPS and CPP.


Data sources
We searched until July 2012: The Cochrane Library, EMBASE (1980-2012), Medline (1950-2012), Web of knowledge (1900-2012), LILACS (1982-2012) and SIGLE (1990-2012) with no language restrictions. We manually searched through bibliographies and conference proceedings of the International Continence Society.


Study selection
Randomized and prospective quasi-randomized controlled studies versus sham nerve stimulation treatment or usual care of patients with CPP and BPS who underwent sacral or tibial nerve stimulation were included. Any studies involving transcutaneous stimulation were excluded. The outcome was a cure or improvement in symptoms.


Results
Three studies with 169 patients treated with tibial nerve stimulation were included; two for CPP and one for BPS. There were improvements in pain, urinary and quality of life scores. There was no reported data for sacral nerve stimulation.


Conclusion
There is scanty literature reporting variable success of posterior tibial nerve stimulation in improving pain, urinary symptoms and quality of life in CPP and BPS. In view of the dearth of quality literature, a large multi-centered clinical trial investigating the effectiveness of electrical nerve stimulation to treat BPS and CPP along with the cost-analysis of this treatment is recommended.
This article is protected by copyright. All rights reserved.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12183" xmlns="http://purl.org/rss/1.0/"><title>Breech delivery – what influences on the mother's choice?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12183</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Breech delivery – what influences on the mother's choice?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Anette H. Glasø, Isa Mari Sandstad, Eszter Vanky</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-24T07:38:07.226106-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12183</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12183</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12183</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12183-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To investigate factors influencing the mother's choice of delivery mode when vaginal breech delivery is considered possible and safe.</p></div></div>
<div class="section" id="aogs12183-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Retrospective study.</p></div></div>
<div class="section" id="aogs12183-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>University Hospital.</p></div></div>
<div class="section" id="aogs12183-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>Singleton, term pregnancies with breech presentation were included, n=390.</p></div></div>
<div class="section" id="aogs12183-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Information was collected from patient records from January 2006 to December 2010. A questionnaire was sent to those 293 women in whom vaginal breech delivery was considered possible and safe.</p></div></div>
<div class="section" id="aogs12183-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Patient characteristics by choice of delivery mode.</p></div></div>
<div class="section" id="aogs12183-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Women who were selected for vaginal breech delivery (n = 187) were younger, more often nulliparous and gave birth to smaller babies. Women who requested a cesarean section (n = 112) became more worried when the breech presentation was diagnosed. They had a more negative initial view on breech presentation, took more often additional advice from non-professionals and trusted them more. Women who requested cesarean section reported a positive birth experience more frequently than women who were selected for vaginal delivery, whether ending as vaginal or emergency cesarean delivery. Women in both groups searched web-based information about breech delivery. We found no differences between the sources of information used.</p></div></div>
<div class="section" id="aogs12183-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Younger, nulliparous women with smaller babies trusted and listened more to professional advice and were more prone to choose vaginal delivery. Women who requested a cesarean section were more worried and had a more negative initial view on breech presentation. Both groups sought web-based information equally.</p></div><div class="para"><p>This article is protected by copyright. All rights reserved.</p></div></div>
]]></content:encoded><description>


Objective
To investigate factors influencing the mother's choice of delivery mode when vaginal breech delivery is considered possible and safe.


Design
Retrospective study.


Setting
University Hospital.


Population
Singleton, term pregnancies with breech presentation were included, n=390.


Methods
Information was collected from patient records from January 2006 to December 2010. A questionnaire was sent to those 293 women in whom vaginal breech delivery was considered possible and safe.


Main outcome measures
Patient characteristics by choice of delivery mode.


Results
Women who were selected for vaginal breech delivery (n = 187) were younger, more often nulliparous and gave birth to smaller babies. Women who requested a cesarean section (n = 112) became more worried when the breech presentation was diagnosed. They had a more negative initial view on breech presentation, took more often additional advice from non-professionals and trusted them more. Women who requested cesarean section reported a positive birth experience more frequently than women who were selected for vaginal delivery, whether ending as vaginal or emergency cesarean delivery. Women in both groups searched web-based information about breech delivery. We found no differences between the sources of information used.


Conclusions
Younger, nulliparous women with smaller babies trusted and listened more to professional advice and were more prone to choose vaginal delivery. Women who requested a cesarean section were more worried and had a more negative initial view on breech presentation. Both groups sought web-based information equally.
This article is protected by copyright. All rights reserved.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12182" xmlns="http://purl.org/rss/1.0/"><title>Successful management of aortic dissection in a patient with Marfan syndrome with total placenta previa</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12182</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Successful management of aortic dissection in a patient with Marfan syndrome with total placenta previa</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tae-Hee Kim, Hae-Hyeog Lee, Jun-Mo Kim, Keun Her</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-24T07:38:05.053954-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12182</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12182</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12182</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>Postpartum hemorrhage presents a difficult situation for obstetricians, and several methods have been developed to reduce mortality and morbidity. We recently read the review of uterine compression sutures for postpartum hemorrhage in this journal, which suggested that compression sutures offer improved hemostasis and preserve future fertility (1). Placenta previa can cause postpartum hemorrhage, and we here report successful management of aortic dissection in a patient with Marfan syndrome with total placenta previa.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This article is protected by copyright. All rights reserved.</p></div>
]]></content:encoded><description>
Postpartum hemorrhage presents a difficult situation for obstetricians, and several methods have been developed to reduce mortality and morbidity. We recently read the review of uterine compression sutures for postpartum hemorrhage in this journal, which suggested that compression sutures offer improved hemostasis and preserve future fertility (1). Placenta previa can cause postpartum hemorrhage, and we here report successful management of aortic dissection in a patient with Marfan syndrome with total placenta previa.
This article is protected by copyright. All rights reserved.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12180" xmlns="http://purl.org/rss/1.0/"><title>Admission CTG: What are the consequences of the current evidence?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12180</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Admission CTG: What are the consequences of the current evidence?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ellen Blix</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-19T23:04:45.788065-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12180</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12180</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12180</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>I thank Drs. Kessler and Yli for their comments where they ask if there is sufficient evidence to conclude anything about the admission CTG. There is sufficient evidence to state that the reliability and predictive values are poor, and that the test causes an increase in minor interventions, - at least in the settings the test has been evaluated (1-3). The test was introduced as a screening test and was evaluated as such</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This article is protected by copyright. All rights reserved.</p></div>
]]></content:encoded><description>
I thank Drs. Kessler and Yli for their comments where they ask if there is sufficient evidence to conclude anything about the admission CTG. There is sufficient evidence to state that the reliability and predictive values are poor, and that the test causes an increase in minor interventions, - at least in the settings the test has been evaluated (1-3). The test was introduced as a screening test and was evaluated as such
This article is protected by copyright. All rights reserved.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12179" xmlns="http://purl.org/rss/1.0/"><title>Transabdominal fetal ECG technique: Reply to Fuchs et al</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12179</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Transabdominal fetal ECG technique: Reply to Fuchs et al</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Wayne R. Cohen, Barrie Hayes-Gill</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-19T23:04:36.470565-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12179</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12179</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12179</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to  the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>We thank Dr. Fuchs and his colleagues for their comments about our study (1). They ask how frequently the FHR tracing from the abdominal fetal ECG technique (afECG) was of sufficient quality to be used clinically. Our study was not designed to answer that specific question, but we can draw some helpful inferences from our data. The study cases were not selected, i.e., they included all of the 75 fetuses monitored simultaneously with a scalp electrode, Doppler ultrasound, and afECG regardless of the tracing's quality.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This article is protected by copyright. All rights reserved.</p></div>
]]></content:encoded><description>
We thank Dr. Fuchs and his colleagues for their comments about our study (1). They ask how frequently the FHR tracing from the abdominal fetal ECG technique (afECG) was of sufficient quality to be used clinically. Our study was not designed to answer that specific question, but we can draw some helpful inferences from our data. The study cases were not selected, i.e., they included all of the 75 fetuses monitored simultaneously with a scalp electrode, Doppler ultrasound, and afECG regardless of the tracing's quality.
This article is protected by copyright. All rights reserved.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12178" xmlns="http://purl.org/rss/1.0/"><title>Women with anorexia nervosa should not be treated with estrogen or birth control pills in a bone sparing effect</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12178</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Women with anorexia nervosa should not be treated with estrogen or birth control pills in a bone sparing effect</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ingrid Bergstrom, Milita Crisby, Anne-May Engstrom, Mats Hölcke, Monika Fored, Pia Jakobsson Kruse, Ann-Marie of Sand berg</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-19T23:04:33.123154-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12178</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12178</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12178</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Commentary</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Eating disorders is a prevalent, serious condition that affects, mainly young women. An early and enduring sign of anorexia is amenorrhea. There is no evidence for benefits of hormone therapy in patients with anorexia, however, hormone medication and oral contraceptives are frequently prescribed for young women with anorexia as a prevention against and treatment for low bone mineral density. The use of estrogens may create a false picture indicating that the skeleton is being protected against osteoporosis. Thus the motivation to regain weight, and adhere to treatment of the eating disorder in itself, may be reduced. The most important intervention is to restore the menstrual periods through increased nutrition. Hormone and oral contraceptive therapy should not be prescribed to young women with amenorrhea and concurrent eating disorders.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This article is protected by copyright. All rights reserved.</p></div>
]]></content:encoded><description>

Eating disorders is a prevalent, serious condition that affects, mainly young women. An early and enduring sign of anorexia is amenorrhea. There is no evidence for benefits of hormone therapy in patients with anorexia, however, hormone medication and oral contraceptives are frequently prescribed for young women with anorexia as a prevention against and treatment for low bone mineral density. The use of estrogens may create a false picture indicating that the skeleton is being protected against osteoporosis. Thus the motivation to regain weight, and adhere to treatment of the eating disorder in itself, may be reduced. The most important intervention is to restore the menstrual periods through increased nutrition. Hormone and oral contraceptive therapy should not be prescribed to young women with amenorrhea and concurrent eating disorders.
This article is protected by copyright. All rights reserved.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12177" xmlns="http://purl.org/rss/1.0/"><title>Diagnostic reliability of Speculum Exam</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12177</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Diagnostic reliability of Speculum Exam</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Susan Peirce, Alistair Ray, Grace Carolan-Rees</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-19T23:04:31.930768-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12177</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12177</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12177</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>In 1997 Ladfors <em>et al</em>. (1) published a study in which they assessed the diagnostic accuracy of sterile speculum examination for the diagnosis of rupture of the membranes (ROM) in pregnancy. The authors reported a 12% false negative rate which has been quoted in several recent articles (2-4). As part of our work for National Institute for Health and Care Excellence (NICE)'s Medical Technology Evaluation Programme (<!--TODO: clickthrough URL--><a href="http://www.nice.org.uk/mt" title="Link to external resource: http://www.nice.org.uk/mt">www.nice.org.uk/mt</a>) we have reviewed the data in the original publication and concluded that this rate has been interpreted inappropriately.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This article is protected by copyright. All rights reserved.</p></div>
]]></content:encoded><description>
In 1997 Ladfors et al. (1) published a study in which they assessed the diagnostic accuracy of sterile speculum examination for the diagnosis of rupture of the membranes (ROM) in pregnancy. The authors reported a 12% false negative rate which has been quoted in several recent articles (2-4). As part of our work for National Institute for Health and Care Excellence (NICE)'s Medical Technology Evaluation Programme (www.nice.org.uk/mt) we have reviewed the data in the original publication and concluded that this rate has been interpreted inappropriately.
This article is protected by copyright. All rights reserved.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12175" xmlns="http://purl.org/rss/1.0/"><title>Anxiety and depression following preeclampsia or HELLP syndrome. A systematic review</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12175</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Anxiety and depression following preeclampsia or HELLP syndrome. A systematic review</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Denise HJ Delahaije, Carmen D Dirksen, Louis L Peeters, Luc J Smits</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-16T02:50:46.763016-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12175</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12175</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12175</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Review Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12175-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Background</h4><div class="para"><p>Women who suffered from pregnancy complications are at increased risk for anxiety and depression.</p></div></div>
<div class="section" id="aogs12175-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To evaluate whether having suffered from preeclampsia or HELLP syndrome is associated with anxiety and depression, and whether preeclampsia/HELLP is an independent risk factor for developing anxiety and depression.</p></div></div>
<div class="section" id="aogs12175-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Search strategy</h4><div class="para"><p>Systematic search on PubMed and PsycInfo with no time limit.</p></div></div>
<div class="section" id="aogs12175-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Selection criteria</h4><div class="para"><p>Studies presenting original data, including women with a history of preeclampsia/HELLP and at least one comparison group of women without preeclampsia/HELLP, reporting the results for each group separately or in a multivariate regression analysis with preeclampsia/HELLP as an independent variable.</p></div></div>
<div class="section" id="aogs12175-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Data collection and analysis</h4><div class="para"><p>Study characteristics and outcomes were extracted using a prespecified form. If necessary, additional calculations were performed.</p></div></div>
<div class="section" id="aogs12175-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>The search yielded 267 articles, with only six being suitable for inclusion in this review. Studies on depression (6) showed generally positive associations between preeclampsia/HELLP and the prevalence of depression or severity of depressive symptoms. However, the results of three studies were not statistically significant. Studies addressing anxiety (2) did not show significant associations between preeclampsia/HELLP and anxiety scores. Associations between posttraumatic stress and preeclampsia/HELLP, investigated in four studies, were often non-significant. Due to heterogeneity of study methods, a meta-analysis of the results was not possible. In most studies, confounder control was poor.</p></div></div>
<div class="section" id="aogs12175-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Evidence is mixed but generally points to positive associations between various forms of psychopathology and previous preeclampsia/HELLP. Causality of the associations can, however, not be judged adequately.</p></div><div class="para"><p>This article is protected by copyright. All rights reserved.</p></div></div>
]]></content:encoded><description>


Background
Women who suffered from pregnancy complications are at increased risk for anxiety and depression.


Objective
To evaluate whether having suffered from preeclampsia or HELLP syndrome is associated with anxiety and depression, and whether preeclampsia/HELLP is an independent risk factor for developing anxiety and depression.


Search strategy
Systematic search on PubMed and PsycInfo with no time limit.


Selection criteria
Studies presenting original data, including women with a history of preeclampsia/HELLP and at least one comparison group of women without preeclampsia/HELLP, reporting the results for each group separately or in a multivariate regression analysis with preeclampsia/HELLP as an independent variable.


Data collection and analysis
Study characteristics and outcomes were extracted using a prespecified form. If necessary, additional calculations were performed.


Results
The search yielded 267 articles, with only six being suitable for inclusion in this review. Studies on depression (6) showed generally positive associations between preeclampsia/HELLP and the prevalence of depression or severity of depressive symptoms. However, the results of three studies were not statistically significant. Studies addressing anxiety (2) did not show significant associations between preeclampsia/HELLP and anxiety scores. Associations between posttraumatic stress and preeclampsia/HELLP, investigated in four studies, were often non-significant. Due to heterogeneity of study methods, a meta-analysis of the results was not possible. In most studies, confounder control was poor.


Conclusions
Evidence is mixed but generally points to positive associations between various forms of psychopathology and previous preeclampsia/HELLP. Causality of the associations can, however, not be judged adequately.
This article is protected by copyright. All rights reserved.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12174" xmlns="http://purl.org/rss/1.0/"><title>Pregnancy outcomes in a cohort of women with a preconception BMI &gt; 50 kg/m2</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12174</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Pregnancy outcomes in a cohort of women with a preconception BMI &gt; 50 kg/m2</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Barbara Bonnesen, Niels J Secher, Lars K Møller, Steen Rasmussen, Kirsten R Andreasen, Kristina Renault</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-16T02:50:41.995639-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12174</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12174</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12174</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Research Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>We describe characteristics and risk factors regarding pregnancy outcome in women with a preconception body mass index (BMI) &gt;50 kg/m<sup>2</sup> compared to women with BMI≤50 kg/m<sup>2</sup> in a retrospective population cohort study in singleton pregnancies from the Danish Medical Birth Registry. Results were analyzed as relative risks by a <b>two-proportion z-test</b>. Women with preconception BMI&gt;50 kg/m<sup>2</sup> smoked, developed gestational diabetes and preeclampsia, and needed induction of labor more frequently than mothers with BMI≤50kg/m<sup>2</sup>. Examination of the case records showed that many attempted vaginal delivery without epidural analgesia, 21% needed an emergency cesarean section (compared to 12% among women with BMI≤50kg/m<sup>2</sup>), and 25% underwent general anesthesia in this context. Many neonates were macrosomic and 34% needed neonatal intensive care and early feeding compared to 6% of neonates from women with BMI≤50kg/m<sup>2</sup>. Women with an extremely high preconception BMI develop more pregnancy complications and their neonates appear affected by this as well.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This article is protected by copyright. All rights reserved.</p></div>
]]></content:encoded><description>

We describe characteristics and risk factors regarding pregnancy outcome in women with a preconception body mass index (BMI) &gt;50 kg/m2 compared to women with BMI≤50 kg/m2 in a retrospective population cohort study in singleton pregnancies from the Danish Medical Birth Registry. Results were analyzed as relative risks by a two-proportion z-test. Women with preconception BMI&gt;50 kg/m2 smoked, developed gestational diabetes and preeclampsia, and needed induction of labor more frequently than mothers with BMI≤50kg/m2. Examination of the case records showed that many attempted vaginal delivery without epidural analgesia, 21% needed an emergency cesarean section (compared to 12% among women with BMI≤50kg/m2), and 25% underwent general anesthesia in this context. Many neonates were macrosomic and 34% needed neonatal intensive care and early feeding compared to 6% of neonates from women with BMI≤50kg/m2. Women with an extremely high preconception BMI develop more pregnancy complications and their neonates appear affected by this as well.
This article is protected by copyright. All rights reserved.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12173" xmlns="http://purl.org/rss/1.0/"><title>Is home based pelvic floor muscle training effective in treatment of urinary incontinence after birth in primiparous women? A randomized controlled trial Pelvic floor muscle training in urinary incontinence</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12173</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Is home based pelvic floor muscle training effective in treatment of urinary incontinence after birth in primiparous women? A randomized controlled trial Pelvic floor muscle training in urinary incontinence</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Susanne Åhlund, Birgitta Nordgren, Eva-Lotta Wilander, Ingela Wiklund, Cecilia Fridén</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-14T09:36:03.016599-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12173</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12173</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12173</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12173-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To assess the effect of pelvic floor muscle training on pelvic floor muscle strength and urinary incontinence (UI) in primiparous women who underwent a home training program between three and nine months after delivery.</p></div></div>
<div class="section" id="aogs12173-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Randomized controlled trial</p></div></div>
<div class="section" id="aogs12173-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>One hundred primiparous women were consecutively recruited from four different antenatal clinics in the urban area of Stockholm, Sweden. Women with UI who had undergone normal term singleton vaginal delivery, 10-16 weeks post partum were randomly allocated to either intervention or control group.</p></div></div>
<div class="section" id="aogs12173-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Maximally voluntary contraction (MVC) and endurance were measured with a perionometer. The Oxford grading scale was used to manually estimate the strength of the pelvic floor muscle and self-reported symptoms of UI was registered through the Bristol Female Lower Urinary Tract Symptoms Module (ICIQ FLUTS) questionnaire.</p></div></div>
<div class="section" id="aogs12173-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measure</h4><div class="para"><p>MVC of the pelvic floor muscle measured with a perionometer.</p></div></div>
<div class="section" id="aogs12173-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>MVC increased significantly in both groups between baseline and follow up (p&lt;0.05). The median MVC in cmHg for the intervention and control group was 16.2 and 12.1 at baseline and 26.0 and 18.2 at follow up, respectively. The median endurance, in seconds, for the intervention and control group was 9.6 and 12.0 at baseline and 26.7 and 23.4 at follow up, respectively. Pelvic floor muscle strength measured with the Oxford Scale increased significantly in both groups between baseline and follow up (p&lt;0.05).</p></div></div>
<div class="section" id="aogs12173-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>The results indicate that home based pelvic floor muscle training is effective. However, written training instructions were as efficient as home based training with follow up visits every sixth week.</p></div><div class="para"><p>This article is protected by copyright. All rights reserved.</p></div></div>
]]></content:encoded><description>


Objective
To assess the effect of pelvic floor muscle training on pelvic floor muscle strength and urinary incontinence (UI) in primiparous women who underwent a home training program between three and nine months after delivery.


Design
Randomized controlled trial


Population
One hundred primiparous women were consecutively recruited from four different antenatal clinics in the urban area of Stockholm, Sweden. Women with UI who had undergone normal term singleton vaginal delivery, 10-16 weeks post partum were randomly allocated to either intervention or control group.


Methods
Maximally voluntary contraction (MVC) and endurance were measured with a perionometer. The Oxford grading scale was used to manually estimate the strength of the pelvic floor muscle and self-reported symptoms of UI was registered through the Bristol Female Lower Urinary Tract Symptoms Module (ICIQ FLUTS) questionnaire.


Main outcome measure
MVC of the pelvic floor muscle measured with a perionometer.


Results
MVC increased significantly in both groups between baseline and follow up (p&lt;0.05). The median MVC in cmHg for the intervention and control group was 16.2 and 12.1 at baseline and 26.0 and 18.2 at follow up, respectively. The median endurance, in seconds, for the intervention and control group was 9.6 and 12.0 at baseline and 26.7 and 23.4 at follow up, respectively. Pelvic floor muscle strength measured with the Oxford Scale increased significantly in both groups between baseline and follow up (p&lt;0.05).


Conclusion
The results indicate that home based pelvic floor muscle training is effective. However, written training instructions were as efficient as home based training with follow up visits every sixth week.
This article is protected by copyright. All rights reserved.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12172" xmlns="http://purl.org/rss/1.0/"><title>To tamponade or not to tamponade?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12172</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">To tamponade or not to tamponade?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alexander Nesbitt, Nabita Rai, Jhuma Limbu, Isla Leslie, Wai Yoong</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-14T09:35:59.134374-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12172</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12172</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12172</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>We read with great interest your series on the use of Bakri balloon tamponade for postpartum hemorrhage (PPH) and commend you for encouraging the use of this simple technique. We would like to share our data on 43 cases of massive PPH (&gt;2000 mls) in which balloon tamponade was attempted between 2007-2012 at an inner city London hospital. In our own series of 43 women, Bakri balloon tamponade succeeded in abating hemorrhage in 93% of cases, obviating the need for hysterectomy.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This article is protected by copyright. All rights reserved.</p></div>
]]></content:encoded><description>
We read with great interest your series on the use of Bakri balloon tamponade for postpartum hemorrhage (PPH) and commend you for encouraging the use of this simple technique. We would like to share our data on 43 cases of massive PPH (&gt;2000 mls) in which balloon tamponade was attempted between 2007-2012 at an inner city London hospital. In our own series of 43 women, Bakri balloon tamponade succeeded in abating hemorrhage in 93% of cases, obviating the need for hysterectomy.
This article is protected by copyright. All rights reserved.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12171" xmlns="http://purl.org/rss/1.0/"><title>Conservative management of abnormally invasive placenta: Choriocarcinoma with uterine arteriovenous fistula from remnant invasive placenta</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12171</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Conservative management of abnormally invasive placenta: Choriocarcinoma with uterine arteriovenous fistula from remnant invasive placenta</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tae-Hee Kim, Hae-Hyeog Lee, Jeong Ja Kwak</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-14T09:35:23.0024-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12171</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12171</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12171</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>We reviewed your article on the conservative management of abnormally invasive placenta (1). Placenta previa with invasion is a serious burden to obstetricians in terms of preserving the uterus. We would like to comment on a rare complication of the remnant placenta. A 36-year-old patient at 20 gestational weeks had total placenta previa with placenta accreta.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This article is protected by copyright. All rights reserved.</p></div>
]]></content:encoded><description>
We reviewed your article on the conservative management of abnormally invasive placenta (1). Placenta previa with invasion is a serious burden to obstetricians in terms of preserving the uterus. We would like to comment on a rare complication of the remnant placenta. A 36-year-old patient at 20 gestational weeks had total placenta previa with placenta accreta.
This article is protected by copyright. All rights reserved.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12170" xmlns="http://purl.org/rss/1.0/"><title>Pregnant women's perception on signs and symptoms during pregnancy and maternal health care in a rural low resource setting</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12170</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Pregnant women's perception on signs and symptoms during pregnancy and maternal health care in a rural low resource setting</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sophie Graner, Marie Klingberg-Allvin, Le Quyen Duong, Gunilla Krantz, Ingrid Mogren</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-10T10:31:08.29258-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12170</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12170</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12170</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12170-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>Women's understanding of pregnancy and antenatal care is influenced by their cultural context. In low income settings women may have limited influence over their reproductive health including when to seek health care. Awareness of signs of pregnancy complications is essential for timely care. The use of antenatal care services in Vietnam has been studied with quantitative methods but there are few qualitative studies on the perceptions of pregnancy and maternal health care among Vietnamese women.</p></div></div>
<div class="section" id="aogs12170-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Four focus group discussions with pregnant women were performed.</p></div></div>
<div class="section" id="aogs12170-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>The study was conducted in a rural district in northern Vietnam.</p></div></div>
<div class="section" id="aogs12170-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>Pregnant women in the last trimester.</p></div></div>
<div class="section" id="aogs12170-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Method</h4><div class="para"><p>Manifest and latent content analysis.</p></div></div>
<div class="section" id="aogs12170-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Result</h4><div class="para"><p>The latent theme that emerged was a need for ‘securing pregnancy during it′s normal course and at deviation’, consisting of the main categories ‘ensuring a healthy pregnancy’ and ‘separating the normal from the abnormal’.</p></div></div>
<div class="section" id="aogs12170-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>This qualitative study of pregnant women in rural Vietnam indicates how women create a strategy to promote a healthy pregnancy through lifestyle adjustments, gathering of information, and seeking timely medical care. Insight into pregnancy-related conditions was sought from various sources and influenced both by local traditions and modern medical knowledge. Public knowledge about deviating symptoms during pregnancy and a high confidence in maternal health care are the most likely contributing factors to the relative good maternal health status in Vietnam.</p></div><div class="para"><p>This article is protected by copyright. All rights reserved.</p></div></div>
]]></content:encoded><description>


Objective
Women's understanding of pregnancy and antenatal care is influenced by their cultural context. In low income settings women may have limited influence over their reproductive health including when to seek health care. Awareness of signs of pregnancy complications is essential for timely care. The use of antenatal care services in Vietnam has been studied with quantitative methods but there are few qualitative studies on the perceptions of pregnancy and maternal health care among Vietnamese women.


Design
Four focus group discussions with pregnant women were performed.


Setting
The study was conducted in a rural district in northern Vietnam.


Population
Pregnant women in the last trimester.


Method
Manifest and latent content analysis.


Result
The latent theme that emerged was a need for ‘securing pregnancy during it′s normal course and at deviation’, consisting of the main categories ‘ensuring a healthy pregnancy’ and ‘separating the normal from the abnormal’.


Conclusion
This qualitative study of pregnant women in rural Vietnam indicates how women create a strategy to promote a healthy pregnancy through lifestyle adjustments, gathering of information, and seeking timely medical care. Insight into pregnancy-related conditions was sought from various sources and influenced both by local traditions and modern medical knowledge. Public knowledge about deviating symptoms during pregnancy and a high confidence in maternal health care are the most likely contributing factors to the relative good maternal health status in Vietnam.
This article is protected by copyright. All rights reserved.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12169" xmlns="http://purl.org/rss/1.0/"><title>Problems experienced by gynecologists/obstetricians in sickness certification consultations</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12169</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Problems experienced by gynecologists/obstetricians in sickness certification consultations</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Catharina Gustavsson, Linnea Kjeldgård, Richard Bränström, Christina Lindholm, Therese Ljungquist, Gunnar H Nilsson, Kristina Alexanderson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-10T10:30:58.7938-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12169</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12169</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12169</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12169-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To explore frequencies and experiences with problems in sickness certification consultations among gynecologists and obstetricians in two different years.</p></div></div>
<div class="section" id="aogs12169-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Cross-sectional surveys on two occasions; in 2004 and 2008.</p></div></div>
<div class="section" id="aogs12169-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Gynecological, obstetric and maternal health care.</p></div></div>
<div class="section" id="aogs12169-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Sample</h4><div class="para"><p>Physicians working in gynecology, obstetrics or maternal health care in two Swedish counties from two samples: in 2004 (n=315), and in 2008 (n=327).</p></div></div>
<div class="section" id="aogs12169-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Data regarding sickness certification consultations were obtained from comprehensive questionnaires that had been mailed to the physicians in two Swedish counties in 2004 and in 2008, respectively.</p></div></div>
<div class="section" id="aogs12169-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Outcome measures</h4><div class="para"><p>Frequencies and types of problems in sickness certification consultations, organizational support, and need to acquire more competence.</p></div></div>
<div class="section" id="aogs12169-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>The majority experienced that patients requested to be on sick leave for some other reason than work incapacity due to disease or injury, at least a few times per year (85% in 2004 and 88% in 2008). The most problematic situation to handle was when the physician and the patient had different opinions about the need for sick leave (2004: 66% and 2008: 58%). The physicians expressed a need for more competence about the options and responsibilities of employers, social insurance officers and physicians in sickness certification cases.</p></div></div>
<div class="section" id="aogs12169-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Most gynecologists/obstetricians find sickness certification consultations problematic and especially when encountering patients requesting to be on sick leave due to other reasons than disease. The physicians expressed a need for more competence in insurance medicine, especially about their own and other stakeholder's options and responsibilities.</p></div><div class="para"><p>This article is protected by copyright. All rights reserved.</p></div></div>
]]></content:encoded><description>


Objective
To explore frequencies and experiences with problems in sickness certification consultations among gynecologists and obstetricians in two different years.


Design
Cross-sectional surveys on two occasions; in 2004 and 2008.


Setting
Gynecological, obstetric and maternal health care.


Sample
Physicians working in gynecology, obstetrics or maternal health care in two Swedish counties from two samples: in 2004 (n=315), and in 2008 (n=327).


Methods
Data regarding sickness certification consultations were obtained from comprehensive questionnaires that had been mailed to the physicians in two Swedish counties in 2004 and in 2008, respectively.


Outcome measures
Frequencies and types of problems in sickness certification consultations, organizational support, and need to acquire more competence.


Results
The majority experienced that patients requested to be on sick leave for some other reason than work incapacity due to disease or injury, at least a few times per year (85% in 2004 and 88% in 2008). The most problematic situation to handle was when the physician and the patient had different opinions about the need for sick leave (2004: 66% and 2008: 58%). The physicians expressed a need for more competence about the options and responsibilities of employers, social insurance officers and physicians in sickness certification cases.


Conclusions
Most gynecologists/obstetricians find sickness certification consultations problematic and especially when encountering patients requesting to be on sick leave due to other reasons than disease. The physicians expressed a need for more competence in insurance medicine, especially about their own and other stakeholder's options and responsibilities.
This article is protected by copyright. All rights reserved.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12168" xmlns="http://purl.org/rss/1.0/"><title>Intrahepatic cholestasis of pregnancy is common among patients’ first degree relatives</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12168</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Intrahepatic cholestasis of pregnancy is common among patients’ first degree relatives</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Kaisa Turunen, Kristiina Helander, Kari J. Mattila, Markku Sumanen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-10T10:30:56.733711-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12168</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12168</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12168</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Research Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Intrahepatic cholestasis of pregnancy has been shown to have a genetic predisposition. We studied whether Finnish women who had suffered from the disorder reported their first degree relatives to have had liver dysfunction during their pregnancies. Questionnaires were sent in autumn 2010 to a total of 544 former intrahepatic cholestasis of pregnancy patients and 1235 controls, all having delivered during 1969-1988. The response rate was 66.2%. The incidence of intrahepatic cholestasis is 0.5-1.5% of pregnancies in Finland. In our survey, altogether 12.8% of mothers (odds ratio 9.2), 15.9% of sisters (odds ratio 5.3) and 10.3% of daughters (odds ratio 4.8) of women who had suffered from intrahepatic cholestasis of pregnancy had had liver dysfunction during pregnancy. Our findings strengthen the earlier knowledge of the genetic component in intrahepatic cholestasis of pregnancy. We suggest that all pregnant women are inquired about their family history regarding liver dysfunction during pregnancy.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This article is protected by copyright. All rights reserved.</p></div>
]]></content:encoded><description>

Intrahepatic cholestasis of pregnancy has been shown to have a genetic predisposition. We studied whether Finnish women who had suffered from the disorder reported their first degree relatives to have had liver dysfunction during their pregnancies. Questionnaires were sent in autumn 2010 to a total of 544 former intrahepatic cholestasis of pregnancy patients and 1235 controls, all having delivered during 1969-1988. The response rate was 66.2%. The incidence of intrahepatic cholestasis is 0.5-1.5% of pregnancies in Finland. In our survey, altogether 12.8% of mothers (odds ratio 9.2), 15.9% of sisters (odds ratio 5.3) and 10.3% of daughters (odds ratio 4.8) of women who had suffered from intrahepatic cholestasis of pregnancy had had liver dysfunction during pregnancy. Our findings strengthen the earlier knowledge of the genetic component in intrahepatic cholestasis of pregnancy. We suggest that all pregnant women are inquired about their family history regarding liver dysfunction during pregnancy.
This article is protected by copyright. All rights reserved.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12167" xmlns="http://purl.org/rss/1.0/"><title>Umbilical Artery Doppler assessment: a clear disparity in ultrasound practice in a national survey</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12167</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Umbilical Artery Doppler assessment: a clear disparity in ultrasound practice in a national survey</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jonathan Cohen, Jeremie Guedj, Nicolas Fries</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-10T10:30:55.29824-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12167</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12167</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12167</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>In spite of the importance of correct interpretation of umbilical artery Doppler velocimetry, we have noticed that practice with regard to this is not homogeneous. Indeed, it is well known that Doppler parameters vary along the length of the umbilical cord and that these variations follow a gradient: resistances are higher when measured closer to the fetus (1). In order to investigate sonographers′ practice, we carried out a survey in France in which we asked practitioners where and why they measured umbilical artery Doppler parameters. In January 2013, we sent an anonymous online questionnaire to French fetal sonographers.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This article is protected by copyright. All rights reserved.</p></div>
]]></content:encoded><description>
In spite of the importance of correct interpretation of umbilical artery Doppler velocimetry, we have noticed that practice with regard to this is not homogeneous. Indeed, it is well known that Doppler parameters vary along the length of the umbilical cord and that these variations follow a gradient: resistances are higher when measured closer to the fetus (1). In order to investigate sonographers′ practice, we carried out a survey in France in which we asked practitioners where and why they measured umbilical artery Doppler parameters. In January 2013, we sent an anonymous online questionnaire to French fetal sonographers.
This article is protected by copyright. All rights reserved.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12166" xmlns="http://purl.org/rss/1.0/"><title>Definitions and roles of a skilled birth attendant: a mapping exercise from four South-Asian countries</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12166</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Definitions and roles of a skilled birth attendant: a mapping exercise from four South-Asian countries</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Bettina Utz, Ghazna Siddiqui, Adetoro Adegoke, Nynke den Broek</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-09T01:45:33.734683-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12166</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12166</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12166</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12166-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To identify which cadres of healthcare providers are considered to be skilled birth attendants in South Asia, which of the signal functions of Emergency Obstetric Care each cadre is reported to provide and whether this is included in their training and legislation.</p></div></div>
<div class="section" id="aogs12166-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Cross-sectional, descriptive study.</p></div></div>
<div class="section" id="aogs12166-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Bangladesh, India, Nepal and Pakistan.</p></div></div>
<div class="section" id="aogs12166-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Sample</h4><div class="para"><p>33 key informants involved in training, regulation, recruitment and deployment of healthcare providers.</p></div></div>
<div class="section" id="aogs12166-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Between November 2011 and March 2012, structured questionnaires were sent out to key informants by email followed up by face-to-face or telephone interviews.</p></div></div>
<div class="section" id="aogs12166-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Mapping of definitions and roles of healthcare providers in four South Asian countries to assess which cadres are skilled birth attendants.</p></div></div>
<div class="section" id="aogs12166-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Cadres of healthcare providers expected to provide skilled birth attendance differ across countries. Although most identified cadres administer parenteral antibiotics, oxytocics and perform newborn resuscitation; administration of anticonvulsants varies by country. Manual removal of the placenta, removal of retained products of conception and assisted vaginal delivery are not provided by all cadres expected to provide skilled birth attendance. Conclusion</p></div><div class="para"><p>Key signal functions of Emergency Obstetric Care are often provided by medical doctors only. Provision of such potentially life-saving interventions by more healthcare provider cadres expected to function as skilled birth attendants can save lives. Ensuring better training and legislation are in place for this is crucial.</p></div><div class="para"><p>This article is protected by copyright. All rights reserved.</p></div></div>
]]></content:encoded><description>


Objective
To identify which cadres of healthcare providers are considered to be skilled birth attendants in South Asia, which of the signal functions of Emergency Obstetric Care each cadre is reported to provide and whether this is included in their training and legislation.


Design
Cross-sectional, descriptive study.


Setting
Bangladesh, India, Nepal and Pakistan.


Sample
33 key informants involved in training, regulation, recruitment and deployment of healthcare providers.


Methods
Between November 2011 and March 2012, structured questionnaires were sent out to key informants by email followed up by face-to-face or telephone interviews.


Main outcome measures
Mapping of definitions and roles of healthcare providers in four South Asian countries to assess which cadres are skilled birth attendants.


Results
Cadres of healthcare providers expected to provide skilled birth attendance differ across countries. Although most identified cadres administer parenteral antibiotics, oxytocics and perform newborn resuscitation; administration of anticonvulsants varies by country. Manual removal of the placenta, removal of retained products of conception and assisted vaginal delivery are not provided by all cadres expected to provide skilled birth attendance. Conclusion
Key signal functions of Emergency Obstetric Care are often provided by medical doctors only. Provision of such potentially life-saving interventions by more healthcare provider cadres expected to function as skilled birth attendants can save lives. Ensuring better training and legislation are in place for this is crucial.
This article is protected by copyright. All rights reserved.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12165" xmlns="http://purl.org/rss/1.0/"><title>Lidocaine-prilocaine (EMLA®) cream as analgesia in hysteroscopy practice: a prospective, randomized, non-blinded, controlled study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12165</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Lidocaine-prilocaine (EMLA®) cream as analgesia in hysteroscopy practice: a prospective, randomized, non-blinded, controlled study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Baldomero Arnau, Esther Jovell, Stephanie Redón, Marta Canals, Vanessa Mir, Elena Jiménez</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-09T01:45:21.487522-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12165</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12165</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12165</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Research Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>We investigated the efficacy of 5% lidocaine 25mg-prilocaine 25mg/g cream (EMLA<sup>®</sup>) applied to the uterine cervix for reducing pain during diagnostic or operative hysteroscopy, using a visual-analogue scale (VAS) for pain in a prospective randomized, non-blinded, controlled study in ninety-two successive patients. Patients were randomized to either 3 ml of EMLA cream or 3 ml of ultrasound gel (placebo), placed endocervically and exocervically, 10 minutes before hysteroscopy. Intensity of pain was evaluated immediately after the procedure using a 10-cm VAS. No differences were found between the two groups (p=0.07). The number of patients who wished to stop the procedure was significantly lower in the EMLA group compared to the control group (p=0.013). We concluded that topical instillation of EMLA does not decrease pain during hysteroscopy, but does reduce a desire to abandon the procedure.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This article is protected by copyright. All rights reserved.</p></div>
]]></content:encoded><description>

We investigated the efficacy of 5% lidocaine 25mg-prilocaine 25mg/g cream (EMLA®) applied to the uterine cervix for reducing pain during diagnostic or operative hysteroscopy, using a visual-analogue scale (VAS) for pain in a prospective randomized, non-blinded, controlled study in ninety-two successive patients. Patients were randomized to either 3 ml of EMLA cream or 3 ml of ultrasound gel (placebo), placed endocervically and exocervically, 10 minutes before hysteroscopy. Intensity of pain was evaluated immediately after the procedure using a 10-cm VAS. No differences were found between the two groups (p=0.07). The number of patients who wished to stop the procedure was significantly lower in the EMLA group compared to the control group (p=0.013). We concluded that topical instillation of EMLA does not decrease pain during hysteroscopy, but does reduce a desire to abandon the procedure.
This article is protected by copyright. All rights reserved.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12164" xmlns="http://purl.org/rss/1.0/"><title>Menopausal hot flushes do not associate with changes in heart rate variability in controlled testing: a randomized trial on hormone therapy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12164</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Menopausal hot flushes do not associate with changes in heart rate variability in controlled testing: a randomized trial on hormone therapy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hanna Hautamäki, Tomi S. Mikkola, Anssi R.A. Sovijärvi, Päivi Piirilä, Petri Haapalahti</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-09T01:45:03.07355-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12164</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12164</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12164</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12164-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To compare in controlled cardiovascular autonomic function tests the effects of hormone therapy (HT) on heart rate variability (HRV) responses in postmenopausal women with and without pre-treatment hot flushes.</p></div></div>
<div class="section" id="aogs12164-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>A randomized placebo-controlled trial.</p></div></div>
<div class="section" id="aogs12164-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Finland, Helsinki University Central Hospital.</p></div></div>
<div class="section" id="aogs12164-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>A total of 150 recently postmenopausal and healthy women with prospectively evaluated hot flushes.</p></div></div>
<div class="section" id="aogs12164-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Women (72 with and 78 without hot flushes) were randomized to receive estradiol alone or in combination with medroxyprogesterone acetate or placebo for six months. Time and frequency domain measures of HRV were assessed at baseline and after HT with short-term recordings during paced quiet and deep breathing and with active orthostatic tests, both under carefully controlled laboratory conditions to avoid confounding factors present in long-term ambulatory HRV measurements.</p></div></div>
<div class="section" id="aogs12164-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main Outcome Measures</h4><div class="para"><p>Responses of time- and frequency domain measures of HRV to HT.</p></div></div>
<div class="section" id="aogs12164-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>At baseline HRV was similar in women with and without hot flushes. Pre-treatment hot flushes did not associate with changes in time domain parameters of HRV during controlled quiet or deep breathing or active orthostatic tests after different types of HT. However, HT reduced HRV in very low frequency power in women with pre-treatment hot flushes (from 371±40 to 258±28 ms<sup>2</sup>, <em>p</em>=0.018). HT did not have an effect on other frequency domain measures during quiet breathing or active orthostatic tests.</p></div></div>
<div class="section" id="aogs12164-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>HT did not significantly modify the HRV responses in women with or without hot flushes under controlled short-term measurements of the cardiovascular autonomic nervous system.</p></div><div class="para"><p>This article is protected by copyright. All rights reserved.</p></div></div>
]]></content:encoded><description>


Objective
To compare in controlled cardiovascular autonomic function tests the effects of hormone therapy (HT) on heart rate variability (HRV) responses in postmenopausal women with and without pre-treatment hot flushes.


Design
A randomized placebo-controlled trial.


Setting
Finland, Helsinki University Central Hospital.


Population
A total of 150 recently postmenopausal and healthy women with prospectively evaluated hot flushes.


Methods
Women (72 with and 78 without hot flushes) were randomized to receive estradiol alone or in combination with medroxyprogesterone acetate or placebo for six months. Time and frequency domain measures of HRV were assessed at baseline and after HT with short-term recordings during paced quiet and deep breathing and with active orthostatic tests, both under carefully controlled laboratory conditions to avoid confounding factors present in long-term ambulatory HRV measurements.


Main Outcome Measures
Responses of time- and frequency domain measures of HRV to HT.


Results
At baseline HRV was similar in women with and without hot flushes. Pre-treatment hot flushes did not associate with changes in time domain parameters of HRV during controlled quiet or deep breathing or active orthostatic tests after different types of HT. However, HT reduced HRV in very low frequency power in women with pre-treatment hot flushes (from 371±40 to 258±28 ms2, p=0.018). HT did not have an effect on other frequency domain measures during quiet breathing or active orthostatic tests.


Conclusions
HT did not significantly modify the HRV responses in women with or without hot flushes under controlled short-term measurements of the cardiovascular autonomic nervous system.
This article is protected by copyright. All rights reserved.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12163" xmlns="http://purl.org/rss/1.0/"><title>The preterm births epidemic in Greece</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12163</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The preterm births epidemic in Greece</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nikolaos Vlachadis, Eleni Kornarou, Eftichios Ktenas</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-09T01:44:54.933108-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12163</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12163</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12163</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>We congratulate Baroutis and co-authors on their brilliant article (1) which highlights the increase in preterm births as a major public health issue in Greece. We would like to contribute to their excellent analysis.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>According to the latest data from the Hellenic Statistical Authority (ELSTAT), preterm births in Greece rose further, reaching 12 831 preterm births (11.18%) in 2010. During 1991-2010, the number of preterm births increased 4.5-fold following an exponential model (R<sup>2</sup>=0.978, average annual rate of change AARC=+8,3%).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This article is protected by copyright. All rights reserved.</p></div>
]]></content:encoded><description>

We congratulate Baroutis and co-authors on their brilliant article (1) which highlights the increase in preterm births as a major public health issue in Greece. We would like to contribute to their excellent analysis.
According to the latest data from the Hellenic Statistical Authority (ELSTAT), preterm births in Greece rose further, reaching 12 831 preterm births (11.18%) in 2010. During 1991-2010, the number of preterm births increased 4.5-fold following an exponential model (R2=0.978, average annual rate of change AARC=+8,3%).
This article is protected by copyright. All rights reserved.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12162" xmlns="http://purl.org/rss/1.0/"><title>HPV-genotypes in high-grade intraepithelial cervical lesions in Danish women</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12162</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">HPV-genotypes in high-grade intraepithelial cervical lesions in Danish women</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Benny Kirschner, Doris Schledermann, Katsiaryna Holl, Mats Rosenlund, Alice Raillard, Wim Quint, Anco Molijn, David Jenkins, Jette Junge</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-06T06:03:38.204863-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12162</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12162</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12162</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12162-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>A study was undertaken to assess the distribution of high-risk HPV-genotypes in high-grade cervical intraepithelial neoplastic lesions in Danish women.</p></div></div>
<div class="section" id="aogs12162-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Observational, cross-sectional.</p></div></div>
<div class="section" id="aogs12162-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>Danish data from a multi-centre study undertaken in 13 European countries.</p></div></div>
<div class="section" id="aogs12162-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>290 archived fixed biopsies with high-grade cervical lesions from the Departments of Pathology at the University Hospitals in Hvidovre and Odense, Denmark.</p></div></div>
<div class="section" id="aogs12162-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Relevant histological samples were anonymized and shipped to a central laboratory for histopathology review and PCR-testing for human papillomavirus (HPV)-DNA. A standardised HPV-test methodology was utilised to enable comparison of HPV-genotype distribution.</p></div></div>
<div class="section" id="aogs12162-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Of 290 Danish cervical samples 276 were evaluated as histologically adequate and all of these were HPV-positive (HPV+). Of the HPV+ samples 77.9% were diagnosed with a single HPV-type, with cervical intraepithelial neoplasia (CIN)3 diagnosed in 82.3% and CIN2, CIN2/3, adenocarcinoma in situ (AIS) and AIS+ other high-grade lesion diagnosed in the remaining 17.7%. The most prevalent HPV-types were: HPV16: 54.0%; HPV33: 13.5%; HPV31: 10.7%; HPV18: 7.9% and HPV52: 4.7%. Of HPV+ samples 21.4% were diagnosed with multiple HPV-types, with CIN3 diagnosed in 79.6% and CIN2, CIN2/3, AIS and AIS+ other high-grade lesion diagnosed in the remaining 20.4%. The most prevalent HPV-types were: HPV16: 49.2%; HPV31: 30.5%; HPV52: 27.1%; HPV51: 20.3%; HPV18: 16.9%; HPV33: 13.6%; HPV45: 11.9% and 0.7% unknown types.</p></div></div>
<div class="section" id="aogs12162-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>HPV16 and HPV18 are detected in approximately 75% of high-grade intraepithelial cervical lesions in a Danish population (single or multiple infections) and these two genotypes are considered causative in at least 61.9% of the high-grade intraepithelial lesions (single infection).</p></div><div class="para"><p>This article is protected by copyright. All rights reserved.</p></div></div>
]]></content:encoded><description>


Objective
A study was undertaken to assess the distribution of high-risk HPV-genotypes in high-grade cervical intraepithelial neoplastic lesions in Danish women.


Design
Observational, cross-sectional.


Population
Danish data from a multi-centre study undertaken in 13 European countries.


Methods
290 archived fixed biopsies with high-grade cervical lesions from the Departments of Pathology at the University Hospitals in Hvidovre and Odense, Denmark.


Main outcome measures
Relevant histological samples were anonymized and shipped to a central laboratory for histopathology review and PCR-testing for human papillomavirus (HPV)-DNA. A standardised HPV-test methodology was utilised to enable comparison of HPV-genotype distribution.


Results
Of 290 Danish cervical samples 276 were evaluated as histologically adequate and all of these were HPV-positive (HPV+). Of the HPV+ samples 77.9% were diagnosed with a single HPV-type, with cervical intraepithelial neoplasia (CIN)3 diagnosed in 82.3% and CIN2, CIN2/3, adenocarcinoma in situ (AIS) and AIS+ other high-grade lesion diagnosed in the remaining 17.7%. The most prevalent HPV-types were: HPV16: 54.0%; HPV33: 13.5%; HPV31: 10.7%; HPV18: 7.9% and HPV52: 4.7%. Of HPV+ samples 21.4% were diagnosed with multiple HPV-types, with CIN3 diagnosed in 79.6% and CIN2, CIN2/3, AIS and AIS+ other high-grade lesion diagnosed in the remaining 20.4%. The most prevalent HPV-types were: HPV16: 49.2%; HPV31: 30.5%; HPV52: 27.1%; HPV51: 20.3%; HPV18: 16.9%; HPV33: 13.6%; HPV45: 11.9% and 0.7% unknown types.


Conclusions
HPV16 and HPV18 are detected in approximately 75% of high-grade intraepithelial cervical lesions in a Danish population (single or multiple infections) and these two genotypes are considered causative in at least 61.9% of the high-grade intraepithelial lesions (single infection).
This article is protected by copyright. All rights reserved.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12161" xmlns="http://purl.org/rss/1.0/"><title>Complete chorion-amnion separation presenting as a stuck fetus</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12161</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Complete chorion-amnion separation presenting as a stuck fetus</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Yoshifumi Kasuga, Kei Miyakoshi, Satoru Ikenoue, Ikuko Kadohira, Tadashi Matsumoto, Kazuhiro Minegishi, Yasunori Yoshimura</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-06T06:03:32.336639-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12161</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12161</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12161</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>During feto-placental development, chorion-amnion fusion occurs in early second trimester and persistent separation of the membranes beyond 17 weeks’ gestation is considered abnormal (1). Several reports have shown that complete chorion-amnion separation, defined as the amnion being separated from the chorion on at least three sides of the gestational sac, is associated with prenatal invasive procedures including amniocentesis (2-4). We would like to call attention to a case of complete chorion-amnion separation that occurred without any invasive procedures.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This article is protected by copyright. All rights reserved.</p></div>
]]></content:encoded><description>
During feto-placental development, chorion-amnion fusion occurs in early second trimester and persistent separation of the membranes beyond 17 weeks’ gestation is considered abnormal (1). Several reports have shown that complete chorion-amnion separation, defined as the amnion being separated from the chorion on at least three sides of the gestational sac, is associated with prenatal invasive procedures including amniocentesis (2-4). We would like to call attention to a case of complete chorion-amnion separation that occurred without any invasive procedures.
This article is protected by copyright. All rights reserved.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12160" xmlns="http://purl.org/rss/1.0/"><title>The admission CTG, is there any evidence to conclude from?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12160</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The admission CTG, is there any evidence to conclude from?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Jørg Kessler, Branka Yli</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-02T03:20:36.270656-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12160</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12160</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12160</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<div class="para" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib" xmlns="http://www.w3.org/1999/xhtml"><p>A commentary by Blix (1) concluded that there is no evidence of benefit in offering admission cardiotocography to low-risk women. It is argued that randomized studies have not shown any advantages in neonatal outcome (2). Furthermore, the admission test has a poor ability to predict adverse events during labor and the neonatal period (3).</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This article is protected by copyright. All rights reserved.</p></div>
]]></content:encoded><description>
A commentary by Blix (1) concluded that there is no evidence of benefit in offering admission cardiotocography to low-risk women. It is argued that randomized studies have not shown any advantages in neonatal outcome (2). Furthermore, the admission test has a poor ability to predict adverse events during labor and the neonatal period (3).
This article is protected by copyright. All rights reserved.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12159" xmlns="http://purl.org/rss/1.0/"><title>Validity of the diagnosis of pre-eclampsia in the Medical Birth Registry of Norway</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12159</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Validity of the diagnosis of pre-eclampsia in the Medical Birth Registry of Norway</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Liv CV Thomsen, Kari Klungsøyr, Linda T Roten, Christian Tappert, Elisabeth Araya, Gunhild Bærheim, Kjersti Tollaksen, Mona H. Fenstad, Ferenc Macsali, Rigmor Austgulen, Line Bjørge</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-26T09:02:02.079178-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12159</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12159</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12159</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12159-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>Evaluating the validity of pre-eclampsia registration in the Medical Birth Registry of Norway (MBRN) according to both broader and restricted disease definitions.</p></div></div>
<div class="section" id="aogs12159-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Retrospective nested cohort study.</p></div></div>
<div class="section" id="aogs12159-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Multicenter study.</p></div></div>
<div class="section" id="aogs12159-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>In this study two cohorts of women with pre-eclamptic pregnancies registered in the MBRN were selected. Study group 1 contained 966 pregnancies from 1967-2002. Concomitant participation in the Nord-Trøndelag Health Study 2 was required. Study group 2 comprised 1138 pregnancies recorded in 1967-2005, examined as a pre-eclampsia biobank was established.</p></div></div>
<div class="section" id="aogs12159-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Diagnostic criteria vary. The broader criteria for pre-eclampsia, used by the MBRN, are one measurement of hypertension and proteinuria (Criterion A). Criteria used internationally today require two measurements of hypertension and proteinuria (Criterion B). The diagnostic validities in Study group 1 and 2 were judged against medical records according to Criterion A and Criterion B, respectively.</p></div></div>
<div class="section" id="aogs12159-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Positive predictive value (PPV) and trend analyses.</p></div></div>
<div class="section" id="aogs12159-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>The diagnosis was confirmed in 88.3% of pregnancies in Study group 1, and in 63.6% in Study group 2. PPV was high for Study group 1 throughout the period while for Study group 2 results improved significantly after 1986.</p></div></div>
<div class="section" id="aogs12159-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>This study ascertains high PPV of pre-eclampsia in the MBRN using broader traditional criteria, although the PPV decreases through assessment by restricted modern criteria. This illustrates how inclusion of direct measurements may improve registration of complex disorders defined by changing diagnostic criteria.</p></div><div class="para"><p>This article is protected by copyright. All rights reserved.</p></div></div>
]]></content:encoded><description>


Objective
Evaluating the validity of pre-eclampsia registration in the Medical Birth Registry of Norway (MBRN) according to both broader and restricted disease definitions.


Design
Retrospective nested cohort study.


Setting
Multicenter study.


Population
In this study two cohorts of women with pre-eclamptic pregnancies registered in the MBRN were selected. Study group 1 contained 966 pregnancies from 1967-2002. Concomitant participation in the Nord-Trøndelag Health Study 2 was required. Study group 2 comprised 1138 pregnancies recorded in 1967-2005, examined as a pre-eclampsia biobank was established.


Methods
Diagnostic criteria vary. The broader criteria for pre-eclampsia, used by the MBRN, are one measurement of hypertension and proteinuria (Criterion A). Criteria used internationally today require two measurements of hypertension and proteinuria (Criterion B). The diagnostic validities in Study group 1 and 2 were judged against medical records according to Criterion A and Criterion B, respectively.


Main outcome measures
Positive predictive value (PPV) and trend analyses.


Results
The diagnosis was confirmed in 88.3% of pregnancies in Study group 1, and in 63.6% in Study group 2. PPV was high for Study group 1 throughout the period while for Study group 2 results improved significantly after 1986.


Conclusions
This study ascertains high PPV of pre-eclampsia in the MBRN using broader traditional criteria, although the PPV decreases through assessment by restricted modern criteria. This illustrates how inclusion of direct measurements may improve registration of complex disorders defined by changing diagnostic criteria.
This article is protected by copyright. All rights reserved.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12158" xmlns="http://purl.org/rss/1.0/"><title>Does cutaneous lupus erythematosus have more favorable pregnancy outcomes than systemic disease? A two-center study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12158</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Does cutaneous lupus erythematosus have more favorable pregnancy outcomes than systemic disease? A two-center study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hossam O Hamed, Salah R Ahmed, Abdallatif Alzolibani, Manal M Kamal, Marwa S Mostafa, Rania M Gamal, Dalia AA Atallah, Diaa-Eldeen M ABD-EL-AALL</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-26T09:01:47.232654-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12158</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12158</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12158</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12158-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To compare pregnancy outcomes in cutaneous lupus erythematosus (CLE) with systemic lupus erythematosus (SLE) and healthy pregnant women.</p></div></div>
<div class="section" id="aogs12158-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Cohort comparative study. <em>Settin</em>. Two university maternity centers in Saudi Arabia and Egypt.</p></div></div>
<div class="section" id="aogs12158-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>Pregnant patients with CLE and SLE and healthy pregnant women.</p></div></div>
<div class="section" id="aogs12158-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Over a three-year period, 201 participants were allocated to three groups; group 1 (n=67) had patients with CLE, group 2 (n=67) SLE patients, and group 3 healthy controls (n=67). Diagnosis of lupus erythematosus was based on American College of Rheumatology criteria. All participants were followed until delivery. Lupus exacerbation was evaluated by lupus Activity Index score. ANOVA and chi-squared tests were used to compare obstetrical and neonatal outcomes and regression analysis to define independent factors of adverse pregnancy outcomes.</p></div></div>
<div class="section" id="aogs12158-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Pregnancy losses, preterm labor, intrauterine growth restriction, preeclampsia, neonatal intensive care unit admissions, cesarean sections and lupus exacerbations.</p></div></div>
<div class="section" id="aogs12158-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>There was no significant difference between groups 1 and 3 in rates of pregnancy loss, preterm labor, preeclampsia, intrauterine growth restriction and neonatal intensive care admission. Group 1 had lower pregnancy loss (<em>p</em>=0.005), growth restriction (<em>p</em>=0.001), preeclampsia (<em>p=0.05</em>), neonatal intensive care admissions (<em>p=0.001</em>), cesarean section (<em>p=0.03,)</em> lupus exacerbations (<em>p=0.05</em>) and anti-phospholipid antibodies (<em>p=0.02</em>) compared to group 2. In groups1 and 2, lupus exacerbation and anti-phospholipid antibodies were significant independent factors for adverse outcomes.</p></div></div>
<div class="section" id="aogs12158-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>CLE means comparable pregnancy outcomes to the healthy population. Lower rates of disease exacerbation and anti-phospholipid antibodies are potential factors for better pregnancy outcome in CLE compared to SLE.</p></div><div class="para"><p>This article is protected by copyright. All rights reserved.</p></div></div>
]]></content:encoded><description>


Objective
To compare pregnancy outcomes in cutaneous lupus erythematosus (CLE) with systemic lupus erythematosus (SLE) and healthy pregnant women.


Design
Cohort comparative study. Settin. Two university maternity centers in Saudi Arabia and Egypt.


Population
Pregnant patients with CLE and SLE and healthy pregnant women.


Methods
Over a three-year period, 201 participants were allocated to three groups; group 1 (n=67) had patients with CLE, group 2 (n=67) SLE patients, and group 3 healthy controls (n=67). Diagnosis of lupus erythematosus was based on American College of Rheumatology criteria. All participants were followed until delivery. Lupus exacerbation was evaluated by lupus Activity Index score. ANOVA and chi-squared tests were used to compare obstetrical and neonatal outcomes and regression analysis to define independent factors of adverse pregnancy outcomes.


Main outcome measures
Pregnancy losses, preterm labor, intrauterine growth restriction, preeclampsia, neonatal intensive care unit admissions, cesarean sections and lupus exacerbations.


Results
There was no significant difference between groups 1 and 3 in rates of pregnancy loss, preterm labor, preeclampsia, intrauterine growth restriction and neonatal intensive care admission. Group 1 had lower pregnancy loss (p=0.005), growth restriction (p=0.001), preeclampsia (p=0.05), neonatal intensive care admissions (p=0.001), cesarean section (p=0.03,) lupus exacerbations (p=0.05) and anti-phospholipid antibodies (p=0.02) compared to group 2. In groups1 and 2, lupus exacerbation and anti-phospholipid antibodies were significant independent factors for adverse outcomes.


Conclusions
CLE means comparable pregnancy outcomes to the healthy population. Lower rates of disease exacerbation and anti-phospholipid antibodies are potential factors for better pregnancy outcome in CLE compared to SLE.
This article is protected by copyright. All rights reserved.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12156" xmlns="http://purl.org/rss/1.0/"><title>Gamete donors’ satisfaction; gender differences and similarities among oocyte and sperm donors in a national sample</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12156</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Gamete donors’ satisfaction; gender differences and similarities among oocyte and sperm donors in a national sample</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Agneta Skoog Svanberg, Claudia Lampic, Ann-Louise Gejerwall, Johannes Gudmundsson, Per-Olof Karlström, Nils-Gunnar Solensten, Gunilla Sydsjö</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-24T03:00:23.089008-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12156</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12156</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12156</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12156-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To explore oocyte and sperm donors’ emotional stress, experiences of care and satisfaction after donation. <em>Design</em>. Prospective multicenter study.</p></div></div>
<div class="section" id="aogs12156-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Settings</h4><div class="para"><p>All fertility clinics performing gamete donation in Sweden during the period 2005 to 2008. Population</p></div><div class="para"><p>Of 220 eligible oocyte donors who were approached, 181 agreed to complete the first questionnaire and 165 completed the second questionnaire two months after oocyte donation. Of 156 eligible sperm donors 119 accepted to complete the first questionnaire prior to donation. Eighty-nine participants completed the second questionnaire two months after sperm donation.</p></div></div>
<div class="section" id="aogs12156-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Standardized and study-specific questionnaires.</p></div></div>
<div class="section" id="aogs12156-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Satisfaction with the donation, respondents′ mental health and overall care.</p></div></div>
<div class="section" id="aogs12156-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>A larger percentage of sperm donors (97.8%) were satisfied with their overall experience of being a donor than oocyte donors (85.9%, <em>p</em>=0.003). Some oocyte and sperm donors did not get sufficient information about practical issues (9.1% and 13.5%, respectively) and future consequences (12.8% and 3.4%, respectively, <em>p= 0.014</em>). The donors’ symptoms of anxiety and depressive did not show any differences in relation to negative or positive perceptions of satisfaction. The donors who did not indicated ambivalence prior to treatment were on average almost five times more satisfied compared to those who did indicate ambivalence (odss ratio 4.71; 95% confidence interval 1.34-16.51).</p></div></div>
<div class="section" id="aogs12156-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Most donors were satisfied with their contribution after the donation. Oocyte and sperm donors who expressed ambivalence before donation were less satisfied after donation. In-vitro fertilization staff fulfilled most of the donors’ needs for information and care.</p></div><div class="para"><p>This article is protected by copyright. All rights reserved.</p></div></div>
]]></content:encoded><description>


Objective
To explore oocyte and sperm donors’ emotional stress, experiences of care and satisfaction after donation. Design. Prospective multicenter study.


Settings
All fertility clinics performing gamete donation in Sweden during the period 2005 to 2008. Population
Of 220 eligible oocyte donors who were approached, 181 agreed to complete the first questionnaire and 165 completed the second questionnaire two months after oocyte donation. Of 156 eligible sperm donors 119 accepted to complete the first questionnaire prior to donation. Eighty-nine participants completed the second questionnaire two months after sperm donation.


Methods
Standardized and study-specific questionnaires.


Main outcome measures
Satisfaction with the donation, respondents′ mental health and overall care.


Results
A larger percentage of sperm donors (97.8%) were satisfied with their overall experience of being a donor than oocyte donors (85.9%, p=0.003). Some oocyte and sperm donors did not get sufficient information about practical issues (9.1% and 13.5%, respectively) and future consequences (12.8% and 3.4%, respectively, p= 0.014). The donors’ symptoms of anxiety and depressive did not show any differences in relation to negative or positive perceptions of satisfaction. The donors who did not indicated ambivalence prior to treatment were on average almost five times more satisfied compared to those who did indicate ambivalence (odss ratio 4.71; 95% confidence interval 1.34-16.51).


Conclusions
Most donors were satisfied with their contribution after the donation. Oocyte and sperm donors who expressed ambivalence before donation were less satisfied after donation. In-vitro fertilization staff fulfilled most of the donors’ needs for information and care.
This article is protected by copyright. All rights reserved.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12154" xmlns="http://purl.org/rss/1.0/"><title>Comment on the article “Accuracy and reliability of fetal heart rate monitoring using maternal abdominal surface electrodes” by Cohen WR et al</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12154</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Comment on the article “Accuracy and reliability of fetal heart rate monitoring using maternal abdominal surface electrodes” by Cohen WR et al</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tomasz Fuchs, Michał Pomorski, Krzysztof Grobelak, Marek Tomiałowicz, Mariusz Zimmer</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-23T02:46:07.450054-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12154</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12154</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12154</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>We have found the article by Cohen and co-workers in the November issue of AOGS, regarding fetal heart function monitoring with electrodes placed on the abdomen of a pregnant woman during labor (fECG), very interesting (1). We are particularly interested in the ratio of cases in which achievement of an electric signal from the fetal heart was successful enough for it to be read, recorded and evaluated; and therefore satisfactory for application of the method for ante- and intralabor monitoring of the fetal condition. In a study at our center we applied transabdominal monitoring to 612 patients between the 28<sup>th</sup> and 42<sup>nd</sup> week in an uncomplicated pregnancy, and in 91 cases of a pregnancy complicated by fetal intrauterine growth restriction or pregnancy-induced hypertension, as well as 84 cases complicated by imminent preterm delivery.</p></div>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>This article is protected by copyright. All rights reserved.</p></div>
]]></content:encoded><description>

We have found the article by Cohen and co-workers in the November issue of AOGS, regarding fetal heart function monitoring with electrodes placed on the abdomen of a pregnant woman during labor (fECG), very interesting (1). We are particularly interested in the ratio of cases in which achievement of an electric signal from the fetal heart was successful enough for it to be read, recorded and evaluated; and therefore satisfactory for application of the method for ante- and intralabor monitoring of the fetal condition. In a study at our center we applied transabdominal monitoring to 612 patients between the 28th and 42nd week in an uncomplicated pregnancy, and in 91 cases of a pregnancy complicated by fetal intrauterine growth restriction or pregnancy-induced hypertension, as well as 84 cases complicated by imminent preterm delivery.
This article is protected by copyright. All rights reserved.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12148" xmlns="http://purl.org/rss/1.0/"><title>Validation study of uterine rupture registration in the Medical Birth Registry of Norway</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12148</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Validation study of uterine rupture registration in the Medical Birth Registry of Norway</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Iqbal Al-Zirqi, Babill Stray-Pedersen, Lisa Forsén, Anne Kjersti Daltveit, Siri Vangen, </dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-20T10:41:32.459136-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12148</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12148</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12148</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12148-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To validate uterine rupture registration in the Medical Birth Registry of Norway (MBRN) between 1999 and 2008, and to identify rupture type and causes of incorrect or missed registration during 1967–2008.</p></div></div>
<div class="section" id="aogs12148-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Population-based study.</p></div></div>
<div class="section" id="aogs12148-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>The validation sample was 392 958 maternities from 21 maternity units registered in MBRN and local Patient Administration Systems in 1999–2008. In addition we identified type of rupture and causes of incorrect registration among 2 422 934 maternities from 48 units, and 1 449 201 maternities from 21 units during 1967–2008.</p></div></div>
<div class="section" id="aogs12148-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Information about uterine rupture in MBRN was compared with information in medical records.</p></div></div>
<div class="section" id="aogs12148-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Sensitivity, specificity, positive and negative predictive value of uterine rupture registration in MBRN.</p></div></div>
<div class="section" id="aogs12148-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>In 1999–2008, there were 10 false positive cases among 151 uterine ruptures registered in MBRN. In addition, 82 ruptures not registered in MBRN, were identified through Patient Administration Systems. The sensitivity, specificity, positive and negative predictive value of the MBRN to detect uterine rupture was 63.2, 99.99, 93.4 and 99.98%, respectively. The incidence of uterine rupture changed after correction from 0.38 to 0.56/1000. During 1967–2008, false positive cases (125) were mainly due to wrong coding by MBRN. Around 60% of 141 false negative cases were due to lack of reporting by maternity units. Complete rupture accounted for 63.9% of ruptures registered in MBRN.</p></div></div>
<div class="section" id="aogs12148-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>The validity of MBRN data on uterine rupture is not optimal, diagnosis being under-reported by around 37%. Ticked boxes may improve the quality of registration.</p></div></div>
]]></content:encoded><description>


Objective
To validate uterine rupture registration in the Medical Birth Registry of Norway (MBRN) between 1999 and 2008, and to identify rupture type and causes of incorrect or missed registration during 1967–2008.


Design
Population-based study.


Population
The validation sample was 392 958 maternities from 21 maternity units registered in MBRN and local Patient Administration Systems in 1999–2008. In addition we identified type of rupture and causes of incorrect registration among 2 422 934 maternities from 48 units, and 1 449 201 maternities from 21 units during 1967–2008.


Methods
Information about uterine rupture in MBRN was compared with information in medical records.


Main outcome measures
Sensitivity, specificity, positive and negative predictive value of uterine rupture registration in MBRN.


Results
In 1999–2008, there were 10 false positive cases among 151 uterine ruptures registered in MBRN. In addition, 82 ruptures not registered in MBRN, were identified through Patient Administration Systems. The sensitivity, specificity, positive and negative predictive value of the MBRN to detect uterine rupture was 63.2, 99.99, 93.4 and 99.98%, respectively. The incidence of uterine rupture changed after correction from 0.38 to 0.56/1000. During 1967–2008, false positive cases (125) were mainly due to wrong coding by MBRN. Around 60% of 141 false negative cases were due to lack of reporting by maternity units. Complete rupture accounted for 63.9% of ruptures registered in MBRN.


Conclusions
The validity of MBRN data on uterine rupture is not optimal, diagnosis being under-reported by around 37%. Ticked boxes may improve the quality of registration.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12157" xmlns="http://purl.org/rss/1.0/"><title>A new population-based reference curve for symphysis–fundus height</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12157</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A new population-based reference curve for symphysis–fundus height</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Aase Serine D. Pay, Jan Frederik Frøen, Anne Cathrine Staff, Bo Jacobsson, Håkon K. Gjessing</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-16T00:43:38.691662-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12157</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12157</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12157</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12157-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To present a new gestational-age-specific percentile curve for symphysis–fundus (SF) height and to determine the effects of maternal and fetal covariates.</p></div></div>
<div class="section" id="aogs12157-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>A population-based register study.</p></div></div>
<div class="section" id="aogs12157-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Antenatal clinics in Västra Götaland County, Sweden, between 2005 and 2010.</p></div></div>
<div class="section" id="aogs12157-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>A total of 42 018 women with ultrasound-dated singleton pregnancies who delivered at Sahlgrenska University Hospital.</p></div></div>
<div class="section" id="aogs12157-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Measurement of SF height.</p></div></div>
<div class="section" id="aogs12157-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>A non-linear regression of SF height on day of pregnancy was used to construct a reference chart for the median and other percentiles of SF height.</p></div></div>
<div class="section" id="aogs12157-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>The new reference curve for SF height showed almost linear growth until term. The median value was considerably larger at each gestational age compared with the curves for SF height used in Norway and Denmark. Compared with the curve currently used in Sweden, higher median values were observed only at gestational ages &gt;34 weeks, accompanied by an upward shift in all percentiles. The only notably influential covariates were maternal pre-pregnancy weight and height.</p></div></div>
<div class="section" id="aogs12157-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>The new reference curve for SF height shows a pattern that is different from the Scandinavian reference curves of older origin, reflecting changes in the pregnant population, as well as methodological differences. The new curve can be adjusted for maternal and fetal covariates to suit individual pregnancies.</p></div></div>
]]></content:encoded><description>


Objective
To present a new gestational-age-specific percentile curve for symphysis–fundus (SF) height and to determine the effects of maternal and fetal covariates.


Design
A population-based register study.


Setting
Antenatal clinics in Västra Götaland County, Sweden, between 2005 and 2010.


Population
A total of 42 018 women with ultrasound-dated singleton pregnancies who delivered at Sahlgrenska University Hospital.


Main outcome measures
Measurement of SF height.


Methods
A non-linear regression of SF height on day of pregnancy was used to construct a reference chart for the median and other percentiles of SF height.


Results
The new reference curve for SF height showed almost linear growth until term. The median value was considerably larger at each gestational age compared with the curves for SF height used in Norway and Denmark. Compared with the curve currently used in Sweden, higher median values were observed only at gestational ages &gt;34 weeks, accompanied by an upward shift in all percentiles. The only notably influential covariates were maternal pre-pregnancy weight and height.


Conclusions
The new reference curve for SF height shows a pattern that is different from the Scandinavian reference curves of older origin, reflecting changes in the pregnant population, as well as methodological differences. The new curve can be adjusted for maternal and fetal covariates to suit individual pregnancies.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12152" xmlns="http://purl.org/rss/1.0/"><title>Evolution of diagnostic criteria for gestational diabetes mellitus</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12152</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Evolution of diagnostic criteria for gestational diabetes mellitus</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Azadeh Houshmand, Dorte Møller Jensen, Elisabeth R. Mathiesen, Peter Damm</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-15T03:55:47.219138-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12152</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12152</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12152</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Acta Commentary</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>The establishment of universal diagnostic guidelines for gestational diabetes mellitus has been a long time coming. The lack of consensus and uniformity in procedures for diagnosing this disease has been a problem ever since its existence was recognized. The USA, European countries, and Australia have each developed their own guidelines through the years, all based either on the maternal risk of subsequent diabetes, on arbitrary statistics, or on studies conducted on non-pregnant women. None of these guidelines have been based on risk for perinatal complications. Recently, the Hyperglycemia and Adverse Pregnancy Outcomes study demonstrated that maternal hyperglycemia is associated with perinatal risk in a linear way with no obvious threshold. The International Association of Diabetes and Pregnancy Study Group has translated these results into clinical practice by proposing new diagnostic criteria for gestational diabetes mellitus, based for the first time on perinatal outcome.</p></div>
]]></content:encoded><description>

The establishment of universal diagnostic guidelines for gestational diabetes mellitus has been a long time coming. The lack of consensus and uniformity in procedures for diagnosing this disease has been a problem ever since its existence was recognized. The USA, European countries, and Australia have each developed their own guidelines through the years, all based either on the maternal risk of subsequent diabetes, on arbitrary statistics, or on studies conducted on non-pregnant women. None of these guidelines have been based on risk for perinatal complications. Recently, the Hyperglycemia and Adverse Pregnancy Outcomes study demonstrated that maternal hyperglycemia is associated with perinatal risk in a linear way with no obvious threshold. The International Association of Diabetes and Pregnancy Study Group has translated these results into clinical practice by proposing new diagnostic criteria for gestational diabetes mellitus, based for the first time on perinatal outcome.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12155" xmlns="http://purl.org/rss/1.0/"><title>Histidine-rich glycoprotein gene polymorphism in patients with recurrent miscarriage</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12155</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Histidine-rich glycoprotein gene polymorphism in patients with recurrent miscarriage</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Karin E. Lindgren, Karin Kårehed, Helena Karypidis, Frida Hosseini, Katarina Bremme, Britt-Marie Landgren, Lottie Skjöldebrand-Sparre, Anneli Stavreus-Evers, Inger Sundström-Poromaa, Helena Åkerud</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-15T03:55:43.424743-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12155</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12155</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12155</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Research Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Association between the histidine-rich glycoprotein (HRG) C633T single nucleotide polymorphism (SNP) and recurrent miscarriage was investigated in a case–control study. The cases constituted 187 women with recurrent miscarriage that were compared with 395 controls who had delivered a child and had no history of miscarriage. Blood samples were collected from each woman, genomic DNA was extracted and genotyped for the HRG C633T SNP. In the whole study population, the percentage of miscarriage was the same, regardless of genotype (C/C 31.2%, C/T 32.9% and T/T 32.5%). However, an association between homozygous T/T carriers and recurrent miscarriage was detected in a subgroup of women with primary recurrent miscarriage (odds ratio 2.44, 95% CI 1.01–5.92). Our results indicate an important role for the HRG C633T SNP in the occurrence of recurrent miscarriage.</p></div>
]]></content:encoded><description>

Association between the histidine-rich glycoprotein (HRG) C633T single nucleotide polymorphism (SNP) and recurrent miscarriage was investigated in a case–control study. The cases constituted 187 women with recurrent miscarriage that were compared with 395 controls who had delivered a child and had no history of miscarriage. Blood samples were collected from each woman, genomic DNA was extracted and genotyped for the HRG C633T SNP. In the whole study population, the percentage of miscarriage was the same, regardless of genotype (C/C 31.2%, C/T 32.9% and T/T 32.5%). However, an association between homozygous T/T carriers and recurrent miscarriage was detected in a subgroup of women with primary recurrent miscarriage (odds ratio 2.44, 95% CI 1.01–5.92). Our results indicate an important role for the HRG C633T SNP in the occurrence of recurrent miscarriage.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12147" xmlns="http://purl.org/rss/1.0/"><title>Fear of childbirth in expectant fathers, subsequent childbirth experience and impact of antenatal education: subanalysis of results from a randomized controlled trial</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12147</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Fear of childbirth in expectant fathers, subsequent childbirth experience and impact of antenatal education: subanalysis of results from a randomized controlled trial</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Malin Bergström, Ann Rudman, Ulla Waldenström, Helle Kieler</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-10T08:06:46.919938-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12147</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12147</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12147</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12147-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To explore if antenatal fear of childbirth in men affects their experience of the birth event and if this experience is associated with type of childbirth preparation.</p></div></div>
<div class="section" id="aogs12147-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Data from a randomized controlled multicenter trial on antenatal education.</p></div></div>
<div class="section" id="aogs12147-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>15 antenatal clinics in Sweden between January 2006 and May 2007.</p></div></div>
<div class="section" id="aogs12147-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Sample</h4><div class="para"><p>762 men, of whom 83 (10.9%) suffered from fear of childbirth. Of these 83 men, 39 were randomized to psychoprophylaxis childbirth preparation where men were trained to coach their partners during labor and 44 to standard care antenatal preparation for childbirth and parenthood without such training.</p></div></div>
<div class="section" id="aogs12147-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Experience of childbirth was compared between men with and without fear of childbirth regardless of randomization, and between fearful men in the randomized groups. Analyses by logistic regression adjusted for sociodemographic variables.</p></div></div>
<div class="section" id="aogs12147-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Self-reported data on experience of childbirth including an adapted version of the Wijma Delivery Experience Questionnaire (W-DEQ B).</p></div></div>
<div class="section" id="aogs12147-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Men with antenatal fear of childbirth more often experienced childbirth as frightening than men without fear: adjusted odds ratio 4.68, 95% confidence interval 2.67–8.20. Men with antenatal fear in the psychoprophylaxis group rated childbirth as frightening less often than those in standard care: adjusted odds ratio 0.30, 95% confidence interval 0.10–0.95.</p></div></div>
<div class="section" id="aogs12147-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Men who suffer from antenatal fear of childbirth are at higher risk of experiencing childbirth as frightening. Childbirth preparation including training as a coach may help fearful men to a more positive childbirth experience. Additional studies are needed to support this conclusion.</p></div></div>
]]></content:encoded><description>


Objective
To explore if antenatal fear of childbirth in men affects their experience of the birth event and if this experience is associated with type of childbirth preparation.


Design
Data from a randomized controlled multicenter trial on antenatal education.


Setting
15 antenatal clinics in Sweden between January 2006 and May 2007.


Sample
762 men, of whom 83 (10.9%) suffered from fear of childbirth. Of these 83 men, 39 were randomized to psychoprophylaxis childbirth preparation where men were trained to coach their partners during labor and 44 to standard care antenatal preparation for childbirth and parenthood without such training.


Methods
Experience of childbirth was compared between men with and without fear of childbirth regardless of randomization, and between fearful men in the randomized groups. Analyses by logistic regression adjusted for sociodemographic variables.


Main outcome measures
Self-reported data on experience of childbirth including an adapted version of the Wijma Delivery Experience Questionnaire (W-DEQ B).


Results
Men with antenatal fear of childbirth more often experienced childbirth as frightening than men without fear: adjusted odds ratio 4.68, 95% confidence interval 2.67–8.20. Men with antenatal fear in the psychoprophylaxis group rated childbirth as frightening less often than those in standard care: adjusted odds ratio 0.30, 95% confidence interval 0.10–0.95.


Conclusions
Men who suffer from antenatal fear of childbirth are at higher risk of experiencing childbirth as frightening. Childbirth preparation including training as a coach may help fearful men to a more positive childbirth experience. Additional studies are needed to support this conclusion.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12150" xmlns="http://purl.org/rss/1.0/"><title>Multi-center experience of robot-assisted laparoscopic para-aortic lymphadenectomy for staging of locally advanced cervical carcinoma</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12150</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Multi-center experience of robot-assisted laparoscopic para-aortic lymphadenectomy for staging of locally advanced cervical carcinoma</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Maxime Fastrez, Frédéric Goffin, Ignace Vergote, Jean Vandromme, Philippe Petit, Karin Leunen, Michel Degueldre</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-10T08:06:43.694854-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12150</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12150</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12150</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12150-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objectives</h4><div class="para"><p>FIGO classification is commonly used for staging of locally advanced cervical cancer. Laparoscopic para-aortic lymphadenectomy is currently used as a diagnostic tool, since we know that presence of para-aortic lymph node metastases identifies patients with poor prognosis. The application of robotics during this procedure needs to be investigated.</p></div></div>
<div class="section" id="aogs12150-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Retrospective multi-center study.</p></div></div>
<div class="section" id="aogs12150-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Three centers participated in building one database.</p></div></div>
<div class="section" id="aogs12150-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>Thirty-seven patients with locally advanced cervical cancer underwent a robot-assisted laparoscopic para-aortic lymphadenectomy.</p></div></div>
<div class="section" id="aogs12150-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Patients were prospectively enrolled in one register. Retrospective analysis of the whole database was performed.</p></div></div>
<div class="section" id="aogs12150-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Surgical outcomes of the robot-assisted procedure and follow-up data.</p></div></div>
<div class="section" id="aogs12150-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Median number of lymph nodes collected was 27.5 (1–54) per patient. Five of 37 patients had para-aortic node metastases. The false negative rate for PET-CT diagnosing para-aortic node metastases was 11.4% (4/35). Two major intra-operative complications occurred (5.4%). Postoperative morbidity was low (13.5%). Median follow-up was 27 months [95% confidence interval (95% CI) was 24–30]. Median disease-free survival was 16 months (95% CI 2.4–29.6). Patients with negative nodes had a median disease-free survival of 24 months (not assessable), although patients with positive nodes had a median disease-free survival of 9 months (95% CI 6.9–11.9).</p></div></div>
<div class="section" id="aogs12150-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>In this series we report that robot-assisted laparoscopic para-aortic lymphadencetomy provided the surgeon with useful information, diagnosing 11.4% of occult para-aortic lymph node metastases in women with locally advanced cervical cancer. Intra-operative and postoperative morbidity were low. The presence of para-aortic lymph node metastases correlated with shorter disease-free survival.</p></div></div>
]]></content:encoded><description>


Objectives
FIGO classification is commonly used for staging of locally advanced cervical cancer. Laparoscopic para-aortic lymphadenectomy is currently used as a diagnostic tool, since we know that presence of para-aortic lymph node metastases identifies patients with poor prognosis. The application of robotics during this procedure needs to be investigated.


Design
Retrospective multi-center study.


Setting
Three centers participated in building one database.


Population
Thirty-seven patients with locally advanced cervical cancer underwent a robot-assisted laparoscopic para-aortic lymphadenectomy.


Methods
Patients were prospectively enrolled in one register. Retrospective analysis of the whole database was performed.


Main outcome measures
Surgical outcomes of the robot-assisted procedure and follow-up data.


Results
Median number of lymph nodes collected was 27.5 (1–54) per patient. Five of 37 patients had para-aortic node metastases. The false negative rate for PET-CT diagnosing para-aortic node metastases was 11.4% (4/35). Two major intra-operative complications occurred (5.4%). Postoperative morbidity was low (13.5%). Median follow-up was 27 months [95% confidence interval (95% CI) was 24–30]. Median disease-free survival was 16 months (95% CI 2.4–29.6). Patients with negative nodes had a median disease-free survival of 24 months (not assessable), although patients with positive nodes had a median disease-free survival of 9 months (95% CI 6.9–11.9).


Conclusions
In this series we report that robot-assisted laparoscopic para-aortic lymphadencetomy provided the surgeon with useful information, diagnosing 11.4% of occult para-aortic lymph node metastases in women with locally advanced cervical cancer. Intra-operative and postoperative morbidity were low. The presence of para-aortic lymph node metastases correlated with shorter disease-free survival.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12145" xmlns="http://purl.org/rss/1.0/"><title>Augmentation index and pulse wave velocity in normotensive and pre-eclamptic pregnancies</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12145</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Augmentation index and pulse wave velocity in normotensive and pre-eclamptic pregnancies</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Maximilian B. Franz, Maximiliane Burgmann, Anna Neubauer, Harald Zeisler, Ramona Sanani, Michael Gottsauner-Wolf, Barbara Schiessl, Martin Andreas</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-10T08:06:40.495245-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12145</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12145</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12145</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12145-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>Hypertensive disorders during pregnancy remain a major health burden. Normal pregnancy is associated with systemic cardiovascular adaptation. The augmentation index and pulse wave velocity measures may serve as surrogate markers of cardiovascular pathology, including pre-eclampsia. We evaluated these parameters during and after normotensive and pre-eclamptic pregnancies.</p></div></div>
<div class="section" id="aogs12145-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Longitudinal cohort trial involving a case–control analysis of healthy women and women with pre-eclampsia.</p></div></div>
<div class="section" id="aogs12145-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>University hospital.</p></div></div>
<div class="section" id="aogs12145-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>Fifty-three healthy pregnant women between 11<sup>+6</sup> and 13<sup>+6</sup> gestational weeks, as well as 21 patients with pre-eclampsia.</p></div></div>
<div class="section" id="aogs12145-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>The augmentation index and pulse wave velocity were measured seven times during pregnancy and postpartum.</p></div></div>
<div class="section" id="aogs12145-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Changes in augmentation index and pulse wave velocity during and after healthy pregnancies were measured. The influence of early-onset and late-onset pre-eclampsia on these measurements both during and after pregnancy was evaluated.</p></div></div>
<div class="section" id="aogs12145-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>The normotensive pregnancies exhibited a significant decrease in the augmentation index from the first trimester to the end of the second trimester; however, the normotensive pregnancies showed an increase in the augmentation index during the third trimester as term approached. The patients with early-onset and late-onset pre-eclampsia displayed a significantly elevated augmentation index during pregnancy. The postpartum augmentation index and pulse wave velocity were significantly elevated in the early-onset pre-eclampsia group.</p></div></div>
<div class="section" id="aogs12145-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>After pregnancy, early-onset and late-onset pre-eclamptic patients exhibit differences in vascular function. This result indicates the presence of a higher cardiovascular risk in patients after early-onset pre-eclampsia.</p></div></div>
]]></content:encoded><description>


Objective
Hypertensive disorders during pregnancy remain a major health burden. Normal pregnancy is associated with systemic cardiovascular adaptation. The augmentation index and pulse wave velocity measures may serve as surrogate markers of cardiovascular pathology, including pre-eclampsia. We evaluated these parameters during and after normotensive and pre-eclamptic pregnancies.


Design
Longitudinal cohort trial involving a case–control analysis of healthy women and women with pre-eclampsia.


Setting
University hospital.


Population
Fifty-three healthy pregnant women between 11+6 and 13+6 gestational weeks, as well as 21 patients with pre-eclampsia.


Methods
The augmentation index and pulse wave velocity were measured seven times during pregnancy and postpartum.


Main outcome measures
Changes in augmentation index and pulse wave velocity during and after healthy pregnancies were measured. The influence of early-onset and late-onset pre-eclampsia on these measurements both during and after pregnancy was evaluated.


Results
The normotensive pregnancies exhibited a significant decrease in the augmentation index from the first trimester to the end of the second trimester; however, the normotensive pregnancies showed an increase in the augmentation index during the third trimester as term approached. The patients with early-onset and late-onset pre-eclampsia displayed a significantly elevated augmentation index during pregnancy. The postpartum augmentation index and pulse wave velocity were significantly elevated in the early-onset pre-eclampsia group.


Conclusion
After pregnancy, early-onset and late-onset pre-eclamptic patients exhibit differences in vascular function. This result indicates the presence of a higher cardiovascular risk in patients after early-onset pre-eclampsia.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12149" xmlns="http://purl.org/rss/1.0/"><title>Antenatal corticosteroid exposure at term increases adult adiposity: an experimental study in sheep</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12149</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Antenatal corticosteroid exposure at term increases adult adiposity: an experimental study in sheep</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Mary J. Berry, Anne L. Jaquiery, Mark H. Oliver, Jane E. Harding, Frank H. Bloomfield</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-10T08:06:36.566457-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12149</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12149</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12149</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Research Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Clinical practice guidelines for elective cesarean section at early-term gestation (37–38 weeks) recommend antenatal corticosteroids to reduce neonatal respiratory morbidity. However, the long-term health implications for offspring exposed to corticosteroids at term are unknown and may differ from the effects of preterm corticosteroid exposure. We therefore randomized singleton-bearing ewes (<em>n </em>=<em> </em>64) to receive a clinically relevant dose of corticosteroids at term or no treatment. Body composition was assessed in adult offspring using dual-energy X-ray absorptiometry. Relative to skeletal size female, but not male, offspring of steroid-treated ewes had increased weight and a greater fat mass than controls (relative weight: 49.1 ± 1.1 vs. 52.9 ± 1.2 kg/m<sup>2</sup>, <em>p</em> = 0.02; relative fat mass: 5.4 ± 0.7 vs. 3.4 ± 0.7 kg/m<sup>2</sup>, <em>p</em> = 0.04). Whether corticosteroid exposure at early-term gestation increases adult adiposity in humans is unknown and needs further investigation.</p></div>
]]></content:encoded><description>

Clinical practice guidelines for elective cesarean section at early-term gestation (37–38 weeks) recommend antenatal corticosteroids to reduce neonatal respiratory morbidity. However, the long-term health implications for offspring exposed to corticosteroids at term are unknown and may differ from the effects of preterm corticosteroid exposure. We therefore randomized singleton-bearing ewes (n = 64) to receive a clinically relevant dose of corticosteroids at term or no treatment. Body composition was assessed in adult offspring using dual-energy X-ray absorptiometry. Relative to skeletal size female, but not male, offspring of steroid-treated ewes had increased weight and a greater fat mass than controls (relative weight: 49.1 ± 1.1 vs. 52.9 ± 1.2 kg/m2, p = 0.02; relative fat mass: 5.4 ± 0.7 vs. 3.4 ± 0.7 kg/m2, p = 0.04). Whether corticosteroid exposure at early-term gestation increases adult adiposity in humans is unknown and needs further investigation.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12144" xmlns="http://purl.org/rss/1.0/"><title>A survey on knowledge of female genital mutilation guidelines</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12144</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A survey on knowledge of female genital mutilation guidelines</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Thomas C.D. Purchase, Maya Lamoudi, Sarah Colman, Siobhan Allen, Pallavi Latthe, Kate Jolly</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-10T08:06:32.482156-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12144</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12144</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12144</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Research Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>The increase in immigration from countries with a high prevalence of female genital mutilation (FGM) has highlighted the need for knowledge and sensitivity in this area of healthcare in high-resource countries. We have surveyed with an online questionnaire 607 members, fellows and trainees of the Royal College of Obstetricians and Gynaecologists (RCOG) on knowledge about the RCOG guidelines for FGM. Completed training and more practical experience with women affected by FGM significantly increased knowledge. Many respondents were not aware of specialist services locally (22.9%) or how to access them (52.3%). Some areas of insufficient knowledge were identified, in particular in relation to psychiatric morbidity, HIV, hepatitis B and pelvic infection. More specialized training efforts might improve this aspect.</p></div>
]]></content:encoded><description>

The increase in immigration from countries with a high prevalence of female genital mutilation (FGM) has highlighted the need for knowledge and sensitivity in this area of healthcare in high-resource countries. We have surveyed with an online questionnaire 607 members, fellows and trainees of the Royal College of Obstetricians and Gynaecologists (RCOG) on knowledge about the RCOG guidelines for FGM. Completed training and more practical experience with women affected by FGM significantly increased knowledge. Many respondents were not aware of specialist services locally (22.9%) or how to access them (52.3%). Some areas of insufficient knowledge were identified, in particular in relation to psychiatric morbidity, HIV, hepatitis B and pelvic infection. More specialized training efforts might improve this aspect.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12151" xmlns="http://purl.org/rss/1.0/"><title>Socioeconomic characteristics, housing conditions and criminal offences among women with cervical neoplasia</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12151</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Socioeconomic characteristics, housing conditions and criminal offences among women with cervical neoplasia</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Emma Billström, Inger Sundström-Poromaa, Karin Stålberg, Anna Asplund, Dan Hellberg</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-10T08:06:26.778914-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12151</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12151</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12151</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12151-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To investigate the association between cervical neoplasia and socioeconomic factors, housing conditions and criminal offences.</p></div></div>
<div class="section" id="aogs12151-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Longitudinal observational study.</p></div></div>
<div class="section" id="aogs12151-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Falun county hospital, Sweden.</p></div></div>
<div class="section" id="aogs12151-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>A total of 1331 women diagnosed with cervical intraepithelial neoplasia I-III or cervical cancer between 1967 and 1978 were compared with 2604 age-matched controls from the same geographical area in Sweden.</p></div></div>
<div class="section" id="aogs12151-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>The Population and Housing Censuses were used for information about civil status, education, housing conditions, employment and socioeconomic status. The Swedish Register of Conviction Decisions was used to access information on criminal offences.</p></div></div>
<div class="section" id="aogs12151-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Socioeconomic status, housing conditions, criminal offences.</p></div></div>
<div class="section" id="aogs12151-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Women with cervical neoplasia had a lower socioeconomic status and a lower educational level than their age-matched controls. They were more often divorced and did not own their home as often as controls. A significant association with criminal offences was observed, and it persisted after adjustment for socioeconomic status. Differences in socioeconomic factors between women with cervical neoplasia and their controls had not diminished in the younger, compared with the older, part of the study population.</p></div></div>
<div class="section" id="aogs12151-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>The results indicate that women with cervical neoplasia belong to a socioeconomically disadvantaged group. Furthermore, the study provides information about an association with criminal offences.</p></div></div>
]]></content:encoded><description>


Objective
To investigate the association between cervical neoplasia and socioeconomic factors, housing conditions and criminal offences.


Design
Longitudinal observational study.


Setting
Falun county hospital, Sweden.


Population
A total of 1331 women diagnosed with cervical intraepithelial neoplasia I-III or cervical cancer between 1967 and 1978 were compared with 2604 age-matched controls from the same geographical area in Sweden.


Methods
The Population and Housing Censuses were used for information about civil status, education, housing conditions, employment and socioeconomic status. The Swedish Register of Conviction Decisions was used to access information on criminal offences.


Main outcome measures
Socioeconomic status, housing conditions, criminal offences.


Results
Women with cervical neoplasia had a lower socioeconomic status and a lower educational level than their age-matched controls. They were more often divorced and did not own their home as often as controls. A significant association with criminal offences was observed, and it persisted after adjustment for socioeconomic status. Differences in socioeconomic factors between women with cervical neoplasia and their controls had not diminished in the younger, compared with the older, part of the study population.


Conclusions
The results indicate that women with cervical neoplasia belong to a socioeconomically disadvantaged group. Furthermore, the study provides information about an association with criminal offences.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12146" xmlns="http://purl.org/rss/1.0/"><title>Prenatal diagnosis: array comparative genomic hybridization in fetuses with abnormal sonographic findings</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12146</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Prenatal diagnosis: array comparative genomic hybridization in fetuses with abnormal sonographic findings</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Else Marie Vestergaard, Rikke Christensen, Olav B. Petersen, Ida Vogel</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-09T12:14:35.260697-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12146</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12146</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12146</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12146-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To evaluate the clinical value of a high-resolution whole-genome array method for examination of genomic imbalances in prenatal samples (46 amniotic fluid, 17 chorionic villus, and 26 products of conception) from fetuses with abnormal ultrasound, in a clinical setting where more than 90% of pregnant women receive first-trimester combined screening and a second-trimester anomaly scan.</p></div></div>
<div class="section" id="aogs12146-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Cross-sectional study.</p></div></div>
<div class="section" id="aogs12146-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Fetal medicine units (national healthcare system) in Central and North Denmark Regions from March 2009 to April 2012.</p></div></div>
<div class="section" id="aogs12146-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Samples</h4><div class="para"><p>Eighty-nine samples obtained at 11.5–35.0 (mean 19.3) gestational weeks, either during ongoing pregnancy or after termination.</p></div></div>
<div class="section" id="aogs12146-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>DNA was extracted directly from amniotic fluid cells and chorionic villus samples, or from cultured cells, and examined with 80-kb resolution oligonucleotide array-based comparative genomic hybridization (aCGH).</p></div></div>
<div class="section" id="aogs12146-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Clinically significant copy number variations identified by aCGH.</p></div></div>
<div class="section" id="aogs12146-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>We detected clinically significant copy number variations in 11 fetuses (12%, confidence interval 6.0–19%) with structural malformations. Three fetuses (3.4%) had uncertain clinical significant variations and incidental findings.</p></div></div>
<div class="section" id="aogs12146-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>aCGH is a valuable diagnostic tool when fetal malformations are detected. More affected fetuses may be diagnosed at an earlier gestational age providing better possibilities for postnatal treatment and allowing for women to decide earlier on termination of pregnancy. When a normal result has reduced the risk of significant chromosomal aberration, aCGH may facilitate parental decision-making on whether to continue the pregnancy.</p></div></div>
]]></content:encoded><description>


Objective
To evaluate the clinical value of a high-resolution whole-genome array method for examination of genomic imbalances in prenatal samples (46 amniotic fluid, 17 chorionic villus, and 26 products of conception) from fetuses with abnormal ultrasound, in a clinical setting where more than 90% of pregnant women receive first-trimester combined screening and a second-trimester anomaly scan.


Design
Cross-sectional study.


Setting
Fetal medicine units (national healthcare system) in Central and North Denmark Regions from March 2009 to April 2012.


Samples
Eighty-nine samples obtained at 11.5–35.0 (mean 19.3) gestational weeks, either during ongoing pregnancy or after termination.


Methods
DNA was extracted directly from amniotic fluid cells and chorionic villus samples, or from cultured cells, and examined with 80-kb resolution oligonucleotide array-based comparative genomic hybridization (aCGH).


Main outcome measures
Clinically significant copy number variations identified by aCGH.


Results
We detected clinically significant copy number variations in 11 fetuses (12%, confidence interval 6.0–19%) with structural malformations. Three fetuses (3.4%) had uncertain clinical significant variations and incidental findings.


Conclusions
aCGH is a valuable diagnostic tool when fetal malformations are detected. More affected fetuses may be diagnosed at an earlier gestational age providing better possibilities for postnatal treatment and allowing for women to decide earlier on termination of pregnancy. When a normal result has reduced the risk of significant chromosomal aberration, aCGH may facilitate parental decision-making on whether to continue the pregnancy.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12098" xmlns="http://purl.org/rss/1.0/"><title>Pregnancy in a non-communicating rudimentary uterine horn in an obese woman</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12098</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Pregnancy in a non-communicating rudimentary uterine horn in an obese woman</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Dorete Frydshou Munck, Algirdas Markauskas, Ronald Francis Lamont, Jan Stener Jørgensen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-26T06:47:10.53215-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12098</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12098</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12098</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12143" xmlns="http://purl.org/rss/1.0/"><title>Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12143</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ellinor Östensson, Ann-Cathrin Hellström, Kristina Hellman, Inger Gustavsson, Ulf Gyllensten, Erik Wilander, Niklas Zethraeus, Sonia Andersson</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-22T06:35:44.250847-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12143</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12143</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12143</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12143-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Background</h4><div class="para"><p>Human papillomavirus (HPV) testing is not currently used in primary cervical cancer screening in Sweden, and corresponding cost-effectiveness is unclear.</p></div></div>
<div class="section" id="aogs12143-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>From a societal perspective, to evaluate the cost-effectiveness of high-risk (HR)-HPV testing using self-collected vaginal samples.</p></div></div>
<div class="section" id="aogs12143-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>A cost-effectiveness analysis.</p></div></div>
<div class="section" id="aogs12143-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>The Swedish organized cervical cancer screening program.</p></div></div>
<div class="section" id="aogs12143-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>We constructed a model to simulate the natural history of cervical cancer using Swedish data on cervical cancer risk. For the base-case analysis we evaluated two screening strategies with different screening intervals: (i) cytology screening throughout the woman's lifetime (i.e. “conventional cytology strategy”) and (ii) conventional cytology screening until age 35 years, followed by HR-HPV testing using self-collected vaginal samples in women aged ≥35 years (i.e. “combination strategy”). Sensitivity analyses were performed, varying model parameters over a significant range of values to identify cost-effective screening strategies.</p></div></div>
<div class="section" id="aogs12143-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Average lifetime cost, discounted and undiscounted life-years gained, reduction in cervical cancer risk, incremental cost-effectiveness ratios with and without the cost of added life-years.</p></div></div>
<div class="section" id="aogs12143-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Depending on screening interval, the incremental cost-effectiveness ratios for the combination strategy ranged from €43 000 to €180 000 per life-years gained without the cost of added life-years, and from €74 000 to €206 000 with costs of added life-years included.</p></div></div>
<div class="section" id="aogs12143-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>The combination strategy with a 5-year screening interval is potentially cost-effective compared with no screening, and with current screening practice when using a threshold value of €80 000 per life-years gained.</p></div></div>
]]></content:encoded><description>


Background
Human papillomavirus (HPV) testing is not currently used in primary cervical cancer screening in Sweden, and corresponding cost-effectiveness is unclear.


Objective
From a societal perspective, to evaluate the cost-effectiveness of high-risk (HR)-HPV testing using self-collected vaginal samples.


Design
A cost-effectiveness analysis.


Setting
The Swedish organized cervical cancer screening program.


Methods
We constructed a model to simulate the natural history of cervical cancer using Swedish data on cervical cancer risk. For the base-case analysis we evaluated two screening strategies with different screening intervals: (i) cytology screening throughout the woman's lifetime (i.e. “conventional cytology strategy”) and (ii) conventional cytology screening until age 35 years, followed by HR-HPV testing using self-collected vaginal samples in women aged ≥35 years (i.e. “combination strategy”). Sensitivity analyses were performed, varying model parameters over a significant range of values to identify cost-effective screening strategies.


Main outcome measures
Average lifetime cost, discounted and undiscounted life-years gained, reduction in cervical cancer risk, incremental cost-effectiveness ratios with and without the cost of added life-years.


Results
Depending on screening interval, the incremental cost-effectiveness ratios for the combination strategy ranged from €43 000 to €180 000 per life-years gained without the cost of added life-years, and from €74 000 to €206 000 with costs of added life-years included.


Conclusion
The combination strategy with a 5-year screening interval is potentially cost-effective compared with no screening, and with current screening practice when using a threshold value of €80 000 per life-years gained.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12132" xmlns="http://purl.org/rss/1.0/"><title>Effectiveness of eye movement desensitization and reprocessing treatment in post-traumatic stress disorder after childbirth: a randomized controlled trial protocol</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12132</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Effectiveness of eye movement desensitization and reprocessing treatment in post-traumatic stress disorder after childbirth: a randomized controlled trial protocol</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Astrid George, Nathalie Thilly, Jenny A. Rydberg, Rita Luz, Elisabeth Spitz</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-22T06:30:56.740908-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12132</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12132</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12132</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Research Protocol</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12141" xmlns="http://purl.org/rss/1.0/"><title>Effect of self-hypnosis on duration of labor and maternal and neonatal outcomes: a randomized controlled trial</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12141</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Effect of self-hypnosis on duration of labor and maternal and neonatal outcomes: a randomized controlled trial</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Anette Werner, Niels Uldbjerg, Robert Zachariae, Ellen A. Nohr</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-22T06:30:48.966943-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12141</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12141</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12141</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12141-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To examine the effect of a brief course in self-hypnosis for childbirth on duration of the labor and other birth outcomes.</p></div></div>
<div class="section" id="aogs12141-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>A randomized, controlled, single-blind trial.</p></div></div>
<div class="section" id="aogs12141-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Aarhus University Hospital Skejby, Denmark.</p></div></div>
<div class="section" id="aogs12141-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>A total of 1222 healthy nulliparous women.</p></div></div>
<div class="section" id="aogs12141-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>A hypnosis group receiving three 1-h lessons in self-hypnosis with additional audio-recordings to ease childbirth, a relaxation group receiving three 1-h lessons in various relaxation methods and mindfulness with audio-recordings for additional training, and a usual-care group receiving only the usual antenatal care were compared.</p></div></div>
<div class="section" id="aogs12141-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Duration of labor, birth complications, lactation success, caring for the child, and preferred future mode of delivery.</p></div></div>
<div class="section" id="aogs12141-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>No differences were found across the three groups on duration from arriving at the birth department until the expulsive phase of second stage of labor, the duration of the expulsive phase, or other birth outcomes. Fewer emergency and more elective cesarean sections occurred in the hypnosis group. No difference was seen across the groups for lactation success or caring for the child but fewer women in the hypnosis group preferred a cesarean section in future pregnancies because of fear of childbirth and negative birth experiences.</p></div></div>
<div class="section" id="aogs12141-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Learning self-hypnosis to ease childbirth taught as a brief course failed to show any effects on duration of childbirth and other birth outcomes.</p></div></div>
]]></content:encoded><description>


Objective
To examine the effect of a brief course in self-hypnosis for childbirth on duration of the labor and other birth outcomes.


Design
A randomized, controlled, single-blind trial.


Setting
Aarhus University Hospital Skejby, Denmark.


Population
A total of 1222 healthy nulliparous women.


Methods
A hypnosis group receiving three 1-h lessons in self-hypnosis with additional audio-recordings to ease childbirth, a relaxation group receiving three 1-h lessons in various relaxation methods and mindfulness with audio-recordings for additional training, and a usual-care group receiving only the usual antenatal care were compared.


Main outcome measures
Duration of labor, birth complications, lactation success, caring for the child, and preferred future mode of delivery.


Results
No differences were found across the three groups on duration from arriving at the birth department until the expulsive phase of second stage of labor, the duration of the expulsive phase, or other birth outcomes. Fewer emergency and more elective cesarean sections occurred in the hypnosis group. No difference was seen across the groups for lactation success or caring for the child but fewer women in the hypnosis group preferred a cesarean section in future pregnancies because of fear of childbirth and negative birth experiences.


Conclusions
Learning self-hypnosis to ease childbirth taught as a brief course failed to show any effects on duration of childbirth and other birth outcomes.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12142" xmlns="http://purl.org/rss/1.0/"><title>Different ways of subcutaneous tissue and skin closure at cesarean section: a randomized clinical trial on the long-term cosmetic outcome</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12142</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Different ways of subcutaneous tissue and skin closure at cesarean section: a randomized clinical trial on the long-term cosmetic outcome</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Aleida G. Huppelschoten, Johanna C. Ginderen, Krista C. Broek, Anne E. Bouwma, Herman P. Oosterbaan</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-22T06:26:49.987908-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12142</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12142</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12142</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12142-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To study the effect of subcutaneous tissue closing and the effect of two different skin closure methods at cesarean section on long-term cosmetic results.</p></div></div>
<div class="section" id="aogs12142-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Randomized controlled trial.</p></div></div>
<div class="section" id="aogs12142-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>A large teaching hospital in the Netherlands.</p></div></div>
<div class="section" id="aogs12142-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>Women undergoing a cesarean section.</p></div></div>
<div class="section" id="aogs12142-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Women undergoing a cesarean section were assigned to subcutaneous tissue closure or not, and skin closure with staples or intracutaneous sutures. Operating time, postoperative pain and incidence of complications were recorded. Long-term cosmetic result was assessed 1 year postoperatively through the Patient and Observer Scar Assessment Scale (POSAS) and Numeric Rating Scale (NRS).</p></div></div>
<div class="section" id="aogs12142-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>The POSAS for subjective and objective scar rating and the NRS to provide an overall opinion on appearance of the scar 1 year after surgery.</p></div></div>
<div class="section" id="aogs12142-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Of the 218 women randomized, data from 145 women could be analysed after 1 year of follow-up. No significant differences were detected in long-term cosmetic outcome between the different closure methods. Except for operating time, no differences in other secondary outcome measures were found.</p></div></div>
<div class="section" id="aogs12142-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>At cesarean section, closing the subcutaneous tissue or not and using staples or intracutaneous sutures results in an equivalent long-term cosmetic appearance of the scar.</p></div></div>
]]></content:encoded><description>


Objective
To study the effect of subcutaneous tissue closing and the effect of two different skin closure methods at cesarean section on long-term cosmetic results.


Design
Randomized controlled trial.


Setting
A large teaching hospital in the Netherlands.


Population
Women undergoing a cesarean section.


Methods
Women undergoing a cesarean section were assigned to subcutaneous tissue closure or not, and skin closure with staples or intracutaneous sutures. Operating time, postoperative pain and incidence of complications were recorded. Long-term cosmetic result was assessed 1 year postoperatively through the Patient and Observer Scar Assessment Scale (POSAS) and Numeric Rating Scale (NRS).


Main outcome measures
The POSAS for subjective and objective scar rating and the NRS to provide an overall opinion on appearance of the scar 1 year after surgery.


Results
Of the 218 women randomized, data from 145 women could be analysed after 1 year of follow-up. No significant differences were detected in long-term cosmetic outcome between the different closure methods. Except for operating time, no differences in other secondary outcome measures were found.


Conclusions
At cesarean section, closing the subcutaneous tissue or not and using staples or intracutaneous sutures results in an equivalent long-term cosmetic appearance of the scar.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12140" xmlns="http://purl.org/rss/1.0/"><title>Education in obstetrical ultrasound – an important factor for increasing the prenatal detection of congenital heart disease</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12140</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Education in obstetrical ultrasound – an important factor for increasing the prenatal detection of congenital heart disease</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nina Asplin, Annika Dellgren, Peter Conner</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T03:18:10.304918-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12140</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12140</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12140</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12140-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To evaluate the effects of postgraduate education in obstetrical ultrasound on the prenatal detection rate of congenital heart disease.</p></div></div>
<div class="section" id="aogs12140-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Tertiary care center.</p></div></div>
<div class="section" id="aogs12140-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>Experienced and less experienced midwives performing ultrasound scans.</p></div></div>
<div class="section" id="aogs12140-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Number of fetuses and live-born children with severe congenital heart malformations were extracted from patient records. The detection rates of experienced and less experienced midwives were compared following a postgraduate training program in obstetrical ultrasound.</p></div></div>
<div class="section" id="aogs12140-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>The prenatal detection rate of complex congenital heart malformations.</p></div></div>
<div class="section" id="aogs12140-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>The prenatal detection rate for the entire unit increased significantly during the study period (32 vs. 69%, <em>p </em>&lt; 0.05). Following education, we observed a significant increase in detection rates (21 vs. 67%, <em>p </em>&lt; 0.01) among experienced midwives. In the group of less experienced midwives, we found a positive effect of training with considerably higher detection rates compared with results achieved by their more experienced colleagues before the program (40 vs. 21%).</p></div></div>
<div class="section" id="aogs12140-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>There is a clear improvement in the prenatal detection rates of complex heart malformations following a postgraduate education in obstetrical ultrasound. Similar training should be offered to both midwives and doctors performing routine scans to increase the standards of antenatal screening for congenital heart disease.</p></div></div>
]]></content:encoded><description>


Objective
To evaluate the effects of postgraduate education in obstetrical ultrasound on the prenatal detection rate of congenital heart disease.


Setting
Tertiary care center.


Population
Experienced and less experienced midwives performing ultrasound scans.


Methods
Number of fetuses and live-born children with severe congenital heart malformations were extracted from patient records. The detection rates of experienced and less experienced midwives were compared following a postgraduate training program in obstetrical ultrasound.


Main outcome measures
The prenatal detection rate of complex congenital heart malformations.


Results
The prenatal detection rate for the entire unit increased significantly during the study period (32 vs. 69%, p &lt; 0.05). Following education, we observed a significant increase in detection rates (21 vs. 67%, p &lt; 0.01) among experienced midwives. In the group of less experienced midwives, we found a positive effect of training with considerably higher detection rates compared with results achieved by their more experienced colleagues before the program (40 vs. 21%).


Conclusion
There is a clear improvement in the prenatal detection rates of complex heart malformations following a postgraduate education in obstetrical ultrasound. Similar training should be offered to both midwives and doctors performing routine scans to increase the standards of antenatal screening for congenital heart disease.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12136" xmlns="http://purl.org/rss/1.0/"><title>Adiponectin and endothelial markers in postmenopausal women taking oral or transdermal hormone therapy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12136</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Adiponectin and endothelial markers in postmenopausal women taking oral or transdermal hormone therapy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Barbara Ruszkowska, Alina Sokup, Arleta Kulwas, Justyna Kwapisz, Krzysztof Góralczyk, Maciej W. Socha, Piotr Rhone, Danuta Rość</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T03:18:06.941276-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12136</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12136</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12136</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12136-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To assess the concentration of adiponectin, soluble E-selectin, soluble thrombomodulin and tissue activator plasminogen antigen in postmenopausal women who received oral or transdermal hormone therapy.</p></div></div>
<div class="section" id="aogs12136-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Case–control study.</p></div></div>
<div class="section" id="aogs12136-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Polish university hospitals.</p></div></div>
<div class="section" id="aogs12136-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>Seventy-six healthy postmenopausal women.</p></div></div>
<div class="section" id="aogs12136-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Method</h4><div class="para"><p>Forty-six women who received oral (<em>n</em> = 26) or transdermal (<em>n</em> = 20) hormone therapy and a control group without such medication (<em>n</em> = 30), all aged 44–58 years.</p></div></div>
<div class="section" id="aogs12136-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Plasma concentrations of adiponectin, soluble E-selectin, soluble thrombomodulin and tissue activator plasminogen antigen by enzyme-linked immunosorbent assay.</p></div></div>
<div class="section" id="aogs12136-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>We found a significantly higher concentration of adiponectin in women on oral and transdermal therapy in comparison to the control group and a significantly lower concentration of soluble E-selectin in women who received oral hormone therapy vs. the control group. A significantly higher concentration of tissue activator plasminogen antigen was obtained in the group of women using transdermal menopausal hormone therapy compared with those receiving oral therapy and with the control group.</p></div></div>
<div class="section" id="aogs12136-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Reduced levels of soluble E-selectin in women using menopausal hormone therapy could lead to reduction in the intensity of expression of the adhesion factors on the surface of the vascular endothelium. Menopausal hormone therapy might have advantageous effects on vascular endothelial function through adiponectin. Transdermal therapy may have adverse effects associated with elevated tissue activator plasminogen antigen levels and thereby the higher risk of ischemic heart disease.</p></div></div>
]]></content:encoded><description>


Objective
To assess the concentration of adiponectin, soluble E-selectin, soluble thrombomodulin and tissue activator plasminogen antigen in postmenopausal women who received oral or transdermal hormone therapy.


Design
Case–control study.


Setting
Polish university hospitals.


Population
Seventy-six healthy postmenopausal women.


Method
Forty-six women who received oral (n = 26) or transdermal (n = 20) hormone therapy and a control group without such medication (n = 30), all aged 44–58 years.


Main outcome measures
Plasma concentrations of adiponectin, soluble E-selectin, soluble thrombomodulin and tissue activator plasminogen antigen by enzyme-linked immunosorbent assay.


Results
We found a significantly higher concentration of adiponectin in women on oral and transdermal therapy in comparison to the control group and a significantly lower concentration of soluble E-selectin in women who received oral hormone therapy vs. the control group. A significantly higher concentration of tissue activator plasminogen antigen was obtained in the group of women using transdermal menopausal hormone therapy compared with those receiving oral therapy and with the control group.


Conclusions
Reduced levels of soluble E-selectin in women using menopausal hormone therapy could lead to reduction in the intensity of expression of the adhesion factors on the surface of the vascular endothelium. Menopausal hormone therapy might have advantageous effects on vascular endothelial function through adiponectin. Transdermal therapy may have adverse effects associated with elevated tissue activator plasminogen antigen levels and thereby the higher risk of ischemic heart disease.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12133" xmlns="http://purl.org/rss/1.0/"><title>A long curved needle with a large radius for uterine compression suture</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12133</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A long curved needle with a large radius for uterine compression suture</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Hitoshi Yano, Tomoyuki Kuwata, Shuichi Kosuge, Shigeki Matsubara</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-18T03:17:58.95989-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12133</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12133</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12133</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12095" xmlns="http://purl.org/rss/1.0/"><title>Comparison of combined, biochemical and nuchal translucency screening for Down syndrome in first trimester in Northern Finland</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12095</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Comparison of combined, biochemical and nuchal translucency screening for Down syndrome in first trimester in Northern Finland</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sini Peuhkurinen, Paivi Laitinen, Timppa Honkasalo, Markku Ryynanen, Jaana Marttala</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-09T06:34:52.734953-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12095</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12095</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12095</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12095-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To compare the efficacy of fetal nuchal translucency screening, maternal serum screening and combined screening for Down syndrome.</p></div></div>
<div class="section" id="aogs12095-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>A prospective study.</p></div></div>
<div class="section" id="aogs12095-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>University hospital and its public health care district in Northern Finland.</p></div></div>
<div class="section" id="aogs12095-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>A total of 35 314 women participated in the first-trimester screening for Down syndrome within the public healthcare system in 2002–08. There were 95 pregnancies involving Down syndrome. Serum samples were obtained from 35 314 women, nuchal translucency was measured in 27 144 pregnancies and full combined screening was performed in those pregnancies, including 76 involving Down syndrome.</p></div></div>
<div class="section" id="aogs12095-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>The adjusted estimated risk for Down syndrome was calculated using the Perkin Elmer AutoDELFIA<sup>®</sup> time-resolved fluoroimmunoassay kit for the measurement of pregnancy-associated plasma protein-A and free β-human chorionic gonadotropin. Nuchal translucency was measured by trained personnel in a university or district hospital. Risk cut-off figures 1:250 and 1:300 at term were used.</p></div></div>
<div class="section" id="aogs12095-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Differences in detection rate, false-positive rate, positive and negative predictive values between nuchal translucency screening, serum screening and combined screening.</p></div></div>
<div class="section" id="aogs12095-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Using the risk cut-off figure 1:250, the detection rates for serum screening, nuchal translucency screening and combined screening were 64.2, 64.5 and 72.4%, respectively and the false-positive rates were 7.8, 4.4 and 4.0%, respectively.</p></div></div>
<div class="section" id="aogs12095-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Combined screening is the method of choice for Down syndrome screening in Finland.</p></div></div>
]]></content:encoded><description>


Objective
To compare the efficacy of fetal nuchal translucency screening, maternal serum screening and combined screening for Down syndrome.


Design
A prospective study.


Setting
University hospital and its public health care district in Northern Finland.


Population
A total of 35 314 women participated in the first-trimester screening for Down syndrome within the public healthcare system in 2002–08. There were 95 pregnancies involving Down syndrome. Serum samples were obtained from 35 314 women, nuchal translucency was measured in 27 144 pregnancies and full combined screening was performed in those pregnancies, including 76 involving Down syndrome.


Methods
The adjusted estimated risk for Down syndrome was calculated using the Perkin Elmer AutoDELFIA® time-resolved fluoroimmunoassay kit for the measurement of pregnancy-associated plasma protein-A and free β-human chorionic gonadotropin. Nuchal translucency was measured by trained personnel in a university or district hospital. Risk cut-off figures 1:250 and 1:300 at term were used.


Main outcome measures
Differences in detection rate, false-positive rate, positive and negative predictive values between nuchal translucency screening, serum screening and combined screening.


Results
Using the risk cut-off figure 1:250, the detection rates for serum screening, nuchal translucency screening and combined screening were 64.2, 64.5 and 72.4%, respectively and the false-positive rates were 7.8, 4.4 and 4.0%, respectively.


Conclusions
Combined screening is the method of choice for Down syndrome screening in Finland.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12129" xmlns="http://purl.org/rss/1.0/"><title>How do delivery mode and parity affect pelvic organ prolapse?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12129</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">How do delivery mode and parity affect pelvic organ prolapse?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">A. Özgür Yeniel, A. Mete Ergenoglu, Niyazi Askar, Ismaİl Mete Itil, Reci Meseri</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-08T02:50:23.699764-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12129</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12129</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12129</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12129-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To determine the association between mode of delivery, parity, and pelvic organ prolapse, as assessed by the pelvic organ prolapse quantification system.</p></div></div>
<div class="section" id="aogs12129-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Cross-sectional study.</p></div></div>
<div class="section" id="aogs12129-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Tertiary referral center, Turkey<b>.</b></p></div></div>
<div class="section" id="aogs12129-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>A total of 1964 women with benign gynecological disorders who presented between October 2009 and July 2011.</p></div></div>
<div class="section" id="aogs12129-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Evaluation using the pelvic organ prolapse quantification system and questionnaire assessing previous obstetrics and medical history.</p></div></div>
<div class="section" id="aogs12129-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Difference in pelvic organ prolapse stages between nulliparous and multiparous women, impact of parity and mode of delivery.</p></div></div>
<div class="section" id="aogs12129-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>In the study population, 86.4, 7.2 and 6.4% had pelvic organ prolapse of stages 0–I, II, and III–IV, respectively, and 7.9% had significant prolapse beyond the hymen. The mean age, parity, and number of vaginal deliveries were significantly higher in the prolapse than in the non-prolapse group. Vaginal delivery was associated with an odds ratio of 2.92 (95% confidence interval 1.19–7.17) for prolapse when compared with nulliparity. Each vaginal delivery increased the risk of prolapse (odds ratio 1.23; 95% confidence interval 1.12–1.35) after controlling for all confounding factors. Cesarean delivery had no impact on the odds for prolapse.</p></div></div>
<div class="section" id="aogs12129-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Vaginal delivery was an independent risk factor for prolapse, and additional vaginal deliveries significantly increased the risk. However, cesarean delivery had no effect on the development of prolapse in this material.</p></div></div>
]]></content:encoded><description>


Objective
To determine the association between mode of delivery, parity, and pelvic organ prolapse, as assessed by the pelvic organ prolapse quantification system.


Design
Cross-sectional study.


Setting
Tertiary referral center, Turkey.


Population
A total of 1964 women with benign gynecological disorders who presented between October 2009 and July 2011.


Methods
Evaluation using the pelvic organ prolapse quantification system and questionnaire assessing previous obstetrics and medical history.


Main outcome measures
Difference in pelvic organ prolapse stages between nulliparous and multiparous women, impact of parity and mode of delivery.


Results
In the study population, 86.4, 7.2 and 6.4% had pelvic organ prolapse of stages 0–I, II, and III–IV, respectively, and 7.9% had significant prolapse beyond the hymen. The mean age, parity, and number of vaginal deliveries were significantly higher in the prolapse than in the non-prolapse group. Vaginal delivery was associated with an odds ratio of 2.92 (95% confidence interval 1.19–7.17) for prolapse when compared with nulliparity. Each vaginal delivery increased the risk of prolapse (odds ratio 1.23; 95% confidence interval 1.12–1.35) after controlling for all confounding factors. Cesarean delivery had no impact on the odds for prolapse.


Conclusions
Vaginal delivery was an independent risk factor for prolapse, and additional vaginal deliveries significantly increased the risk. However, cesarean delivery had no effect on the development of prolapse in this material.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12137" xmlns="http://purl.org/rss/1.0/"><title>Comparative analysis of adiponectin isoform distribution in pregnant women with gestational diabetes mellitus and after delivery</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12137</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Comparative analysis of adiponectin isoform distribution in pregnant women with gestational diabetes mellitus and after delivery</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Beata Matuszek, Agata Burska, Bożena Leszczyńska–Gorzelak, Helena Donica, Andrzej Nowakowski</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-29T06:09:13.238541-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12137</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12137</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12137</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12137-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To evaluate the distribution of circulating adiponectin isoforms in pregnant women with gestational diabetes mellitus (GDM) and compare isoform distribution changes 12 months after delivery.</p></div></div>
<div class="section" id="aogs12137-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4></div>
<div class="section" id="aogs12137-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Cross-sectional study</h4></div>
<div class="section" id="aogs12137-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>University Hospital.</p></div></div>
<div class="section" id="aogs12137-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>Sixty-four consecutive pregnant women who underwent routine prenatal tests for GDM between 24 and 28 weeks of gestation. The study group included 36 women diagnosed with GDM, 30 of whom underwent re-testing for diabetes 12 months after delivery. The control group included 28 healthy pregnant women.</p></div></div>
<div class="section" id="aogs12137-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Quantitative determination of total adiponectin and its isoforms in serum was performed with the multimeric adiponectin enzyme-linked immunosorbent assay.</p></div></div>
<div class="section" id="aogs12137-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Total adiponectin concentration in women with GDM was significantly lower than in women without GDM. Among adiponectin isoforms, significantly lower concentrations of multimers and trimers in women with GDM were found in comparison to controls, while the concentration of hexamers did not differ between the groups. After delivery, a significant increase in total adiponectin and in the concentration of multimers and trimers was found in women with history of GDM. Additionally, we found that multimers and hexamers were negatively correlated with body mass index before and during gestation, as well as after delivery, and middle molecular weight isoforms in gestation were negatively correlated with birthweight.</p></div></div>
<div class="section" id="aogs12137-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Hypoadiponectinemia during GDM was characterized by a significant, reversible decrease in multimeric levels; thus this isoform seems to function in a cohesive way with total adiponectin. Negative correlations of adiponectin isomers with body mass index indicate that there is a possibility to normalize total adiponectin and prevent GDM.</p></div></div>
]]></content:encoded><description>


Objective
To evaluate the distribution of circulating adiponectin isoforms in pregnant women with gestational diabetes mellitus (GDM) and compare isoform distribution changes 12 months after delivery.


Design


Cross-sectional study


Setting
University Hospital.


Population
Sixty-four consecutive pregnant women who underwent routine prenatal tests for GDM between 24 and 28 weeks of gestation. The study group included 36 women diagnosed with GDM, 30 of whom underwent re-testing for diabetes 12 months after delivery. The control group included 28 healthy pregnant women.


Methods
Quantitative determination of total adiponectin and its isoforms in serum was performed with the multimeric adiponectin enzyme-linked immunosorbent assay.


Results
Total adiponectin concentration in women with GDM was significantly lower than in women without GDM. Among adiponectin isoforms, significantly lower concentrations of multimers and trimers in women with GDM were found in comparison to controls, while the concentration of hexamers did not differ between the groups. After delivery, a significant increase in total adiponectin and in the concentration of multimers and trimers was found in women with history of GDM. Additionally, we found that multimers and hexamers were negatively correlated with body mass index before and during gestation, as well as after delivery, and middle molecular weight isoforms in gestation were negatively correlated with birthweight.


Conclusions
Hypoadiponectinemia during GDM was characterized by a significant, reversible decrease in multimeric levels; thus this isoform seems to function in a cohesive way with total adiponectin. Negative correlations of adiponectin isomers with body mass index indicate that there is a possibility to normalize total adiponectin and prevent GDM.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12131" xmlns="http://purl.org/rss/1.0/"><title>Psychological determinants of pregnancy-related lumbopelvic pain: a prospective cohort study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12131</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Psychological determinants of pregnancy-related lumbopelvic pain: a prospective cohort study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Esther C. Bakker, Carola W. Nimwegen-Matzinger, Winneke Ekkel-van der Voorden, Marjan D. Nijkamp, Trijntje Völlink</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-29T05:18:18.736132-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12131</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12131</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12131</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12131-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To study whether pregnancy-related lumbopelvic pain outcomes at 36 weeks of gestation can be predicted by psychological determinants earlier in pregnancy.</p></div></div>
<div class="section" id="aogs12131-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Prospective cohort study.</p></div></div>
<div class="section" id="aogs12131-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Nine midwifery practices in different regions of the Netherlands.</p></div></div>
<div class="section" id="aogs12131-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>A cohort of 223 low-risk pregnant women in the Netherlands was followed from week 12 of gestation until 36 weeks of gestation.</p></div></div>
<div class="section" id="aogs12131-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Both psychological determinants and lumbopelvic pain symptoms were investigated with a set of questionnaires at 12, 24 and 36 weeks of gestation. Psychological determinants were measured with the Perceived Stress Scale (PSS), the Symptom Checklist-90-Revised (SCL-90), the Pregnancy-related Anxiety Questionnaire (PRAQ), and the Utrecht Coping List (UCL). Lumbopelvic pain outcomes were measured with the Pregnancy Mobility Index (PMI) and the Overall Complaints Index (OCI).</p></div></div>
<div class="section" id="aogs12131-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Lumbopelvic pain symptoms and their impact at 36 weeks of gestation.</p></div></div>
<div class="section" id="aogs12131-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>There was a significant increase in scores on both the PMI and OCI across the three sampling occasions in pregnancy. Lumbopelvic pain outcomes showed significant associations with the psychological determinants perceived stress and recently perceived psychological and physical distress at all three times during pregnancy. Pregnancy-related anxiety was not a significant predictor of lumbopelvic pain outcomes, neither was coping.</p></div></div>
<div class="section" id="aogs12131-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Lumbopelvic pain symptoms and their impact on daily activities at 36 weeks of gestation can be predicted by psychological determinants earlier in pregnancy; the combination of perceived stress and physical disability at 24 weeks of pregnancy seems to be the best predictor of disability in later pregnancy.</p></div></div>
]]></content:encoded><description>


Objective
To study whether pregnancy-related lumbopelvic pain outcomes at 36 weeks of gestation can be predicted by psychological determinants earlier in pregnancy.


Design
Prospective cohort study.


Setting
Nine midwifery practices in different regions of the Netherlands.


Population
A cohort of 223 low-risk pregnant women in the Netherlands was followed from week 12 of gestation until 36 weeks of gestation.


Methods
Both psychological determinants and lumbopelvic pain symptoms were investigated with a set of questionnaires at 12, 24 and 36 weeks of gestation. Psychological determinants were measured with the Perceived Stress Scale (PSS), the Symptom Checklist-90-Revised (SCL-90), the Pregnancy-related Anxiety Questionnaire (PRAQ), and the Utrecht Coping List (UCL). Lumbopelvic pain outcomes were measured with the Pregnancy Mobility Index (PMI) and the Overall Complaints Index (OCI).


Main outcome measures
Lumbopelvic pain symptoms and their impact at 36 weeks of gestation.


Results
There was a significant increase in scores on both the PMI and OCI across the three sampling occasions in pregnancy. Lumbopelvic pain outcomes showed significant associations with the psychological determinants perceived stress and recently perceived psychological and physical distress at all three times during pregnancy. Pregnancy-related anxiety was not a significant predictor of lumbopelvic pain outcomes, neither was coping.


Conclusions
Lumbopelvic pain symptoms and their impact on daily activities at 36 weeks of gestation can be predicted by psychological determinants earlier in pregnancy; the combination of perceived stress and physical disability at 24 weeks of pregnancy seems to be the best predictor of disability in later pregnancy.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12114" xmlns="http://purl.org/rss/1.0/"><title>The effects of reducing the thermal index for bone from 1.0 to 0.5 and 0.1 on common obstetric pulsed wave Doppler measurements in the second half of pregnancy</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12114</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The effects of reducing the thermal index for bone from 1.0 to 0.5 and 0.1 on common obstetric pulsed wave Doppler measurements in the second half of pregnancy</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ragnar K. Sande, Knut Matre, Geir E. Eide, Torvid Kiserud</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-21T08:17:07.406497-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12114</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12114</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12114</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12114-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To test the hypothesis that clinically relevant vessels can be visualized and interrogated with Doppler recording during the second half of pregnancy at an output energy below the currently advocated limits without loss of information.</p></div></div>
<div class="section" id="aogs12114-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Observational cross-sectional study.</p></div></div>
<div class="section" id="aogs12114-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Tertiary fetal medicine center.</p></div></div>
<div class="section" id="aogs12114-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Sample</h4><div class="para"><p>Based on a power calculation for equivalence studies, we recruited 65 pregnant women.</p></div></div>
<div class="section" id="aogs12114-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Ultrasound examination was performed at 18, 24 or 36 weeks of gestation. The umbilical artery, middle cerebral artery, ductus venosus, and both uterine arteries were identified using color Doppler, and the blood velocities were measured using pulsed wave Doppler at a thermal index for bone (TIB) of 1.0. This procedure was repeated at TIB values of 0.5 and 0.1. The depth of Doppler recording was noted.</p></div></div>
<div class="section" id="aogs12114-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Visualization of the vessels by color Doppler at all power levels and any systematic changes or increased variance of the recorded parameters with decreasing power level.</p></div></div>
<div class="section" id="aogs12114-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>All vessels could be visualized by color Doppler and their flow velocities measured using pulsed wave Doppler in all participants and at all power levels. There were no systematic changes or increased parameter variance when reducing the power level, despite the insonation depth being significantly greater than in early pregnancy.</p></div></div>
<div class="section" id="aogs12114-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Reducing the ultrasound power from TIB 1.0 to 0.1 does not alter color Doppler visualization or pulsed wave Doppler measurements in the second half of pregnancy. The lower power level can be recommended as a starting point for clinical examinations throughout pregnancy.</p></div></div>
]]></content:encoded><description>


Objective
To test the hypothesis that clinically relevant vessels can be visualized and interrogated with Doppler recording during the second half of pregnancy at an output energy below the currently advocated limits without loss of information.


Design
Observational cross-sectional study.


Setting
Tertiary fetal medicine center.


Sample
Based on a power calculation for equivalence studies, we recruited 65 pregnant women.


Methods
Ultrasound examination was performed at 18, 24 or 36 weeks of gestation. The umbilical artery, middle cerebral artery, ductus venosus, and both uterine arteries were identified using color Doppler, and the blood velocities were measured using pulsed wave Doppler at a thermal index for bone (TIB) of 1.0. This procedure was repeated at TIB values of 0.5 and 0.1. The depth of Doppler recording was noted.


Main outcome measures
Visualization of the vessels by color Doppler at all power levels and any systematic changes or increased variance of the recorded parameters with decreasing power level.


Results
All vessels could be visualized by color Doppler and their flow velocities measured using pulsed wave Doppler in all participants and at all power levels. There were no systematic changes or increased parameter variance when reducing the power level, despite the insonation depth being significantly greater than in early pregnancy.


Conclusions
Reducing the ultrasound power from TIB 1.0 to 0.1 does not alter color Doppler visualization or pulsed wave Doppler measurements in the second half of pregnancy. The lower power level can be recommended as a starting point for clinical examinations throughout pregnancy.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12115" xmlns="http://purl.org/rss/1.0/"><title>Pre-pregnant body mass index, gestational weight gain and the risk of operative delivery</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12115</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Pre-pregnant body mass index, gestational weight gain and the risk of operative delivery</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nils-Halvdan Morken, Kari Klungsøyr, Per Magnus, Rolv Skjærven</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-19T01:24:55.27341-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12115</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12115</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12115</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12115-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To estimate the risk of operative delivery according to maternal pre-pregnant body mass index (BMI) and gestational weight gain.</p></div></div>
<div class="section" id="aogs12115-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Population-based pregnancy cohort study.</p></div></div>
<div class="section" id="aogs12115-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>The Norwegian Mother and Child Cohort Study.</p></div></div>
<div class="section" id="aogs12115-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Sample</h4><div class="para"><p>Term singleton deliveries in cephalic presentation, excluding preeclampsia, chronic hypertension, diabetes, gestational diabetes and placenta previa (<em>n </em>=<em> </em>50 416).</p></div></div>
<div class="section" id="aogs12115-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Relative risks (RR) were obtained using general linear models.</p></div></div>
<div class="section" id="aogs12115-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>RR of operative vaginal delivery and cesarean section.</p></div></div>
<div class="section" id="aogs12115-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Overweight and obese women had an increased risk of cesarean section, strongest for women with a pre-pregnancy BMI &gt;40 (RR: 3.4, 95% confidence interval (CI): 2.8–4.1). There was also an increased risk of vacuum extraction delivery for women with a pre-pregnancy BMI &gt;40 (RR: 1.5, 95% CI: 1.04–2.2). Women with a gestational weight gain of ≥16 kg had a significantly increased risk of forceps, vacuum extraction and cesarean section (RR: 1.2, 95% CI: 1.03–1.4, RR: 1.2, 95% CI: 1.1–1.23 and RR: 1.3, 95% CI: 1.26–1.4, respectively). Weight gain during pregnancy was significantly lower in obese women, but the children tended to be larger.</p></div></div>
<div class="section" id="aogs12115-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Obese women have an increased risk of operative delivery with vacuum extraction and cesarean section. Independently of pre-pregnancy BMI, we found an increased risk of operative intervention during delivery for women with gestational weight gain above 16 kg.</p></div></div>
]]></content:encoded><description>


Objective
To estimate the risk of operative delivery according to maternal pre-pregnant body mass index (BMI) and gestational weight gain.


Design
Population-based pregnancy cohort study.


Setting
The Norwegian Mother and Child Cohort Study.


Sample
Term singleton deliveries in cephalic presentation, excluding preeclampsia, chronic hypertension, diabetes, gestational diabetes and placenta previa (n = 50 416).


Methods
Relative risks (RR) were obtained using general linear models.


Main outcome measures
RR of operative vaginal delivery and cesarean section.


Results
Overweight and obese women had an increased risk of cesarean section, strongest for women with a pre-pregnancy BMI &gt;40 (RR: 3.4, 95% confidence interval (CI): 2.8–4.1). There was also an increased risk of vacuum extraction delivery for women with a pre-pregnancy BMI &gt;40 (RR: 1.5, 95% CI: 1.04–2.2). Women with a gestational weight gain of ≥16 kg had a significantly increased risk of forceps, vacuum extraction and cesarean section (RR: 1.2, 95% CI: 1.03–1.4, RR: 1.2, 95% CI: 1.1–1.23 and RR: 1.3, 95% CI: 1.26–1.4, respectively). Weight gain during pregnancy was significantly lower in obese women, but the children tended to be larger.


Conclusions
Obese women have an increased risk of operative delivery with vacuum extraction and cesarean section. Independently of pre-pregnancy BMI, we found an increased risk of operative intervention during delivery for women with gestational weight gain above 16 kg.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12116" xmlns="http://purl.org/rss/1.0/"><title>Long-term adherence to follow-up after treatment of cervical intraepithelial neoplasia: nationwide population-based study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12116</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Long-term adherence to follow-up after treatment of cervical intraepithelial neoplasia: nationwide population-based study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Sidsel S. Barken, Elsebeth Lynge, Erik S. Andersen, Matejka Rebolj</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-12T05:44:19.105819-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12116</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12116</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12116</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12116-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To measure adherence to annual follow-up among women treated for cervical intraepithelial neoplasia.</p></div></div>
<div class="section" id="aogs12116-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Prospective, population-based, register study.</p></div></div>
<div class="section" id="aogs12116-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Denmark, 1996–2007.</p></div></div>
<div class="section" id="aogs12116-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>All women treated for cervical intraepithelial neoplasia with conization.</p></div></div>
<div class="section" id="aogs12116-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Treated women were routinely recommended to have follow-up with annual smears for at least 5 years.</p></div></div>
<div class="section" id="aogs12116-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Using individually linked nationwide register data on conizations and follow-up tests (smears and biopsies), we calculated the cumulative proportion of treated women undergoing the recommended follow-up. We measured this cumulative proportion conservatively in 15-month intervals for 5 years.</p></div></div>
<div class="section" id="aogs12116-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Adherence to annual follow-up among 45 984 treated women decreased gradually. In total, 90% of these women obtained at least one smear in the first post-treatment year, but only 40% obtained the recommended tests for 5 years. Five-year adherence was substantially better outside the capital area, for example, the odds ratio for women from Jutland compared with women from the capital area was 1.70 (95% confidence interval 1.60–1.82).</p></div></div>
<div class="section" id="aogs12116-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Adherence to follow-up after conization was poor in Denmark. Our findings suggest that because of this poor adherence, recommendations for long-term annual follow-up after treatment of cervical intraepithelial neoplasia may not be highly effective. Shorter follow-up schedules using highly sensitive tests appear attractive.</p></div></div>
]]></content:encoded><description>


Objective
To measure adherence to annual follow-up among women treated for cervical intraepithelial neoplasia.


Design
Prospective, population-based, register study.


Setting
Denmark, 1996–2007.


Population
All women treated for cervical intraepithelial neoplasia with conization.


Methods
Treated women were routinely recommended to have follow-up with annual smears for at least 5 years.


Main outcome measures
Using individually linked nationwide register data on conizations and follow-up tests (smears and biopsies), we calculated the cumulative proportion of treated women undergoing the recommended follow-up. We measured this cumulative proportion conservatively in 15-month intervals for 5 years.


Results
Adherence to annual follow-up among 45 984 treated women decreased gradually. In total, 90% of these women obtained at least one smear in the first post-treatment year, but only 40% obtained the recommended tests for 5 years. Five-year adherence was substantially better outside the capital area, for example, the odds ratio for women from Jutland compared with women from the capital area was 1.70 (95% confidence interval 1.60–1.82).


Conclusions
Adherence to follow-up after conization was poor in Denmark. Our findings suggest that because of this poor adherence, recommendations for long-term annual follow-up after treatment of cervical intraepithelial neoplasia may not be highly effective. Shorter follow-up schedules using highly sensitive tests appear attractive.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12104" xmlns="http://purl.org/rss/1.0/"><title>Placental weight relative to birthweight in pregnancies with maternal diabetes mellitus</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12104</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Placental weight relative to birthweight in pregnancies with maternal diabetes mellitus</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ellen M. Strøm-Roum, Camilla Haavaldsen, Tom G. Tanbo, Anne Eskild</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-09T01:59:47.963864-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12104</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12104</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12104</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12104-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objectives</h4><div class="para"><p>To study the association of maternal diabetes mellitus with placental weight, birthweight and placental weight-to-birthweight ratio.</p></div></div>
<div class="section" id="aogs12104-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Population-based study.</p></div></div>
<div class="section" id="aogs12104-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Medical Birth Registry of Norway.</p></div></div>
<div class="section" id="aogs12104-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>All singleton births in Norway during 1999–2008 (<em>n</em> = 536 997).</p></div></div>
<div class="section" id="aogs12104-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>We compared the distribution of placental weight z-scores and placental weight-to-birthweight ratio between pregnancies with and without diabetes. The associations of diabetes with placental weight z-scores were also estimated as odds ratios with and without adjustment for birthweight, maternal age, parity, preeclampsia, smoking and cesarean delivery.</p></div></div>
<div class="section" id="aogs12104-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Placental weight, birthweight and placental weight-to-birthweight ratio.</p></div></div>
<div class="section" id="aogs12104-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Mean placental weight was 736.6 g in diabetic pregnancies and 672.1 g in non-diabetic pregnancies. The corresponding birthweights were 3682.1 g and 3557.0 g. In diabetic pregnancies, 26.2% of the placentas were in the highest decile of placental weight z-score, as compared with 9.7% in non-diabetic pregnancies (<em>p </em>&lt; 0.001). The corresponding figures for being in the highest decile of placental weight-to-birthweight ratio were 18.2 and 9.9% (<em>p </em>&lt; 0.001). The crude odds ratio for having a placenta in the highest decile of placental weight z-score was 3.29 (95% confidence interval 3.14–3.45) in diabetic pregnancies with non-diabetic pregnancies as the reference. After adjustment for birthweight and other variables, the odds ratio was 2.42 (95% confidence interval 2.29–2.56).</p></div></div>
<div class="section" id="aogs12104-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>In diabetic pregnancies, placental weight as well as placental weight relative to birthweight were higher than in non-diabetic pregnancies.</p></div></div>
]]></content:encoded><description>


Objectives
To study the association of maternal diabetes mellitus with placental weight, birthweight and placental weight-to-birthweight ratio.


Design
Population-based study.


Setting
Medical Birth Registry of Norway.


Population
All singleton births in Norway during 1999–2008 (n = 536 997).


Methods
We compared the distribution of placental weight z-scores and placental weight-to-birthweight ratio between pregnancies with and without diabetes. The associations of diabetes with placental weight z-scores were also estimated as odds ratios with and without adjustment for birthweight, maternal age, parity, preeclampsia, smoking and cesarean delivery.


Main outcome measures
Placental weight, birthweight and placental weight-to-birthweight ratio.


Results
Mean placental weight was 736.6 g in diabetic pregnancies and 672.1 g in non-diabetic pregnancies. The corresponding birthweights were 3682.1 g and 3557.0 g. In diabetic pregnancies, 26.2% of the placentas were in the highest decile of placental weight z-score, as compared with 9.7% in non-diabetic pregnancies (p &lt; 0.001). The corresponding figures for being in the highest decile of placental weight-to-birthweight ratio were 18.2 and 9.9% (p &lt; 0.001). The crude odds ratio for having a placenta in the highest decile of placental weight z-score was 3.29 (95% confidence interval 3.14–3.45) in diabetic pregnancies with non-diabetic pregnancies as the reference. After adjustment for birthweight and other variables, the odds ratio was 2.42 (95% confidence interval 2.29–2.56).


Conclusions
In diabetic pregnancies, placental weight as well as placental weight relative to birthweight were higher than in non-diabetic pregnancies.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12096" xmlns="http://purl.org/rss/1.0/"><title>Effects of craniosacral therapy as adjunct to standard treatment for pelvic girdle pain in pregnant women: a multicenter, single blind, randomized controlled trial</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12096</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Effects of craniosacral therapy as adjunct to standard treatment for pelvic girdle pain in pregnant women: a multicenter, single blind, randomized controlled trial</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Helen Elden, Hans-Christian Östgaard, Anna Glantz, Pia Marciniak, Ann-Charlotte Linnér, Monika Fagevik Olsén</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-04T06:57:30.739295-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12096</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12096</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12096</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12096-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>Pelvic girdle pain (PGP) is a disabling condition affecting 30% of pregnant women. The aim of this study was to investigate the efficacy of craniosacral therapy as an adjunct to standard treatment compared with standard treatment alone for PGP during pregnancy.</p></div></div>
<div class="section" id="aogs12096-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Randomized, multicenter, single blind, controlled trial.</p></div></div>
<div class="section" id="aogs12096-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>University hospital, a private clinic and 26 maternity care centers in Gothenburg, Sweden.</p></div></div>
<div class="section" id="aogs12096-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>A total of 123 pregnant women with PGP.</p></div></div>
<div class="section" id="aogs12096-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Participants were randomly assigned to standard treatment (control group, <em>n</em> = 60) or standard treatment plus craniosacral therapy (intervention group, <em>n</em> = 63).</p></div></div>
<div class="section" id="aogs12096-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Primary outcome measures: pain intensity (visual analog scale 0–100 mm) and sick leave. Secondary outcomes: function (Oswestry Disability Index), health-related quality of life (European Quality of Life measure), unpleasantness of pain (visual analog scale), and assessment of the severity of PGP by an independent examiner.</p></div></div>
<div class="section" id="aogs12096-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Between-group differences for morning pain, symptom-free women and function in the last treatment week were in favor of the intervention group. Visual analog scale median was 27 mm (95% confidence interval 24.6–35.9) vs. 35 mm (95% confidence interval 33.5–45.7) (<em>p </em>= 0.017) and the function disability index was 40 (range 34–46) vs. 48 (range 40–56) (<em>p</em> = 0.016).</p></div></div>
<div class="section" id="aogs12096-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Lower morning pain intensity and less deteriorated function was seen after craniosacral therapy in conjunction with standard treatment compared with standard treatment alone, but no effects regarding evening pain and sick-leave. Treatment effects were small and clinically questionable and conclusions should be drawn carefully. Further studies are warranted before recommending craniosacral therapy for PGP.</p></div></div>
]]></content:encoded><description>


Objective
Pelvic girdle pain (PGP) is a disabling condition affecting 30% of pregnant women. The aim of this study was to investigate the efficacy of craniosacral therapy as an adjunct to standard treatment compared with standard treatment alone for PGP during pregnancy.


Design
Randomized, multicenter, single blind, controlled trial.


Setting
University hospital, a private clinic and 26 maternity care centers in Gothenburg, Sweden.


Population
A total of 123 pregnant women with PGP.


Methods
Participants were randomly assigned to standard treatment (control group, n = 60) or standard treatment plus craniosacral therapy (intervention group, n = 63).


Main outcome measures
Primary outcome measures: pain intensity (visual analog scale 0–100 mm) and sick leave. Secondary outcomes: function (Oswestry Disability Index), health-related quality of life (European Quality of Life measure), unpleasantness of pain (visual analog scale), and assessment of the severity of PGP by an independent examiner.


Results
Between-group differences for morning pain, symptom-free women and function in the last treatment week were in favor of the intervention group. Visual analog scale median was 27 mm (95% confidence interval 24.6–35.9) vs. 35 mm (95% confidence interval 33.5–45.7) (p = 0.017) and the function disability index was 40 (range 34–46) vs. 48 (range 40–56) (p = 0.016).


Conclusions
Lower morning pain intensity and less deteriorated function was seen after craniosacral therapy in conjunction with standard treatment compared with standard treatment alone, but no effects regarding evening pain and sick-leave. Treatment effects were small and clinically questionable and conclusions should be drawn carefully. Further studies are warranted before recommending craniosacral therapy for PGP.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12062" xmlns="http://purl.org/rss/1.0/"><title>Birth outcomes of cases with isolated atrial septal defect type II – a population-based case-control study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12062</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Birth outcomes of cases with isolated atrial septal defect type II – a population-based case-control study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Attila Vereczkey, Zsolt Kósa, Melinda Csáky-Szunyogh, Róbert Urbán, Andrew E. Czeizel</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-21T07:55:31.163051-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12062</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12062</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12062</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">n/a</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12062-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objectives</h4><div class="para"><p>In general, epidemiological studies have evaluated cases with congenital cardiovascular abnormalities together. The aim of this study is to describe the birth outcomes of cases with isolated/single atrial septal defect type II (ASD-II, i.e. only a fossa ovalis defect) after surgical correction or lethal outcome in the light of maternal sociodemographic data.</p></div></div>
<div class="section" id="aogs12062-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Comparison of birth outcomes and maternal characteristics of cases with ASD-II and controls without defect.</p></div></div>
<div class="section" id="aogs12062-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>The population-based Hungarian Case-Control Surveillance of Congenital Abnormalities.</p></div></div>
<div class="section" id="aogs12062-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>Hungarian newborn infants with or without ASD-II.</p></div></div>
<div class="section" id="aogs12062-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Medically recorded birth outcomes, maternal age and birth order were evaluated. Marital and employment status was based on maternal information. The lifestyle factors were analyzed in a subsample of mothers visited at home based on a personal interview with mothers and their close relatives, and the family consensus was accepted.</p></div></div>
<div class="section" id="aogs12062-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Mean gestational age at delivery and birthweight, rate of preterm birth and low birthweight, maternal age, birth order, marital and employment status.</p></div></div>
<div class="section" id="aogs12062-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>The evaluation of 471 cases with ASD-II and 38 151 controls without any defects showed a female excess in cases with ASD-II, having shorter gestational age and lower mean birthweight, and thus a higher rate of preterm births and low birthweight.</p></div></div>
<div class="section" id="aogs12062-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Intrauterine growth restriction and shorter gestational age were found in cases with ASD-II, particularly in female children. These factors may have a general developmental process in which there was not closure of the foramen ovale, thus echocardiographic screening of these babies might be of value.</p></div></div>
]]></content:encoded><description>


Objectives
In general, epidemiological studies have evaluated cases with congenital cardiovascular abnormalities together. The aim of this study is to describe the birth outcomes of cases with isolated/single atrial septal defect type II (ASD-II, i.e. only a fossa ovalis defect) after surgical correction or lethal outcome in the light of maternal sociodemographic data.


Design
Comparison of birth outcomes and maternal characteristics of cases with ASD-II and controls without defect.


Setting
The population-based Hungarian Case-Control Surveillance of Congenital Abnormalities.


Population
Hungarian newborn infants with or without ASD-II.


Methods
Medically recorded birth outcomes, maternal age and birth order were evaluated. Marital and employment status was based on maternal information. The lifestyle factors were analyzed in a subsample of mothers visited at home based on a personal interview with mothers and their close relatives, and the family consensus was accepted.


Main outcome measures
Mean gestational age at delivery and birthweight, rate of preterm birth and low birthweight, maternal age, birth order, marital and employment status.


Results
The evaluation of 471 cases with ASD-II and 38 151 controls without any defects showed a female excess in cases with ASD-II, having shorter gestational age and lower mean birthweight, and thus a higher rate of preterm births and low birthweight.


Conclusions
Intrauterine growth restriction and shorter gestational age were found in cases with ASD-II, particularly in female children. These factors may have a general developmental process in which there was not closure of the foramen ovale, thus echocardiographic screening of these babies might be of value.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12153" xmlns="http://purl.org/rss/1.0/"><title>How to improve the quality of research reporting?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12153</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">How to improve the quality of research reporting?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Henriette Svarre Nielsen, Seppo Heinonen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-16T10:05:31.37254-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12153</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12153</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12153</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Editors Message</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">611</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">612</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12091" xmlns="http://purl.org/rss/1.0/"><title>The admission CTG: is there any evidence for still using the test?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12091</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">The admission CTG: is there any evidence for still using the test?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ellen Blix</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-09T01:01:39.959894-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12091</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12091</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12091</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Commentary</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">613</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">619</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Admission cardiotocography (CTG) was introduced as a screening test for fetal distress in labor in the late 1980s. No systematic assessments of the test were performed before it was taken into widespread use. A screening test is meant to identify individuals with an increased risk for a disease or condition before symptoms occur, to prevent and reduce morbidity or mortality. A screening test should be evaluated according to its effectiveness, prognostic values and reliability. A careful review of the research literature states that routine use of the admission CTG in low-risk women increases the incidence of minor obstetric interventions, may increase the incidence of cesarean sections, but has no impact on other important outcomes. The prognostic values are poor, and the reliability varies from good to poor. There is no evidence showing that the admission CTG is beneficial, and the test should not be offered to low-risk women.</p></div>
]]></content:encoded><description>

Admission cardiotocography (CTG) was introduced as a screening test for fetal distress in labor in the late 1980s. No systematic assessments of the test were performed before it was taken into widespread use. A screening test is meant to identify individuals with an increased risk for a disease or condition before symptoms occur, to prevent and reduce morbidity or mortality. A screening test should be evaluated according to its effectiveness, prognostic values and reliability. A careful review of the research literature states that routine use of the admission CTG in low-risk women increases the incidence of minor obstetric interventions, may increase the incidence of cesarean sections, but has no impact on other important outcomes. The prognostic values are poor, and the reliability varies from good to poor. There is no evidence showing that the admission CTG is beneficial, and the test should not be offered to low-risk women.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1600-0412.2012.01473.x" xmlns="http://purl.org/rss/1.0/"><title>New developments in the treatment of osteoporosis</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1600-0412.2012.01473.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">New developments in the treatment of osteoporosis</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">ERIK FINK ERIKSEN, JOHAN HALSE, METTE HAASE MOEN</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-05-16T10:05:31.37254-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0412.2012.01473.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0412.2012.01473.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1600-0412.2012.01473.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">REVIEW ARTICLE</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">620</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">636</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract </h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>The last 25 years have seen the development of a plethora of new, effective agents for the treatment of osteoporosis. These agents reduce the risk of spine fractures by up to 70%, hip fractures by 40–50% and non-vertebral fractures by up to 50–80%. Amino-bisphosphonates, taken orally or intravenously, remain the dominant treatment modalities for osteoporosis. These so-called anti-resorptive or anti-catabolic agents stabilize the skeleton and reduce fracture risk in osteoporotic as well as osteopenic individuals. A monoclonal antibody against receptor activator of nuclear factor κB ligand, Denosumab, constitutes a new anti-resorptive agent recently approved worldwide. In younger postmenopausal women, low-dose estrogen or estrogen/progestin still has a place for short-term (up to 5 years) preservation of bone mass, especially in women with menopausal symptoms. Likewise, selective estrogen receptor modulators should be considered in younger postmenopausal women, especially those at increased risk of breast cancer. Anabolic (bone forming) regimens, of which parathyroid hormone is the only agent currently available, aid in the build up of new bone, increase bone mass and improve bone architecture. In cancellous bone, 30–60% increases of bone mass have been documented, but cortical bone thickness also increases. These improvements lead to profound reduction in fracture rates in both the axial and appendicular skeleton. Owing to cost and the need for parenteral administration, in most countries these agents are reserved for severe osteoporosis with multiple fractures.</p></div>
]]></content:encoded><description>

The last 25 years have seen the development of a plethora of new, effective agents for the treatment of osteoporosis. These agents reduce the risk of spine fractures by up to 70%, hip fractures by 40–50% and non-vertebral fractures by up to 50–80%. Amino-bisphosphonates, taken orally or intravenously, remain the dominant treatment modalities for osteoporosis. These so-called anti-resorptive or anti-catabolic agents stabilize the skeleton and reduce fracture risk in osteoporotic as well as osteopenic individuals. A monoclonal antibody against receptor activator of nuclear factor κB ligand, Denosumab, constitutes a new anti-resorptive agent recently approved worldwide. In younger postmenopausal women, low-dose estrogen or estrogen/progestin still has a place for short-term (up to 5 years) preservation of bone mass, especially in women with menopausal symptoms. Likewise, selective estrogen receptor modulators should be considered in younger postmenopausal women, especially those at increased risk of breast cancer. Anabolic (bone forming) regimens, of which parathyroid hormone is the only agent currently available, aid in the build up of new bone, increase bone mass and improve bone architecture. In cancellous bone, 30–60% increases of bone mass have been documented, but cortical bone thickness also increases. These improvements lead to profound reduction in fracture rates in both the axial and appendicular skeleton. Owing to cost and the need for parenteral administration, in most countries these agents are reserved for severe osteoporosis with multiple fractures.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12111" xmlns="http://purl.org/rss/1.0/"><title>Can transabdominal ultrasound identify women at high risk for short cervical length?</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12111</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Can transabdominal ultrasound identify women at high risk for short cervical length?</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Alexander M. Friedman, Nadav Schwartz, Jack Ludmir, Samuel Parry, Jamie A. Bastek, Harish M. Sehdev</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-17T05:23:37.233322-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12111</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12111</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12111</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">637</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">641</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12111-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To determine whether transabdominal cervical length screening could identify women at high risk for having a short cervix on transvaginal ultrasound.</p></div></div>
<div class="section" id="aogs12111-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Retrospective cohort study.</p></div></div>
<div class="section" id="aogs12111-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Tertiary referral center.</p></div></div>
<div class="section" id="aogs12111-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>A total of 703 patients with a singleton pregnancy at 18 to 23<sup>+6</sup> weeks of gestation who underwent transabdominal and transvaginal cervical length assessment during anatomy ultrasound at a single institution between January 2007 and October 2011.</p></div></div>
<div class="section" id="aogs12111-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Electronic medical records were reviewed to identify women who met the study criteria.</p></div></div>
<div class="section" id="aogs12111-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>The primary outcome was the number of women with a short transabdominal cervical length (defined as ≤30 mm) who needed to undergo transvaginal ultrasound to detect one woman with a short transvaginal cervical length of ≤20 mm.</p></div></div>
<div class="section" id="aogs12111-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>In all, 703 patients were included in the primary analysis; 3.42 women with transabdominal cervical length ≤30 mm needed to undergo transvaginal ultrasound to detect one woman with transvaginal ultrasound cervical length ≤20 mm. Of women with short transvaginal cervical length ≤20 mm, 89.8% had a transabdominal measurement ≤30 mm and 96.7% had a transabdominal measurement ≤33 mm.</p></div></div>
<div class="section" id="aogs12111-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Screening of transabdominal cervical length may represent a useful strategy for detecting women with short cervix on transvaginal ultrasound.</p></div></div>
]]></content:encoded><description>


Objective
To determine whether transabdominal cervical length screening could identify women at high risk for having a short cervix on transvaginal ultrasound.


Design
Retrospective cohort study.


Setting
Tertiary referral center.


Population
A total of 703 patients with a singleton pregnancy at 18 to 23+6 weeks of gestation who underwent transabdominal and transvaginal cervical length assessment during anatomy ultrasound at a single institution between January 2007 and October 2011.


Methods
Electronic medical records were reviewed to identify women who met the study criteria.


Main outcome measures
The primary outcome was the number of women with a short transabdominal cervical length (defined as ≤30 mm) who needed to undergo transvaginal ultrasound to detect one woman with a short transvaginal cervical length of ≤20 mm.


Results
In all, 703 patients were included in the primary analysis; 3.42 women with transabdominal cervical length ≤30 mm needed to undergo transvaginal ultrasound to detect one woman with transvaginal ultrasound cervical length ≤20 mm. Of women with short transvaginal cervical length ≤20 mm, 89.8% had a transabdominal measurement ≤30 mm and 96.7% had a transabdominal measurement ≤33 mm.


Conclusions
Screening of transabdominal cervical length may represent a useful strategy for detecting women with short cervix on transvaginal ultrasound.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12097" xmlns="http://purl.org/rss/1.0/"><title>Pregnancy rates and pregnancy loss in Eastern Ethiopia</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12097</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Pregnancy rates and pregnancy loss in Eastern Ethiopia</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Nega Assefa, Yemane Berhane, Alemayehu Worku</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-04T06:57:39.898083-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12097</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12097</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12097</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">642</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">647</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12097-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To determine pregnancy, pregnancy loss and fertility rates in a rural community of Ethiopia.</p></div></div>
<div class="section" id="aogs12097-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>A prospective population-based pregnancy surveillance.</p></div></div>
<div class="section" id="aogs12097-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Kersa Demographic Surveillance and Health Research Center, a demographic surveillance site in Eastern Ethiopia.</p></div></div>
<div class="section" id="aogs12097-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>For pregnancy rates, the study included 7738 women of reproductive age permanently residing in the field research site. For pregnancy loss, 2072 pregnant women were included.</p></div></div>
<div class="section" id="aogs12097-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Method</h4><div class="para"><p>Pregnancy screening was done every third month from 1 December 2009 to 30 November 2010 using a questionnaire and a urine pregnancy test. Descriptive analysis was done to calculate the pregnancy rate and pregnancy loss.</p></div></div>
<div class="section" id="aogs12097-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Outcome measures</h4><div class="para"><p>Pregnancy rate and pregnancy loss.</p></div></div>
<div class="section" id="aogs12097-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Result</h4><div class="para"><p>The pregnancy rate was 227/year/1000 women of reproductive age. During the study period, 1438 pregnancies ended, with 1295 live births and 143 pregnancies that did not yield a live birth (116 due to bleeding and 27 stillbirths). The incidence of pregnancy loss was 220/year/1000 pregnancies. Based on the one-year data, the total fertility rate was found to be 5.52. The overall pregnancy loss and stillbirth ratio were 11 and 2.1/100 live births, respectively.</p></div></div>
<div class="section" id="aogs12097-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>The study identified a high fertility rate that is probably accentuated by a high proportion of pregnancy loss in the study population. Improving access to family planning service to limit the number of pregnancies and access to antenatal care (to identify higher risk women) is essential.</p></div></div>
]]></content:encoded><description>


Objective
To determine pregnancy, pregnancy loss and fertility rates in a rural community of Ethiopia.


Design
A prospective population-based pregnancy surveillance.


Setting
Kersa Demographic Surveillance and Health Research Center, a demographic surveillance site in Eastern Ethiopia.


Population
For pregnancy rates, the study included 7738 women of reproductive age permanently residing in the field research site. For pregnancy loss, 2072 pregnant women were included.


Method
Pregnancy screening was done every third month from 1 December 2009 to 30 November 2010 using a questionnaire and a urine pregnancy test. Descriptive analysis was done to calculate the pregnancy rate and pregnancy loss.


Outcome measures
Pregnancy rate and pregnancy loss.


Result
The pregnancy rate was 227/year/1000 women of reproductive age. During the study period, 1438 pregnancies ended, with 1295 live births and 143 pregnancies that did not yield a live birth (116 due to bleeding and 27 stillbirths). The incidence of pregnancy loss was 220/year/1000 pregnancies. Based on the one-year data, the total fertility rate was found to be 5.52. The overall pregnancy loss and stillbirth ratio were 11 and 2.1/100 live births, respectively.


Conclusions
The study identified a high fertility rate that is probably accentuated by a high proportion of pregnancy loss in the study population. Improving access to family planning service to limit the number of pregnancies and access to antenatal care (to identify higher risk women) is essential.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12124" xmlns="http://purl.org/rss/1.0/"><title>Effects of maternal smokeless tobacco use on selected pregnancy outcomes in Alaska Native women: a case–control study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12124</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Effects of maternal smokeless tobacco use on selected pregnancy outcomes in Alaska Native women: a case–control study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lucinda J. England, Shin Y. Kim, Carrie K. Shapiro-Mendoza, Hoyt G. Wilson, Juliette S. Kendrick, Glen A. Satten, Claire A. Lewis, Myra J. Tucker, William M. Callaghan</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-29T05:18:30.393414-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12124</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12124</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12124</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">648</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">655</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12124-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To examine the potential effects of prenatal smokeless tobacco use on selected birth outcomes.</p></div></div>
<div class="section" id="aogs12124-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>A population-based, case–control study using a retrospective medical record review.</p></div></div>
<div class="section" id="aogs12124-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>Singleton deliveries 1997–2005 to Alaska Native women residing in western Alaska.</p></div></div>
<div class="section" id="aogs12124-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Hospital discharge codes were used to identify potential case deliveries and a random control sample. Data on tobacco use and confirmation of pregnancy outcomes were abstracted from medical records for 1123 deliveries. Logistic regression was used to examine associations between tobacco use and pregnancy outcomes. Adjusted odds ratios (OR), 95% confidence intervals (95% CI), and <em>p</em>-values were calculated.</p></div></div>
<div class="section" id="aogs12124-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcomes measures</h4><div class="para"><p>Preterm delivery, pregnancy-associated hypertension, and placental abruption.</p></div></div>
<div class="section" id="aogs12124-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>In unadjusted analysis, smokeless tobacco use was not significantly associated with preterm delivery (OR 1.44, 95% CI 0.97–2.15). After adjustment for parity, pre-pregnancy body mass index, and maternal age, the point estimate was attenuated and remained non-significant. No significant associations were observed between smokeless tobacco use and pregnancy-associated hypertension (adjusted OR 0.92, 95% CI 0.56–1.51) or placental abruption (adjusted OR 1.11, 95% CI 0.53–2.33).</p></div></div>
<div class="section" id="aogs12124-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Prenatal smokeless tobacco use does not appear to reduce risk of pregnancy-associated hypertension or to substantially increase risk of abruption. An association between smokeless tobacco and preterm delivery could not be ruled out. Components in tobacco other than nicotine likely play a major role in decreased pre-eclampsia risk in smokers. Nicotine adversely affects fetal neurodevelopment and our results should not be construed to mean that smokeless tobacco use is safe during pregnancy.</p></div></div>
]]></content:encoded><description>


Objective
To examine the potential effects of prenatal smokeless tobacco use on selected birth outcomes.


Design
A population-based, case–control study using a retrospective medical record review.


Population
Singleton deliveries 1997–2005 to Alaska Native women residing in western Alaska.


Methods
Hospital discharge codes were used to identify potential case deliveries and a random control sample. Data on tobacco use and confirmation of pregnancy outcomes were abstracted from medical records for 1123 deliveries. Logistic regression was used to examine associations between tobacco use and pregnancy outcomes. Adjusted odds ratios (OR), 95% confidence intervals (95% CI), and p-values were calculated.


Main outcomes measures
Preterm delivery, pregnancy-associated hypertension, and placental abruption.


Results
In unadjusted analysis, smokeless tobacco use was not significantly associated with preterm delivery (OR 1.44, 95% CI 0.97–2.15). After adjustment for parity, pre-pregnancy body mass index, and maternal age, the point estimate was attenuated and remained non-significant. No significant associations were observed between smokeless tobacco use and pregnancy-associated hypertension (adjusted OR 0.92, 95% CI 0.56–1.51) or placental abruption (adjusted OR 1.11, 95% CI 0.53–2.33).


Conclusions
Prenatal smokeless tobacco use does not appear to reduce risk of pregnancy-associated hypertension or to substantially increase risk of abruption. An association between smokeless tobacco and preterm delivery could not be ruled out. Components in tobacco other than nicotine likely play a major role in decreased pre-eclampsia risk in smokers. Nicotine adversely affects fetal neurodevelopment and our results should not be construed to mean that smokeless tobacco use is safe during pregnancy.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12070" xmlns="http://purl.org/rss/1.0/"><title>Fetal aortic isthmus Doppler measurements for prediction of perinatal morbidity and mortality associated with fetal growth restriction</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12070</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Fetal aortic isthmus Doppler measurements for prediction of perinatal morbidity and mortality associated with fetal growth restriction</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Khalil Abdelrazzaq, Ahmet Özgür Yeniel, Ahmet Mete Ergenoglu, Nuri Yildirim, Fuat Akercan, Nedim Karadadaş</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-02-15T02:08:09.753392-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12070</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12070</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12070</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">656</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">661</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12070-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To identify the role of longitudinal measurements of fetal aortic isthmus blood flow using Doppler ultrasonography in the prediction of perinatal morbidity and mortality.</p></div></div>
<div class="section" id="aogs12070-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Obstetrics department of a university hospital.</p></div></div>
<div class="section" id="aogs12070-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Population and design</h4><div class="para"><p>This prospective study includes women with fetal growth restriction and abnormal umbilical artery Doppler results, seen between November 2009 and January 2011.</p></div></div>
<div class="section" id="aogs12070-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>31 women were divided into two groups according to the aortic isthmus blood flow pattern just before birth: anterograde (<em>n </em>=<em> </em>12) or retrograde (<em>n </em>=<em> </em>19).</p></div></div>
<div class="section" id="aogs12070-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measure</h4><div class="para"><p>Longitudinal measurements of fetal aortic isthmus in relation to perinatal outcome.</p></div></div>
<div class="section" id="aogs12070-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Total morbidity and mortality rates were significantly higher in the retrograde flow group. There was no statistically significant difference for respiratory distress syndrome, intraventricular hemorrhage, bronchopulmonary dysplasia or necrotizing enterocolitis, but the neonatal sepsis rate was significantly higher in the retrograde flow group. An abnormal aortic isthmus flow pattern was detected approximately 15–20 days after umbilical artery and middle cerebral artery Doppler flow abnormalities and 3–7 days before deterioration in ductus venosus blood flow.</p></div></div>
<div class="section" id="aogs12070-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>We suggest that aortic isthmus Doppler measurements are useful for identifying fetal growth restriction before deterioration in ductus venosus blood flow and fetal acidosis.</p></div></div>
]]></content:encoded><description>


Objective
To identify the role of longitudinal measurements of fetal aortic isthmus blood flow using Doppler ultrasonography in the prediction of perinatal morbidity and mortality.


Setting
Obstetrics department of a university hospital.


Population and design
This prospective study includes women with fetal growth restriction and abnormal umbilical artery Doppler results, seen between November 2009 and January 2011.


Methods
31 women were divided into two groups according to the aortic isthmus blood flow pattern just before birth: anterograde (n = 12) or retrograde (n = 19).


Main outcome measure
Longitudinal measurements of fetal aortic isthmus in relation to perinatal outcome.


Results
Total morbidity and mortality rates were significantly higher in the retrograde flow group. There was no statistically significant difference for respiratory distress syndrome, intraventricular hemorrhage, bronchopulmonary dysplasia or necrotizing enterocolitis, but the neonatal sepsis rate was significantly higher in the retrograde flow group. An abnormal aortic isthmus flow pattern was detected approximately 15–20 days after umbilical artery and middle cerebral artery Doppler flow abnormalities and 3–7 days before deterioration in ductus venosus blood flow.


Conclusion
We suggest that aortic isthmus Doppler measurements are useful for identifying fetal growth restriction before deterioration in ductus venosus blood flow and fetal acidosis.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12090" xmlns="http://purl.org/rss/1.0/"><title>Association between umbilical cord artery pCO2 and the Apgar score; elevated levels of pCO2 may be beneficial for neonatal vitality after moderate acidemia</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12090</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Association between umbilical cord artery pCO2 and the Apgar score; elevated levels of pCO2 may be beneficial for neonatal vitality after moderate acidemia</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Grete A.B. Kro, Branka M. Yli, Svein Rasmussen, Håkan Norèn, Isis Amer-Wåhlin, Karl G. Rosén, Babill Stray-Pedersen, Ola D. Saugstad</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-29T05:18:14.931267-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12090</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12090</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12090</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">662</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">670</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12090-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To determine the association between 5-min Apgar score and umbilical cord artery carbon dioxide tension (pCO<sub>2</sub>).</p></div></div>
<div class="section" id="aogs12090-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Observational study.</p></div></div>
<div class="section" id="aogs12090-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>European hospital labor wards.</p></div></div>
<div class="section" id="aogs12090-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>Data from 36 432 newborns ≥36 gestational weeks were obtained from three sources: two trials of monitoring with fetal electrocardiogram (the Swedish randomized controlled trial and the European Union Fetal ECG trial) and Mölndal Hospital data. After validation of the acid–base values, 25 806 5-min Apgar scores were available for analysis.</p></div></div>
<div class="section" id="aogs12090-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Validation of the umbilical cord acid–base values was performed to obtain reliable data. 5-min Apgar score was regressed against cord artery pCO<sub>2</sub> in a polynomial multilevel model.</p></div></div>
<div class="section" id="aogs12090-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Five-min Apgar score, umbilical cord pCO<sub>2</sub>, pH, and base deficit.</p></div></div>
<div class="section" id="aogs12090-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Overall, a higher cord artery pCO<sub>2</sub> was found to be associated with lower 5-min Apgar scores. However, among newborns with moderate acidemia, lower umbilical cord artery pCO<sub>2</sub> (≤median pCO<sub>2</sub> for the specific cord artery pH) was associated with lower 5-min Apgar scores, with a relative risk of 2.0 (95% confidence interval: 1.4–2.8) for 5-min Apgar scores 0–6.</p></div></div>
<div class="section" id="aogs12090-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Metabolic acidosis affects the newborn's vitality more than respiratory acidosis. In addition, elevated levels of pCO<sub>2</sub> may be beneficial for fetuses with moderate acidemia, and thus cord artery pCO<sub>2</sub> is a factor that should be considered when assessing the compromised newborn.</p></div></div>
]]></content:encoded><description>


Objective
To determine the association between 5-min Apgar score and umbilical cord artery carbon dioxide tension (pCO2).


Design
Observational study.


Setting
European hospital labor wards.


Population
Data from 36 432 newborns ≥36 gestational weeks were obtained from three sources: two trials of monitoring with fetal electrocardiogram (the Swedish randomized controlled trial and the European Union Fetal ECG trial) and Mölndal Hospital data. After validation of the acid–base values, 25 806 5-min Apgar scores were available for analysis.


Methods
Validation of the umbilical cord acid–base values was performed to obtain reliable data. 5-min Apgar score was regressed against cord artery pCO2 in a polynomial multilevel model.


Main outcome measures
Five-min Apgar score, umbilical cord pCO2, pH, and base deficit.


Results
Overall, a higher cord artery pCO2 was found to be associated with lower 5-min Apgar scores. However, among newborns with moderate acidemia, lower umbilical cord artery pCO2 (≤median pCO2 for the specific cord artery pH) was associated with lower 5-min Apgar scores, with a relative risk of 2.0 (95% confidence interval: 1.4–2.8) for 5-min Apgar scores 0–6.


Conclusions
Metabolic acidosis affects the newborn's vitality more than respiratory acidosis. In addition, elevated levels of pCO2 may be beneficial for fetuses with moderate acidemia, and thus cord artery pCO2 is a factor that should be considered when assessing the compromised newborn.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12092" xmlns="http://purl.org/rss/1.0/"><title>Change in risk status during labor in a large Norwegian obstetric department: a prospective study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12092</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Change in risk status during labor in a large Norwegian obstetric department: a prospective study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Tonje Lippert, Ellen Nesje, Karen Sofie Koss, Pål Øian</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-12T05:44:26.492427-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12092</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12092</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12092</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">671</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">678</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12092-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>This study aimed to observe risk status on admission to hospital and change in risk status during labor.</p></div></div>
<div class="section" id="aogs12092-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>A prospective observational study allocating all women into low-risk and high-risk groups on admittance to hospital and during labor based on prespecified risk criteria.</p></div></div>
<div class="section" id="aogs12092-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Department of Obstetrics and Gynecology in a district hospital.</p></div></div>
<div class="section" id="aogs12092-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>All 6406 deliveries from 2 May 2004 to 30 September 2006.</p></div></div>
<div class="section" id="aogs12092-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>A special form was filled out for all women admitted to the department in labor classifying them as either low or high risk. A change in risk status during labor was also recorded.</p></div></div>
<div class="section" id="aogs12092-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Risk status (low and high risk) on admittance to hospital and change in risk status during first stage of labor.</p></div></div>
<div class="section" id="aogs12092-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>On admittance, 67% of women with an intended vaginal delivery were low risk. During the first stage of labor, 41% of the low-risk women changed risk status. Use of epidural anesthesia gave rise to 73% of the risk changes during the first stage of labor and use of oxytocin caused 12%.</p></div></div>
<div class="section" id="aogs12092-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Two-thirds of the women were low risk before labor, and 39% of these remained low-risk at the end of the first stage of labor. The main reason for a change of risk status in the obstetric department was the use of epidural anesthesia.</p></div></div>
]]></content:encoded><description>


Objective
This study aimed to observe risk status on admission to hospital and change in risk status during labor.


Design
A prospective observational study allocating all women into low-risk and high-risk groups on admittance to hospital and during labor based on prespecified risk criteria.


Setting
Department of Obstetrics and Gynecology in a district hospital.


Population
All 6406 deliveries from 2 May 2004 to 30 September 2006.


Methods
A special form was filled out for all women admitted to the department in labor classifying them as either low or high risk. A change in risk status during labor was also recorded.


Main outcome measures
Risk status (low and high risk) on admittance to hospital and change in risk status during first stage of labor.


Results
On admittance, 67% of women with an intended vaginal delivery were low risk. During the first stage of labor, 41% of the low-risk women changed risk status. Use of epidural anesthesia gave rise to 73% of the risk changes during the first stage of labor and use of oxytocin caused 12%.


Conclusions
Two-thirds of the women were low risk before labor, and 39% of these remained low-risk at the end of the first stage of labor. The main reason for a change of risk status in the obstetric department was the use of epidural anesthesia.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12059" xmlns="http://purl.org/rss/1.0/"><title>A taxonomy of possible reasons for and against sperm donation</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12059</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">A taxonomy of possible reasons for and against sperm donation</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ercolie R. Bossema, Pim M.W. Janssens, Frieda Landwehr, Roswitha G.L. Treucker, Kor Duinen, Annemiek W. Nap, Rinie Geenen</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-01-21T07:55:39.936602-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12059</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12059</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12059</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">679</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">685</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12059-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>Various reasons may guide the decision of men to become a sperm donor. Our aim was to identify a comprehensive set of possible reasons for and against sperm donation.</p></div></div>
<div class="section" id="aogs12059-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Concept mapping.</p></div></div>
<div class="section" id="aogs12059-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Assisted reproduction clinics.</p></div></div>
<div class="section" id="aogs12059-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Sample</h4><div class="para"><p>Nine sperm donors and seven non-sperm donors.</p></div></div>
<div class="section" id="aogs12059-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Interviews to obtain statements for and against sperm donation, card-sorting tasks to categorize these statements according to similarity, and hierarchical cluster analysis to structure these categorizations.</p></div></div>
<div class="section" id="aogs12059-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Hierarchical structure with reasons for and against sperm donation.</p></div></div>
<div class="section" id="aogs12059-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>The hierarchical structure with 91 reasons comprised selfishness (including narcissism and procreation), psychosocial drives (including altruism, detached procreation, and sexual/financial satisfaction), and psychosocial barriers (including normative and moral barriers related to oneself, one's spouse, the donor child, and society).</p></div></div>
<div class="section" id="aogs12059-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>The identified hierarchical overview of reasons for and against sperm donation may help potential sperm donors when considering becoming a sperm donor, enable more systematic counseling of potential sperm donors, and guide further research on reasons for and against sperm donation.</p></div></div>
]]></content:encoded><description>


Objective
Various reasons may guide the decision of men to become a sperm donor. Our aim was to identify a comprehensive set of possible reasons for and against sperm donation.


Design
Concept mapping.


Setting
Assisted reproduction clinics.


Sample
Nine sperm donors and seven non-sperm donors.


Methods
Interviews to obtain statements for and against sperm donation, card-sorting tasks to categorize these statements according to similarity, and hierarchical cluster analysis to structure these categorizations.


Main outcome measures
Hierarchical structure with reasons for and against sperm donation.


Results
The hierarchical structure with 91 reasons comprised selfishness (including narcissism and procreation), psychosocial drives (including altruism, detached procreation, and sexual/financial satisfaction), and psychosocial barriers (including normative and moral barriers related to oneself, one's spouse, the donor child, and society).


Conclusions
The identified hierarchical overview of reasons for and against sperm donation may help potential sperm donors when considering becoming a sperm donor, enable more systematic counseling of potential sperm donors, and guide further research on reasons for and against sperm donation.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12128" xmlns="http://purl.org/rss/1.0/"><title>Conservative medical treatment of ovarian hyperstimulation syndrome: a single center series and cost analysis study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12128</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Conservative medical treatment of ovarian hyperstimulation syndrome: a single center series and cost analysis study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Gemma Casals, Francisco Fábregues, Marco Pavesi, Vicente Arroyo, Juan Balasch</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-09T06:29:05.01427-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12128</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12128</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12128</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">686</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">691</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12128-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To present the results of a large series of patients with ovarian hyperstimulation syndrome treated with a conservative medical approach and to compare the cost of this treatment with outpatient management with paracentesis according to published data.</p></div></div>
<div class="section" id="aogs12128-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Retrospective case series and cost analysis study using a decision-tree model.</p></div></div>
<div class="section" id="aogs12128-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>University hospital.</p></div></div>
<div class="section" id="aogs12128-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>496 consecutive patients with ovarian hyperstimulation syndrome treated in our center from 1991 to 2010.</p></div></div>
<div class="section" id="aogs12128-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>All patients were treated with a conservative medical approach: (a) conservative outpatient approach: bed rest and a low-sodium diet or (b) hospitalized patients: bed rest, low-sodium diet, 20% albumin (60 g/day) and furosemide (20 mg/8 h).</p></div></div>
<div class="section" id="aogs12128-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Percentage of admissions, length of hospital stay and readmissions. Total cost of each therapeutic approach.</p></div></div>
<div class="section" id="aogs12128-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>(a) Conservative outpatient approach (<em>n</em> = 377): all cases solved without admission. (b) Hospitalized patients with conservative medical treatment (<em>n</em> = 119): 2.8 days of mean hospital stay, no patient required paracentesis or admission to intensive care unit. Readmissions: Five patients (4.2%) resolved on restarting medical treatment. (c) Cost-analysis comparison: Cost of the outpatient approach with paracentesis: US$980 (range US$519–3557). Cost of conservative medical treatment: US$570 (range US$232–1640).</p></div></div>
<div class="section" id="aogs12128-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Ovarian hyperstimulation syndrome can be safely managed with a conservative medical approach, which was not found to be more expensive than outpatient management with paracentesis.</p></div></div>
]]></content:encoded><description>


Objective
To present the results of a large series of patients with ovarian hyperstimulation syndrome treated with a conservative medical approach and to compare the cost of this treatment with outpatient management with paracentesis according to published data.


Design
Retrospective case series and cost analysis study using a decision-tree model.


Setting
University hospital.


Population
496 consecutive patients with ovarian hyperstimulation syndrome treated in our center from 1991 to 2010.


Methods
All patients were treated with a conservative medical approach: (a) conservative outpatient approach: bed rest and a low-sodium diet or (b) hospitalized patients: bed rest, low-sodium diet, 20% albumin (60 g/day) and furosemide (20 mg/8 h).


Main outcome measures
Percentage of admissions, length of hospital stay and readmissions. Total cost of each therapeutic approach.


Results
(a) Conservative outpatient approach (n = 377): all cases solved without admission. (b) Hospitalized patients with conservative medical treatment (n = 119): 2.8 days of mean hospital stay, no patient required paracentesis or admission to intensive care unit. Readmissions: Five patients (4.2%) resolved on restarting medical treatment. (c) Cost-analysis comparison: Cost of the outpatient approach with paracentesis: US$980 (range US$519–3557). Cost of conservative medical treatment: US$570 (range US$232–1640).


Conclusions
Ovarian hyperstimulation syndrome can be safely managed with a conservative medical approach, which was not found to be more expensive than outpatient management with paracentesis.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12138" xmlns="http://purl.org/rss/1.0/"><title>Colposcopically directed cervical biopsy during pregnancy; minor surgical and obstetrical complications and high rates of persistence and regression</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12138</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Colposcopically directed cervical biopsy during pregnancy; minor surgical and obstetrical complications and high rates of persistence and regression</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Cecilia Kärrberg, Mats Brännström, Björn Strander, Lars Ladfors, Thomas Rådberg</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-17T05:23:34.020982-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12138</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12138</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12138</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">692</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">699</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12138-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To evaluate whether colposcopically directed cervical biopsies during pregnancy are associated with surgical/obstetric complications and to examine the natural course (regression, persistence, progression) of dysplasia during pregnancy.</p></div></div>
<div class="section" id="aogs12138-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Prospective clinical study.</p></div></div>
<div class="section" id="aogs12138-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting and population</h4><div class="para"><p>University Hospital and 251 pregnant women with atypical cervical cytology in early pregnancy.</p></div></div>
<div class="section" id="aogs12138-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>The patients were investigated by colposcopically directed punch biopsies, colposcopically directed loop-biopsies or LEEP-cones. The histology results during pregnancy were compared with those after delivery to evaluate the natural course of dysplastic lesions during pregnancies. Postoperative complications were recorded. Obstetric outcome was recorded and compared with the 54 919 other births in the same geographical area during the study period.</p></div></div>
<div class="section" id="aogs12138-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Persistence, regression and progression of cervical dysplasia, surgical complications after diagnostic procedure, incidence of preterm birth, mode of delivery.</p></div></div>
<div class="section" id="aogs12138-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Only a minor part (12.3%) of the dysplastic lesions showed progression during pregnancy, with 54.6 and 33.1% showing persistence and regression, respectively. No surgically related postoperative bleeding that needed surgical (diathermy/suture) treatment occurred and the miscarriage rate was low (0.8%). There were no differences in mode of delivery, preterm birth or other obstetrical variables between the study group and the large control cohort.</p></div></div>
<div class="section" id="aogs12138-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>Investigation of atypical cytology during pregnancy with biopsy including large loop excisions is a safe procedure with regard to surgical complications and obstetrical outcome. There is a high rate of persistence and regression of dysplasia during pregnancy.</p></div></div>
]]></content:encoded><description>


Objective
To evaluate whether colposcopically directed cervical biopsies during pregnancy are associated with surgical/obstetric complications and to examine the natural course (regression, persistence, progression) of dysplasia during pregnancy.


Design
Prospective clinical study.


Setting and population
University Hospital and 251 pregnant women with atypical cervical cytology in early pregnancy.


Methods
The patients were investigated by colposcopically directed punch biopsies, colposcopically directed loop-biopsies or LEEP-cones. The histology results during pregnancy were compared with those after delivery to evaluate the natural course of dysplastic lesions during pregnancies. Postoperative complications were recorded. Obstetric outcome was recorded and compared with the 54 919 other births in the same geographical area during the study period.


Main outcome measures
Persistence, regression and progression of cervical dysplasia, surgical complications after diagnostic procedure, incidence of preterm birth, mode of delivery.


Results
Only a minor part (12.3%) of the dysplastic lesions showed progression during pregnancy, with 54.6 and 33.1% showing persistence and regression, respectively. No surgically related postoperative bleeding that needed surgical (diathermy/suture) treatment occurred and the miscarriage rate was low (0.8%). There were no differences in mode of delivery, preterm birth or other obstetrical variables between the study group and the large control cohort.


Conclusion
Investigation of atypical cytology during pregnancy with biopsy including large loop excisions is a safe procedure with regard to surgical complications and obstetrical outcome. There is a high rate of persistence and regression of dysplasia during pregnancy.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12107" xmlns="http://purl.org/rss/1.0/"><title>Induced abortion and breast cancer among parous women: a Danish cohort study</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12107</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Induced abortion and breast cancer among parous women: a Danish cohort study</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Christina Marie Braüner, Kim Overvad, Anne Tjønneland, Jørn Attermann</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-13T01:06:52.09058-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12107</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12107</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12107</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">700</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">705</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12107-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>We investigated whether induced abortion is associated with breast cancer when lifestyle confounders, including smoking and alcohol consumption, are adjusted for. <em>Design</em>. Prospective cohort study.</p></div></div>
<div class="section" id="aogs12107-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Danish women from the Diet, Cancer and Health study.</p></div></div>
<div class="section" id="aogs12107-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>A total of 25 576 women.</p></div></div>
<div class="section" id="aogs12107-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>We obtained exposure data from baseline questionnaires filled in by the women between 1993 and 1997. Information on breast cancer and emigration was retrieved from Danish national registries. The study power was approximately 85% when applying a minimum detection hazard ratio of 1.2.</p></div></div>
<div class="section" id="aogs12107-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Long-term effects of induced abortion on the risk of breast cancer among women above 50 years of age.</p></div></div>
<div class="section" id="aogs12107-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>During a follow up of approximately 12 years, 1215 women were diagnosed with breast cancer. When comparing parous women who had an abortion with parous women who never had an abortion, there was no association between breast cancer risk and induced abortion (ever vs. never), with a hazard ratio 0.95 (95% confidence interval 0.83–1.09), regardless of whether the abortion occurred before the first birth (hazard ratio 0.86; 95% confidence interval 0.65–1.14), or after the first birth (hazard ratio 0.97; 95% confidence interval 0.84–1.13).</p></div></div>
<div class="section" id="aogs12107-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Our study did not show evidence of an association between induced abortion and breast cancer risk.</p></div></div>
]]></content:encoded><description>


Objective
We investigated whether induced abortion is associated with breast cancer when lifestyle confounders, including smoking and alcohol consumption, are adjusted for. Design. Prospective cohort study.


Setting
Danish women from the Diet, Cancer and Health study.


Population
A total of 25 576 women.


Methods
We obtained exposure data from baseline questionnaires filled in by the women between 1993 and 1997. Information on breast cancer and emigration was retrieved from Danish national registries. The study power was approximately 85% when applying a minimum detection hazard ratio of 1.2.


Main outcome measures
Long-term effects of induced abortion on the risk of breast cancer among women above 50 years of age.


Results
During a follow up of approximately 12 years, 1215 women were diagnosed with breast cancer. When comparing parous women who had an abortion with parous women who never had an abortion, there was no association between breast cancer risk and induced abortion (ever vs. never), with a hazard ratio 0.95 (95% confidence interval 0.83–1.09), regardless of whether the abortion occurred before the first birth (hazard ratio 0.86; 95% confidence interval 0.65–1.14), or after the first birth (hazard ratio 0.97; 95% confidence interval 0.84–1.13).


Conclusions
Our study did not show evidence of an association between induced abortion and breast cancer risk.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12134" xmlns="http://purl.org/rss/1.0/"><title>Frequent detection of cytomegalovirus and Epstein–Barr virus in cervical secretions from healthy young women</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12134</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Frequent detection of cytomegalovirus and Epstein–Barr virus in cervical secretions from healthy young women</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Matilda Berntsson, Lejla Dubicanac, Petra Tunbäck, Agneta Ellström, Gun-Britt Löwhagen, Tomas Bergström</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-29T05:49:08.589579-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12134</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12134</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12134</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">706</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">710</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12134-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To investigate asymptomatic shedding from the uterine cervix of five human herpes viruses: cytomegalovirus (CMV), Epstein–Barr virus (EBV), herpes simplex virus (HSV) type 1 and type 2 and varicella zoster virus (VZV), in young women.</p></div></div>
<div class="section" id="aogs12134-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>A descriptive study.</p></div></div>
<div class="section" id="aogs12134-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Sahlgrenska University Hospital.</p></div></div>
<div class="section" id="aogs12134-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>Three hundred and five young, healthy Swedish women.</p></div></div>
<div class="section" id="aogs12134-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Cervical specimens were analyzed for the presence of viral DNA with a quantitative real-time PCR assay.</p></div></div>
<div class="section" id="aogs12134-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Detection of viral DNA.</p></div></div>
<div class="section" id="aogs12134-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Viral DNA was detected in 66 (21.6%) of the cervical samples. The most common findings were CMV DNA, detected in 35 (11.5%), and EBV DNA, found in 32 (10.5%) of the women. HSV-1 DNA was detected in 5 (1.7%) and HSV-2 DNA in 4 (1.4%), but VZV DNA was not found. The estimated DNA level for the detected viruses was similar with a mean DNA quantity of 2.6 log genome equivalents (Geq)/mL for CMV (range 1.7–4.3), 2.5 log Geq/mL for EBV (range 1.7–4.7), 2.4 log Geq/mL for HSV-1 (range 1.7–3.5) and 2.6 log Geq/mL for HSV-2 (range 1.7–4.1). The simultaneous presence of DNA from two or more herpes viruses was detected in eight specimens.</p></div></div>
<div class="section" id="aogs12134-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Asymptomatic shedding of CMV and EBV from the uterine cervix was found in one-fifth of young women. In four of the cervical samples; two with EBV, one with CMV, one with HSV-2, high amounts of viral DNA (&gt;4 log Geq/mL) were detected suggesting a greater risk of transmitting the virus perinatally or sexually.</p></div></div>
]]></content:encoded><description>


Objective
To investigate asymptomatic shedding from the uterine cervix of five human herpes viruses: cytomegalovirus (CMV), Epstein–Barr virus (EBV), herpes simplex virus (HSV) type 1 and type 2 and varicella zoster virus (VZV), in young women.


Design
A descriptive study.


Setting
Sahlgrenska University Hospital.


Population
Three hundred and five young, healthy Swedish women.


Methods
Cervical specimens were analyzed for the presence of viral DNA with a quantitative real-time PCR assay.


Main outcome measures
Detection of viral DNA.


Results
Viral DNA was detected in 66 (21.6%) of the cervical samples. The most common findings were CMV DNA, detected in 35 (11.5%), and EBV DNA, found in 32 (10.5%) of the women. HSV-1 DNA was detected in 5 (1.7%) and HSV-2 DNA in 4 (1.4%), but VZV DNA was not found. The estimated DNA level for the detected viruses was similar with a mean DNA quantity of 2.6 log genome equivalents (Geq)/mL for CMV (range 1.7–4.3), 2.5 log Geq/mL for EBV (range 1.7–4.7), 2.4 log Geq/mL for HSV-1 (range 1.7–3.5) and 2.6 log Geq/mL for HSV-2 (range 1.7–4.1). The simultaneous presence of DNA from two or more herpes viruses was detected in eight specimens.


Conclusions
Asymptomatic shedding of CMV and EBV from the uterine cervix was found in one-fifth of young women. In four of the cervical samples; two with EBV, one with CMV, one with HSV-2, high amounts of viral DNA (&gt;4 log Geq/mL) were detected suggesting a greater risk of transmitting the virus perinatally or sexually.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12119" xmlns="http://purl.org/rss/1.0/"><title>Smoking is accompanied by a suppressed cervical nitric oxide release in women with high-risk human papillomavirus infection</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12119</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Smoking is accompanied by a suppressed cervical nitric oxide release in women with high-risk human papillomavirus infection</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Päivi Rahkola-Soisalo, Tomi S. Mikkola, Saara Vuorento, Olavi Ylikorkala, Mervi Väisänen-Tommiska</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-29T05:49:04.106855-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12119</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12119</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12119</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">711</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">715</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12119-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>Both smoking and the release of nitric oxide (NO) in the uterine cervix are determinants for high-risk human papillomavirus (hrHPV) infection. We compared the cervical NO release between smoking and non-smoking women with and without hrHPV infection.</p></div></div>
<div class="section" id="aogs12119-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>Open clinical cohort study.</p></div></div>
<div class="section" id="aogs12119-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>University Hospital in Finland.</p></div></div>
<div class="section" id="aogs12119-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Population</h4><div class="para"><p>One hundred and twenty-five smoking and 301 non-smoking women, with (<em>n</em> = 244) and without (<em>n</em> = 182) hrHPV infection. In total, 264 women showed cytological and/or histological cervical epithelial changes.</p></div></div>
<div class="section" id="aogs12119-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>The presence of hrHPV was tested by an HPV DNA test and the release of NO was assessed from NO metabolites in the cervical fluid by the Griess reaction.</p></div></div>
<div class="section" id="aogs12119-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>The difference in cervical NO release between smoking and non-smoking women with and without hrHPV.</p></div></div>
<div class="section" id="aogs12119-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>Infection with hrHPV in smokers (70%) was more frequent (<em>p </em>= 0.001) than in non-smokers (52%). As a whole, smoking was accompanied by a 35% decrease (<em>p </em>= 0.04) in NO release in hrHPV-infected women (35.9 μmol/L, 95% confidence interval 27.0–44.2) compared with non-smoking hrHPV- infected women (48.3 μmol/L, 95% confidence interval 38.0–56.2). No difference in NO release between smokers and non-smokers was seen in women with healthy cervical epithelium, but smoking was accompanied by a suppressed (26%) NO release (<em>p </em>= 0.03) in women with either cytological or histological changes.</p></div></div>
<div class="section" id="aogs12119-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusions</h4><div class="para"><p>Smoking may suppress NO release in the uterine cervix in women with hrHPV infection.</p></div></div>
]]></content:encoded><description>


Objective
Both smoking and the release of nitric oxide (NO) in the uterine cervix are determinants for high-risk human papillomavirus (hrHPV) infection. We compared the cervical NO release between smoking and non-smoking women with and without hrHPV infection.


Design
Open clinical cohort study.


Setting
University Hospital in Finland.


Population
One hundred and twenty-five smoking and 301 non-smoking women, with (n = 244) and without (n = 182) hrHPV infection. In total, 264 women showed cytological and/or histological cervical epithelial changes.


Methods
The presence of hrHPV was tested by an HPV DNA test and the release of NO was assessed from NO metabolites in the cervical fluid by the Griess reaction.


Main outcome measures
The difference in cervical NO release between smoking and non-smoking women with and without hrHPV.


Results
Infection with hrHPV in smokers (70%) was more frequent (p = 0.001) than in non-smokers (52%). As a whole, smoking was accompanied by a 35% decrease (p = 0.04) in NO release in hrHPV-infected women (35.9 μmol/L, 95% confidence interval 27.0–44.2) compared with non-smoking hrHPV- infected women (48.3 μmol/L, 95% confidence interval 38.0–56.2). No difference in NO release between smokers and non-smokers was seen in women with healthy cervical epithelium, but smoking was accompanied by a suppressed (26%) NO release (p = 0.03) in women with either cytological or histological changes.


Conclusions
Smoking may suppress NO release in the uterine cervix in women with hrHPV infection.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12135" xmlns="http://purl.org/rss/1.0/"><title>Training health workers for magnesium sulfate use reduces case fatality from eclampsia: results from a multicenter trial</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12135</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Training health workers for magnesium sulfate use reduces case fatality from eclampsia: results from a multicenter trial</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Friday E. Okonofua, Rosemary N. Ogu, Adetokunbo O. Fabamwo, Innocent O. Ujah, Calvin M. Chama, Eric I. Archibong, Hyacinth E. Onah, Hadiza S. Galadanci, James T. Akuse</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-13T01:06:46.200043-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12135</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12135</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12135</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Main Research Article</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">716</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">720</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="section" id="aogs12135-sec-0001" xmlns="http://www.w3.org/1999/xhtml"><h4>Objective</h4><div class="para"><p>To investigate the effectiveness of an intervention aimed at improving the case management of eclampsia.</p></div></div>
<div class="section" id="aogs12135-sec-0002" xmlns="http://www.w3.org/1999/xhtml"><h4>Design</h4><div class="para"><p>A multi-center intervention study.</p></div></div>
<div class="section" id="aogs12135-sec-0003" xmlns="http://www.w3.org/1999/xhtml"><h4>Setting</h4><div class="para"><p>Six teaching hospitals in Nigeria.</p></div></div>
<div class="section" id="aogs12135-sec-0004" xmlns="http://www.w3.org/1999/xhtml"><h4>Sample</h4><div class="para"><p>Clinical records of cases of eclampsia treated before and 1 year after the intervention.</p></div></div>
<div class="section" id="aogs12135-sec-0005" xmlns="http://www.w3.org/1999/xhtml"><h4>Methods</h4><div class="para"><p>Doctors and midwives in selected hospitals were re-trained to manage eclampsia using magnesium sulfate according to the Pritchard protocol.</p></div></div>
<div class="section" id="aogs12135-sec-0006" xmlns="http://www.w3.org/1999/xhtml"><h4>Main outcome measures</h4><div class="para"><p>Eclampsia case fatality rates, maternal and perinatal mortality rates before and after the intervention.</p></div></div>
<div class="section" id="aogs12135-sec-0007" xmlns="http://www.w3.org/1999/xhtml"><h4>Results</h4><div class="para"><p>A total of 219 cases of eclampsia were managed over a 12-month period. There were seven maternal deaths. The post intervention case fatality rate of 3.2% was significantly less than the pre-intervention rate of 15.1% (<em>p</em> &lt; 0.001). The overall maternal and perinatal mortality ratios and rates respectively in the hospitals declined from 1199.2 to 954 per 100 000 deliveries and 141.5 to 129.8 per 1000 births, respectively (<em>p</em> &gt; 0.05).</p></div></div>
<div class="section" id="aogs12135-sec-0008" xmlns="http://www.w3.org/1999/xhtml"><h4>Conclusion</h4><div class="para"><p>An intervention to build the capacity of care-providers to use an evidence-based protocol for the treatment of eclampsia in Nigeria was successful in reducing associated case fatality rate. The increased and widespread use of such an intervention in maternity units might contribute to the reduction of maternal mortality in low-income countries.</p></div></div>
]]></content:encoded><description>


Objective
To investigate the effectiveness of an intervention aimed at improving the case management of eclampsia.


Design
A multi-center intervention study.


Setting
Six teaching hospitals in Nigeria.


Sample
Clinical records of cases of eclampsia treated before and 1 year after the intervention.


Methods
Doctors and midwives in selected hospitals were re-trained to manage eclampsia using magnesium sulfate according to the Pritchard protocol.


Main outcome measures
Eclampsia case fatality rates, maternal and perinatal mortality rates before and after the intervention.


Results
A total of 219 cases of eclampsia were managed over a 12-month period. There were seven maternal deaths. The post intervention case fatality rate of 3.2% was significantly less than the pre-intervention rate of 15.1% (p &lt; 0.001). The overall maternal and perinatal mortality ratios and rates respectively in the hospitals declined from 1199.2 to 954 per 100 000 deliveries and 141.5 to 129.8 per 1000 births, respectively (p &gt; 0.05).


Conclusion
An intervention to build the capacity of care-providers to use an evidence-based protocol for the treatment of eclampsia in Nigeria was successful in reducing associated case fatality rate. The increased and widespread use of such an intervention in maternity units might contribute to the reduction of maternal mortality in low-income countries.

</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12127" xmlns="http://purl.org/rss/1.0/"><title>Diagnostic accuracy of risk of malignancy index in predicting complete tumor removal at primary debulking surgery for ovarian cancer patients</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12127</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Diagnostic accuracy of risk of malignancy index in predicting complete tumor removal at primary debulking surgery for ovarian cancer patients</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Carsten L. Fagö-Olsen, Fanny Håkansson, Sofie L. Antonsen, Estrid Høgdall, Lene Lundvall, Lotte Nedergaard, Svend A. Engelholm, Claus Høgdall</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-04-09T06:28:51.824471-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12127</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12127</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12127</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Research Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">721</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">726</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Ovarian cancer patients in whom complete tumor removal is impossible with primary debulking surgery (PDS) may benefit from neoadjuvant chemotherapy and interval debulking surgery. However, the task of performing a pre-operative evaluation of the feasibility of PDS is difficult. We aimed to investigate whether the risk of malignancy index (RMI) was a useful marker for this evaluation. RMI and surgical outcome were investigated in 164 patients, 49 of whom had no residual tumor after PDS. The receiver operating characteristic curve showed an area under the curve of 0.72 (confidence interval: 0.64–0.80). The possibility of complete tumor removal decreased with increasing RMI and there was a tendency towards higher RMI in patients with residual tumor after PDS, but no single cut-off value of RMI produced useful clinical predictive values. In conclusion, RMI alone is not an optimal method to determine whether complete tumor removal is possible with PDS.</p></div>
]]></content:encoded><description>

Ovarian cancer patients in whom complete tumor removal is impossible with primary debulking surgery (PDS) may benefit from neoadjuvant chemotherapy and interval debulking surgery. However, the task of performing a pre-operative evaluation of the feasibility of PDS is difficult. We aimed to investigate whether the risk of malignancy index (RMI) was a useful marker for this evaluation. RMI and surgical outcome were investigated in 164 patients, 49 of whom had no residual tumor after PDS. The receiver operating characteristic curve showed an area under the curve of 0.72 (confidence interval: 0.64–0.80). The possibility of complete tumor removal decreased with increasing RMI and there was a tendency towards higher RMI in patients with residual tumor after PDS, but no single cut-off value of RMI produced useful clinical predictive values. In conclusion, RMI alone is not an optimal method to determine whether complete tumor removal is possible with PDS.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12120" xmlns="http://purl.org/rss/1.0/"><title>Restless legs syndrome in combined hormonal contraception users</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12120</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Restless legs syndrome in combined hormonal contraception users</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Lyla Kamsheh, Ilana Ambrogi, Cherridan Rambally, Hrayr Attarian</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-18T07:02:07.754752-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12120</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12120</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12120</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Research Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">727</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">729</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>The goal of the study was to estimate the prevalence of restless legs syndrome (RLS) among women of childbearing age taking combined hormonal or combined oral contraception (CHC). A survey that included demographic information, contraceptive use history, the four criteria necessary for RLS diagnosis and an International RLS study group severity scale was distributed to 145 women taking CHC and 169 matched control women not on CHC. A high prevalence of moderate to severe RLS of 20.7% was found. A significant correlation between CHC use and RLS was not found (<em>p</em> = 0.53). RLS severity was not significantly associated with CHC use either (<em>p</em> = 0.2127). Women with RLS were significantly heavier compared with those without RLS (<em>p</em> = 0.0015). RLS severity weakly correlated with body mass index (<em>R</em> = 0.26, <em>p</em> = 0.044). Hormonal contraceptive therapy does not increase the risk of developing RLS symptoms.</p></div>
]]></content:encoded><description>

The goal of the study was to estimate the prevalence of restless legs syndrome (RLS) among women of childbearing age taking combined hormonal or combined oral contraception (CHC). A survey that included demographic information, contraceptive use history, the four criteria necessary for RLS diagnosis and an International RLS study group severity scale was distributed to 145 women taking CHC and 169 matched control women not on CHC. A high prevalence of moderate to severe RLS of 20.7% was found. A significant correlation between CHC use and RLS was not found (p = 0.53). RLS severity was not significantly associated with CHC use either (p = 0.2127). Women with RLS were significantly heavier compared with those without RLS (p = 0.0015). RLS severity weakly correlated with body mass index (R = 0.26, p = 0.044). Hormonal contraceptive therapy does not increase the risk of developing RLS symptoms.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12088" xmlns="http://purl.org/rss/1.0/"><title>Electrohysterographic evaluation of preterm contractions in a patient with a unicornuate uterus</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12088</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">Electrohysterographic evaluation of preterm contractions in a patient with a unicornuate uterus</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Janneke Hooft, Chiara Rabotti, S.Guid Oei</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2013-03-12T05:48:42.919493-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/aogs.12088</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/aogs.12088</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Faogs.12088</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Research Report</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">730</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">733</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[
<h3 xhtml="http://www.w3.org/1999/xhtml" xmlns:ol="http://www.wiley.com/namespaces/ol/xsl-lib">Abstract</h3>
<div class="para" xmlns="http://www.w3.org/1999/xhtml"><p>Women with Müllerian anomalies are at increased risk of preterm labor. The analysis of parameters derived by the electrohysterogram such as its conduction velocity are promising for preterm delivery prediction. However, an electrohysterogram has never been measured in Müllerian anomalies. A multiparous woman with a unicornuate uterus presented at 28 weeks of gestation with preterm contractions. Three electrohysterogram recordings were performed between 28 and 30 weeks of gestation, 4 weeks before delivery. The conduction velocity values were in line with previous literature and differed significantly (<em>p </em>&lt; 0.001) showing an increase between the first and last two recordings. The parameters derived from the electrohysterogram such as conduction velocity and power density spectrum peak frequency are promising ones to follow the evolution of pregnancy towards labor, and to distinguish between productive and unproductive uterine contractions, in the case of a unicornuate uterus as well as one that is normally developed.</p></div>
]]></content:encoded><description>

Women with Müllerian anomalies are at increased risk of preterm labor. The analysis of parameters derived by the electrohysterogram such as its conduction velocity are promising for preterm delivery prediction. However, an electrohysterogram has never been measured in Müllerian anomalies. A multiparous woman with a unicornuate uterus presented at 28 weeks of gestation with preterm contractions. Three electrohysterogram recordings were performed between 28 and 30 weeks of gestation, 4 weeks before delivery. The conduction velocity values were in line with previous literature and differed significantly (p &lt; 0.001) showing an increase between the first and last two recordings. The parameters derived from the electrohysterogram such as conduction velocity and power density spectrum peak frequency are promising ones to follow the evolution of pregnancy towards labor, and to distinguish between productive and unproductive uterine contractions, in the case of a unicornuate uterus as well as one that is normally developed.
</description></item><item rdf:about="http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1600-0412.2012.01513.x" xmlns="http://purl.org/rss/1.0/"><title>MY (Matsubara–Yano) uterine compression suture to prevent acute recurrence of uterine inversion</title><link>http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1600-0412.2012.01513.x</link><dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">MY (Matsubara–Yano) uterine compression suture to prevent acute recurrence of uterine inversion</dc:title><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Shigeki Matsubara, Yosuke Baba</dc:creator><dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2012-09-18T04:44:16.622797-05:00</dc:date><dc:identifier xmlns:dc="http://purl.org/dc/elements/1.1/">doi:10.1111/j.1600-0412.2012.01513.x</dc:identifier><dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/"/><dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">John Wiley &amp; Sons, Inc.</dc:publisher><prism:doi xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">10.1111/j.1600-0412.2012.01513.x</prism:doi><prism:url xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">http://onlinelibrary.wiley.com/resolve/doi?DOI=10.1111%2Fj.1600-0412.2012.01513.x</prism:url><prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">LETTER TO THE EDITOR</prism:section><prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">734</prism:startingPage><prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">735</prism:endingPage><content:encoded xmlns:content="http://purl.org/rss/1.0/modules/content/"><![CDATA[]]></content:encoded><description/></item></rdf:RDF>